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ABSTRACT 
This thesis will provide new information on carbohydrate and lipid metabolic control 
in various related physiological states both in vitro and in vivo in the rat model. 
Pregnancy is one such state which elicits many complex changes both physiologically 
and metabolically, one major consequence of which is the development of insulin 
resistance/glucose intolerance by the mother. The aim was to evaluate the mother's 
capacity to utilise glucose during the various stages of pregnancy. For the first time, 
an unrestrained un-anaesthetised rat model was used to produce indices of glucose 
utilisation (GUI) in a wide range of tissue types ranging from non-working postural 
muscles to continually contracting muscles like the heart. In the various fed 
conditions investigated, significant reductions in the GUI of up to 80% were seen 
during- late pregnancy in some tissues. A method of feeding was also applied to the 
pregnant model producing results contrary to normal pregnant glucose utilisation 
values ie. increasing the GUI up to 90% of normal pregnancy values in some tissues. 
Lipogenic rates in five major tissue sites were concurrently investigated which showed 
increases of between 2.2 and 4 fold during late pregnancy compared with virgin 
controls. Analysis of glycogen levels and an attempt to probe the pyruvate 
dehydrogenase activities of the heart and diaphragm in the various physiological states 
are also discussed. 
To obtain further insight into glycogen synthesis/non-oxidative disposal of glucose in 
the liver, a less invasive approach was then followed to explore, by non-invasive 
techniques, the extent to which insulin resistant states, like pregnancy, can be 
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explained by in vivo hepatic glucose metabolic studies. For this, carbon-13 magnetic 
resonance spectroscopy (MRS) was employed to determine the fate of 1-"C glucose 
in the liver of rats in the same physiological states as those studied in the above 
methodology. Bolus infusions of "C-glucose were administered into the hepatic 
portal vein of the rats under investigation. The incorporation or degradation of the 
glucose was followed in real time by observing rapid proton-decoupled carbon 
spectra. From this methodology, continuous real time glucose utilisation rates 
together with glycogen synthesis rates were measured. "C incorporation into the 
glycogen macromolecule was seen to be negligible in 20 day pregnant ad libitum fed 
rats however in routine meal fed (RMF - allowed free access to food for 2h per 24h 
day) 20 day pregnant rats, incorporation reached a level 2.3 fold higher than the 
former. Maximal increases of IIC incorporation were shown by the 10 day pregnant 
RMF rats which attained levels 2.4 fold higher than the 20 day pregnant RMF group. 
Results indicate an enhancement of the direct route for glycogen deposition during 
RMF regimes in pregnancy. 
A consequence to the above MRS study led an investigation into gluconeogenic 
control in the rat model. Gluconeogenesis is a major metabolic pathway which may 
be perturbed in insulin resistant states like non-insulin dependent diabetes mellitus. 
In this study "P MRS was employed as a tool to look at the relative changes in vivo 
of the hepatic phosphorus spectrum. This study involved external manipulation of 
hepatic gluconeogenesis by the infusion of alanine. Large increases in the 
phosphomonoester region of the phosphorous spectrum were seen both in vivo and in 
vitro which was secondary to increases in 3-phosphoglycerate. The inorganic 
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phosphates also increased dramatically together with concomitant declines in ATP 
both of which recovered to pre-infusion values. This study shows many promising 
features which could be applied to clinical studies in humans. 
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CHAPTER 1. 
1.1. Physiological and metabolic changes during pregnancy. 
Pregnancy has been characterised as producing a varied array of physiological and 
metabolic effects to both the mother and developing conceptus (foetus(es) and 
placenta(s). Pregnancy resembles an almost symbiotic partnership between the 
mother and foetus(es) in which any factors imposed onto the mother, whether they 
be environmental or metabolic, may threaten foetal development. Most of the 
changes brought about during pregnancy are hormonal, originating from both the 
mothers endocrine system and the placenta, which plays an ever increasing role as 
gestation progresses. - The changes to be discussed are essential for the continuous 
well being of the conceptus, ensuring its correct development, as well as the mothers 
well being. 
1.2. Hormonal changes during pregnangL 
The normal development of pregnancy is dependent on the secretion of specific 
steroid and polypeptide hormones. These hormones increase in circulation at the 
same rate as foetal growth (Tulchinsky and Ryan, 1980). Most of these hormones 
originate from the placenta (Everett and MacDonald, 1979; Tulchinsky and Ryan, 
1980) and influence a wide range of maternal metabolism. 
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1.2.1. Steroid honnones of gestation. 
Steroid and sterol precursors from both maternal and foetal blood are converted to 
progesterone and oestrogens (oestradiol, oestrone and oestriol). More specifically, 
progesterone is synthesised from maternal cholesterol; oestradiol and oestrone from 
maternal and foetal dehydroepiandrosterone sulphate, and oestriol from foetal 16 ct- 
hydroxydehydroepiandrosterone sulphate (Diezfalusy, 1969). Placental steroid 
production does not begin until week 7-8 of gestation in humans, therefore the initial 
supply of progesterone and oestrogen are met by the maternal corpus luteum. 
1.2.2. Polypeptide hormones of gestation. 
The principle Polypeptide hormones synthesised by the placenta include the human 
chorionic gonadotropin (hCG) and the growth hormone-like human chorionic 
somatomarnmotropin (hCS) [placental lactogen (hPL)j, a full list is shown in Table 
1. These hormones can be detected in the maternal blood system 5-10 days post 
conception in humans. 
Tabk 1. Placental polypeptide hormones of iDreenane 
Human chorionic gonadotropin (glycopolypeptide, 39 000 MW) 
Human chorionic somatomammotropin (single chain polypeptide, 22 308) 
Human chorionic corticotropin and 6-endorphin 
Human chorionic thyrotropin 
Human chorionic follicle stimulating hormone 
Human uterotropic placental hormone 
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1.2.3. Synopsis of the metabolic effects of speciflc hormones during pregnaLaM 
The physiological role of a given hormone is difficult to assess since considerable 
interactions occur. The effects of progesterone on maternal metabolism include 
increased tubular reabsorption of sodium (Davey et al., 1961; Gray et al., 1964), an 
increase in respiration and an increased sensitivity of arterial smooth muscle cells to 
angiotensin 11, preventing hypertension otherwise associated with elevated levels of 
this compound (Everett et al., 1978). It is thought that progesterone may also play 
a significant role in stimulating triglyceride uptake by maternal adipose tissue sites. 
However there is a degree of controversy depending on the animal model used. A 
study on pre-menopausal women, who have elevated progesterone levels, showed 
increases in plasma triglyceride removal (Kissebah, 1973), however only small 
increases were seen in late pregnant rats (Kim and Kalkhoff, 1975). Oestrogens are 
thought to play an important role in lipid , protein and vitamin metabolism. Human 
studies have shown that administration of progesterone and oestrogen alone, in 
starved individuals,, produced no net effect on circulating glucose, alanine and ketone 
body concentrations. However when both hormones are administered, states of 
ketonaemia, triglyceridaemia and hypoalaninaemia together with the elevation in free 
fatty acid circulation (see above) are seen, but plasma glucose levels remain constant 
(Morrow et aL, 1981). It is likely that these hormones have an ever increasing 
collaborative role in eliciting the above effects during pregnancy and consequently 
reducing maternal insulin sensitivity, despite hyperinsulinaemia through increased 
pancreatic islet secretion. 
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Human chorionic somatomammotropin is the major hormone responsible for elevated 
free fatty acids (Samman et aL, 1968), in the maternal blood, and a contributory 
factor to the insulin resistance seen in late pregnancy (see section 1.8. ). Finally, 
human chorionic gonadotropin is also thought to have a minor role in lipid 
mobilisation, but also is thought to act as an immunosuppressive agent thus preventing 
blastocyte rejection (Younger et al., 1969). 
1.2.4. Hormonal effects on maternal dietaEl intake during pregnancy. 
The exponential growth of the conceptus places an increasing nutritional demand on 
the mother, reflected in the increased maternal food intake, during the course of 
gestation in the rat, see Table 5. This increase in maternal nutrient consumption is 
controlled by a number of interacting physiological and metabolic factors. 
Progesterone and oestrogen have both been implicated in changes in the dietary intake 
(Hervey and Hervey, 1967). In this study progesterone was administered to virgin 
rats resulting in increased food consumption. The opposite was seen when oestradiol 
was administered to rats, which can act as an opiate receptor antagonist (Morley et 
al., 1984), by decreasing the response to ketocyclazocine, a kappa agonist which also 
stimulates feeding (Mclaughlin et al., 1983). Another important factor is the gradual 
increase in the conceptus mass which naturally implies a greater nutrient supply for 
the foetus(es) as well as for the mother. ' The physical consequence of an increased 
conceptus weight results in an extra nutrient requirement for day to day mobility. 
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Maternal blood flow 
1.3.1. Distribution and reeulation of maternal blood flow durine Dreenanc 
Placento-foetal development invokes an increase in nutritional and respiratory 
demands on the mother. These demands are met by the expansion of the blood 
volume to supply the extra mobilized metabolites and oxidisable substrates together 
with the increased oxygen quotient required by the rapid metabolism of the foetus(es). 
Any disruptions in supply to the conceptus can cause developmental abnormalities. 
Therefore maternal blood flow undergoes dramatic changes to cope with the extra 
demands associated with gestation. The changes seen in blood volume represent 
increases in blood cell mass as well as plasma volume. Increase in blood cell mass, 
representing 30% in man (Pritchard, 1965), is thought to be influenced by a variety 
of hormones which include progesterone, placental lactogen, and oestrogen (Jepson, 
1968), together with erythropoietin, a specific hormone for erythrocyte production. 
Plasma volume expansion involves greater fluid retention, controlled by increased 
sodium reabsorption and influenced by aldosterone (Ehrlich, 1971), as well as an 
increase in the circulating protein pool which involves movement of interstitial 
albumin into the vascular system, rather than synthesising new albumin (H6nger, 
1968). 
Blood flow changes have been investigated and have shown a variety of responses, 
these include an increased blood flow to the uterus of 25-fold in the average sized 
woman (Assali et al., 1960) as the development of the placenta and foetus demand 
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an increased transfer rate of vital catabolic products, oxygen and foetal waste. The 
rat uterine system requires blood flow not to just one conceptus, but an average of 12 
implying an even greater bulk flow of blood, and hence the importance of this model 
in pregnant studies. Studies conducted on pregnant rats, where uterine blood flows 
were restricted by uterine artery ligation or embolism of the uterine vasculature, 
resulted in retarded growth in both the placenta and foetus (Wigglesworth, 1964). 
Increases in blood flow of up to 75% (Tindall, 1975) and 50% (Sims and Krantz, 
1958) in the maternal liver and kidneys respectively, reflect the increases in 
metabolite processing by the mother, to control substrate and waste product levels of 
both mother and offspring, see section I. I. Two other areas of blood flow increase 
include the vascular system of the skin (Hytten and Leitch, 1971) and the mammary 
glands. The mammary glands during the latter stages of gestation require a continual 
supply of substrates for maternal milk production, reflected in the high enzyme 
activities of lipoprotein lipase [EC 3.1.1.341 and 3-hydroxybutyrate dehydrogenase 
[EC 1.1.1.301, during lactation (Crabtree and Newsholme, 1972). Various human 
studies on skin vascularity have shown increases in the feet and hands while the 
forearm-and leg remain constant. 
1.3.2. Effects of starvation on blood flow during pregnancy. 
During prolonged starvation periods fat mobilisation - (Tyson et al., 1971), 
glycogenolysis and gluconeogenesis are enhanced (Freinkel, 1972; Felig et aL, 1972), 
under the control of catecholamine, glucagon and placental lactogen release. 
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Concurrently, there are distinct changes in blood flow to various regions of the 
mother. In a study on sheep there was a significant reduction in blood flow to the 
uterine system of 25 % (Morris et al., 1980). Reductions were also seen in the skin 
and mammary glands. However blood flow to the liver increased. These changes 
are thought to be due to concentration fluctuations of prostaglandins (Wallenburg, 
1981), oestrogen (Meschia, 1975), angiotensin II (Ferris et al., 1972) and 
catecholamines (Barton et al., 1974). During the fasted state the vasoconstrictive 
hormones such as the catecholamines, angiotensin 11 and oestrogen are elevated, thus 
reducing blood flow to the uterus. Under normal nutritional conditions, naturally 
occurring prostaglandins are thought to interact with the other vasoactive compounds 
resulting in the net increase in vascularity. 
1.3.3. Cardiac output and blood volume during pregnancy. 
There are two significant implications of elevated blood flow to the various organs 
during pregnancy, firstly a substantial increase in circulating blood volume and 
secondly, an increased cardiac output. The increase in cardiac output results from 
an initial increase in stroke volume, reflected in a small degree of hypertrophy, see 
section 3.1., followed by a more gradual increase in heart rate nearer term (Hytten 
and Leitch, 1971). Cardiac output increases occur more rapidly during the second 
and third trimester with a term output 40% higher than pre-gestation in pregnant 
ewes, compared with non-pregnant values (Metcalfe et al. 1966). From this value 
it was estimated that 24% of the increase represented the extra flow for the provisions 
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of the uterine system (Clapp, 1978) and hence cardiac output increases were primarily 
due to the expansion in flow through this "organ". Therefore, cardiac output during 
pregnancy is more a function of stroke volume rather than time. 
1.4. Energy demands imposed onto to heart during pregnancy 
The heart is a continually contracting muscle, producing a sufficient pressure to pump 
blood around the body. During pregnancy, the blood capacity of the vascular system 
is greatly increased, which places more strain on the heart to perform at its optimal 
capacity under the ever changing physiological and functional aspects of pregnancy. 
This extra strain on the heart must be met by the utilisation of additional oxidisable 
substrates to produce the required ATP levels associated with this extra demand. 
During a normal fed state the heart is an aerobically respiring organ obtaining its 
energy requirement largely from glucose and lactate, but in states of exercise or 
starvation, the heart utilises an increasing amount of lipid derived fuels for its 
contractile activity. The heart, therefore has the advantage of having the capacity to 
utilise a variety of different fuels such as glucose, ketone bodies, lactate and amino 
acids depending on nutritional status. Experiments have shown for example, that 
perfusing the heart with high concentrations of fatty acids and ketone bodies 
(breakdown products from long chain fatty acids in the liver), as would -be the 
situation during a period of starvation, can cause a suppression in glycolytic activity 
of the heart and hence, increase B-oxidation of fatty acids to ketone bodies and 
probably more importantly, the oxidation of free ketone bodies to acetyl CoA (Randle 
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et al., 1964), seefigure L. Utilisation of circulating ketone bodies probably prevails 
over the utilisation of fatty acids for two reasons. Firstly, before fatty acids can be 
oxidised by the heart, they need to be transported in a non-toxic form and so are 
associated with albumin. Association with this protein will decrease the relative 
amounts of free unbound fatty acids, and hence diffusion rates into the cell will be 
very much reduced. Secondly, oxidising the long chain fatty acids in the liver, rather 
than in the peripheral tissues, produces ketone bodies which are readily soluble in the 
blood and easily transported across plasma membranes. With this in mind, ketone 
bodies can play a very important role during starvation states when glucose levels are 
relatively low. Due to their ease of extracellular and intracellular transport, ketone 
bodies can act in a buffering capacity to provide an alternative source of energy for 
the heart. 
1.5. Conc ments. 
1.5.1. Substrate suPPIv to the foetus(es). 
Any disruption in placental function may produce adverse affects on the development 
of the young and in this respect the placenta is better equipped to sustain disruptions 
to normal metabolism than the foetus. All nutrients required by the foetus must pass 
the synciotrophoblast and cytotrophoblast, before entering the foetal blood-stream. 
This is achieved by a number of transport mechanisms namely, simple and facilitated 
diffusion, active transport and endocytosis. Water supply to the foetus(es) however, 
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is dependent on the osmolarity and hydrostatic differences between mother and foetus. 
Carbohydrates are transported to the foetus by facilitated diffusion via stereospecific 
carriers with a high K. for maternal glucose (Leturque et al., 1987). 
Requirements of the conceptus mass increase exponentially as gestation progresses 
and so development is totally dependent on the mothers ability to provide the 
substrates required for foetal oxidative metabolism, storage compounds and new 
molecular synthesis at the same level. Most of the nutrient requirements depend on 
the rates of placental transfer and the ability of the nutrient to pass across the 
maternal-foetal blood membrane'via various transport processes. During the second 
half of gestation some nutrients can be obtained from the amniotic fluid via 
swallowing, however, this route is negligible in comparison to the more direct route. 
1-5.1-1. Afflmhno 
-acids. 
The foetus has a very high dependence on the 10 essential amino acids for protein 
synthesis and catabolic processes. Studies of foetal lambs indicate that 50% of 
maternally derived amino acids are retained by the foetus (Rattray et al., 1974; 
McDonald et al., 1979) and the rest catabolised to urea, ammonia, glutamate 
production and oxidation (Gresham et al., 1972; Holzman et al., 1977; Lemons and 
Schreiner, 1983; Krishnaumurti and Kitts, 1982). The neutral and basic amino acids 
traverse the placenta by a concentration dependent active transport system (Holzman 
et al., 1979). 
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1.5.1.2. Lipids. 
Lipids are thought to be a minor metabolic fuel for the foetus (Battaglia and Meschia, 
1978) but uptake is high, depending on maternal dietary intake and the rate 
differences in placental transfer seen in various species. Lipid uptake is prevalent 
during the second half of gestation and accelerated near term [human] (Ziegel et al., 
1976) and is primarily for accumulation as a postpartum fuel reserve. Lipids can 
also be synthesised by the foetal liver and adipose tissue sites from 2 and 3 carbon 
glucose metabolic products and amino acids. Free fatty acids and cholesterol transfer 
easily across the placenta, whereas triglycerides and phospholipids must be 
metabolised by the placenta before entering the foetal blood circulation (Noble and 
Shand, 1981). 
oucose. 
Amino acids and lipids are both essential requirements but it seems glucose is by far 
the most important metabolite, see section 1.8.. In humans, glucose-oxygen quotient 
values suggest that 80% of the daily energy requirement of a near term foetus is 
provided by glucose (Morris et al., 1975). This transcribes to a total of 
approximately 40 g/day (Rosso and Lederman, 1984) of glucose required by the 
foetus for the demands on energy and glycogen, lipid, glycoprotein and 
mucopolysaccharide synthesis. In the normal adult woman, total glucose turnover is 
approximately 200 g/day (Kalhan et al., 1979). During normoglycaemic conditions 
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in the rat, the conceptus uses glucose as its primary fuel substrate. However, during 
periods of starvation and hence hypoglycaemia, ketone bodies can be utilised as 
precursors for energy generation and lipid synthesis (Robinson & Williamson, 1980; 
Edmond, 1974; Leturque et al., 1987). Ketone bodies have been shown to pass 
easily across the placental barrier in rats and humans, depending on maternal 
concentrations (Girard et al., 1977; Kim & Felig, 1972). This is a very important 
consideration since both humans and animals are easily susceptible to ketosis during 
pregnancy (Felig & Lynch, 1970; Scow et al., 1964; Girard et al., 1977); Miodovnik 
et al., 1982). 
1.6. Background to fuel selection 
1.6.1. CarbjhXdEgLAjaggggMgflLqLlhLflyM 
The liver has an enormously varied role as an organ of storage, supply and 
detoxification of blood. Without the organ, life would last for only 6 hours due to 
severe hypoglycaernia and the accumulation of toxic metabolites within the blood. 
Its role in the homeostatic control of blood glucose levels during adverse 
physiological conditions such as starvation, diabetes mellitus and insulin resistance 
during pregnancy, is by far the most important aspect and is one which this thesis has 
concentrated on. During periods of feeding, carbohydrates are transported to the 
liver for accumulation to glycogen. As blood glucose levels fall following feeding, 
the liver will break down glycogen to glucose, to be released into the blood supply 
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as free glucose. Normoglycaemic conditions are maintained by glycogenolysis during 
short term starvation, however during periods of prolonged starvation (> 24h), 
glycogen stores become depleted thus stimulating gluconeogenesis from protein 
derived amino acids together with increased fat mobilisation. The important hepatic 
pathways of gluconeogenesis, glycogen synthesis, glycogenolysis, lipogenesis and 
lipolysis are outlined below (seefigure 1. ). 
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1.6.2. Blood glucose homeostasis and fuel selection during the fed-starve 
transition. 
The nutritional and physiological states of the animal depict the contribution of 
glucose, free fatty acids and ketone bodies to the respiratory fuel selection of the 
major tissues. The liver has a unique role of storing and processing these subunits 
from triacylglycerol (producing subunits of fatty acids and ketone bodies) and 
glycogen (producing glucose subunits, a process also prevalent in muscle where 
glucose- I -phosphate subunits are produced). During a fasting period, glycogen will 
be broken down in both the liver and muscle to maintain blood glucose levels. 
However, glycogen stores in both rat and man are largely depleted after a 24 h 
starvation period. Triacylglycerols, which produce five times more energy than 
glycogen, gram per gram, are then relied on to a greater extent. Unfortunately, not 
all cells can survive solely on fat derivatives but require a constant supply of glucose 
at a level exceeding 2.2 mmol/l. Such cells include erythrocytes, those of the renal 
medulla, lens and some from the small intestine, all of which do not possess 
enzyme(s) required for B-oxidation. The brain and some cells of the central nervous 
system could be categorised as also being glucose dependent. However, these cells 
do have the capacity to'adapt to utilising high concentrations of ketone bodies (N. B. 
free fatty acids cannot pass across the haemato-encephalic barrier). - In order to supply 
glucose to cells dependent on glycolysis amino acids from protein degradation, are 
transported to the liver (see figure 1. ) for gluconeogenesis. Gluconeogenesis is 
thought to play an very important role during short term starvation, IDDM, glycogen 
storage diseases, NIDDM and other insulin resistant states such as pregnancy, as well 
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as being a mechanism for supplying glucose for glycogen synthesis. Gluconeogenic 
pre-cursors include glycerol, lactate, pyruvate and amino acids (notably alanine), (see 
chapter 6. for further discussion on the control and mechanism of this pathway). In 
order to conserve glucose reserves, regulatory mechanisms at enzymatic levels exist 
which switch fuel selection predominantly towards fat utilisation. After an overnight 
fast in humans in comparison with the fed state, on an average Western diet, the 
contribution of fat to the fuel requirement increases from 33% to 70% with a 
concomitant decrease in carbohydrate selection from 50 % to 12 %. This mechanism, 
known as the glucose-fatty acid cycle protects against accelerated hypoglycaernia and 
depletion of protein reserves. The glucose-fatty acid cycle is hormonally 
independent, relying solely on the competition of the relative concentrations of 
glucose and free fatty acids. However, it is the consequence of hormone action. 
1.6.3. The conservation and regulation of carbohydrate. 
During a period of starvation the insulin/glucagon ratio is decreased, this promotes 
glycogenolysis in liver and muscle together with increased lipolysis from adipose 
tissue sites, producing glycerol and non esterified fatty acids (NEFA) which 
competitively inhibit glucose utilisation by the muscles (especially the oxidative 
working muscles). The hypoinsulinaernic state directly "de-stimulates" glucose uptake 
and oxidative phosphorylation by skeletal muscle, and the elevated glucagon levels 
elevate the intrahepatic concentration of cyclic AMP, hence promoting glycogenolysis 
and gluconeogenesis (due to increased transport of amino acids to the liver) in the 
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liver. The control of complete oxidation of carbohydrate is tightly controlled by one 
particular enzyme, the pyruvate dehydrogenase complex (PDH), as flux mediated by 
this enzyme represents an irreversible loss of carbon as carbohydrate for which there 
is no known mammalian system for re-synthesis. The PDH complex is inhibited by 
the increased activity of PDH kinase, which phosphorylates the complex, due to the 
elevated mitochondrial levels of acetyl CoA/CoA, NADH/NAD1 ratios (Kerbey et 
aL, 1977) (from B-oxidation of fatty acids) and cyclic AMP levels. Increases in the 
citrate pool, due to 8-oxidation, have a de-activating allosteric effect on the 6- 
phosphofructo-l-kinase [EC. 2.7.1.111 (together with the indirect action of glucagon 
via cyclic AMP) activity reducing fructose 1,6 bisphosphate concentrations and 
causing a build up of fructose-6-phosphate and glucose-6-phosphate which further 
inhibit uptake of circulating glucose. 
1.6.4. The effects of meal feeding on heDatic fuel devosition 
The metabolic adaptations acquired upon placing rats on strict feeding regimes, where 
food is available for a few hours in a day ("meal-feeding"), was first shown by 
D ickerson et al. (1943) and Tepperman and Tepperman (195 8). These groups noticed 
increased lipogenic rates in liver slices of meal fed rats, compared with ad libitum fed 
rats, when incubated with 14C_Iabelled acetate or glucose. Pallardo and Williamson 
(1989) compared glycogen, fatty acid and cholesterol synthesis rates in ad libitum and 
routinely meal fed (RMF) rats and showed 6-fold higher total lipid (fatty acids and 
cholesterol) synthesis rates upon refeeding in the RMF group. Glycogen synthesis 
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rates in the two groups however, were comparable, with slight increases seen 90 min 
after the start of refeeding in the RMF group. In general, lipid synthesis was shown 
to be greatly enhanced at all time intervals following re-feeding and more importantly 
the lipogenic response time to re-feeding was significantly reduced. Since the rate 
of glycogen synthesis was similar in the two groups, carbohydrate flux in the RMF 
group must be greatly enhanced. One explanation could be that glycogen is repleted 
directly from glucose units rather than through the indirect route of gluconeogenesis 
(see section 5.3.4. ), ie both glycolysis and direct glycogen synthesis could be 
operating at near maximal rates. However, a similar study by Holness and Sugden 
(1989), failed to show the same levels of glycogen synthesis within the two groups 
following 60 mins after refeeding. Hepatic PDH activity was also measured during 
re-feeding, showing 14-fold increases 60 min into re-feeding compared with ad 
libitum rats. PDH activity continued to remain higher after 2h of refeeding. These 
results suggest increased glycolysis and therefore carbon loss to supply the acetyl 
CoA requirements for lipogenesis. Unfortunately this study did not measure lipogenic 
rates to confirm the findings of reduced glycogenesis and increased PDH activity. 
1.7. Glycaemic control during pregnaaM 
Pregnancy constitutes a very important nutritional stress upon the mother where very 
strict control of substrate oxidation has to be employed so as to protect both the 
mother and foetus(es). During pregnancy plasma glucose decreases to hypoglycaernic 
levels during the post absorptive state (4-6 hours after the last meal) (Scow et al., 
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1964; Knopp et al., 1973; Herrera et al., 1969). This decrease in plasma glucose 
levels can be looked upon in two different ways; firstly, it could be the direct result 
of the haemodilution effect caused by the expansion in blood volume (Kalhan et al., 
1979). Secondly, it could be the consequence of the developing foetus placing an 
increased glucose demand on the mother who cannot accelerate glucose production 
at the levels required. (Spellacy, 1975; Adam and Felig, 1978). This glucose decline 
becomes more interesting when you bring in two other facts of pregnancy. Firstly, 
during the course of gestation glucose turnover increases at the same rate as the 
growth of the conceptus but total turnover per kg body weight remains the same 
(Leturque et al., 1981; Ogata et al., 1980). This implies that hypoglycaernia is not 
a result of the haemodilution effect unless blood volume increases disproportionately 
to the increase in body size. The second, is that the mother's tissues develop a 
degree of insulin resistance, (Leturque et al., 1984; Leturque et al., 1986; Hauguel 
et al., 1987) therefore, decreasing their capacity to utilise glucose. So despite an 
increased turnover of circulating glucose, in parallel with the growth of the conceptus, 
and a reduced maternal glucose utilisation, blood glucose levels still decrease. This 
then raises two questions, to what degree are the mothers' tissues insensitive to the 
insulin action and do the developing foetus(es) constitute a major drain on the 
maternal glucose pool (see chapter 3. )? 
Thus far a very general insight into the metabolic control of the mother during 
pregnancy has been given but the events are far more intricate as the variables are 
considered. Glucose metabolism is very closely controlled by one hormone in 
particular, insulin. Insulin is a relatively small polypeptide produced by the 6-cells 
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of the islets of Langerhans in the pancreas. This hormone has far reaching effects 
on the metabolism of various fuel substrates depending on the nutritional status of the 
subject. Its actions include the control of glucose metabolism, in the liver and 
muscle; lipid synthesis rates in the liver and adipose tissue sites together with protein 
breakdown, and various aspects of protein metabolism. Its regulatory action of 
control is at the enzymatic level where a particular regulatory enzyme in a particular 
metabolic process is targeted. The most important of these enzymes include pyruvate 
dehydrogenase, glycogen synthase, acetyl-CoA carboxylase, phosphorylase kinase, 
3-hydroxy-3-methylglutaryl-CoA (HMG) reductase and triacylglycerol lipase. 
Pyruvate dehydrogenase, a multi-holoenzyme (consisting of 3 different polypeptide 
chains; El, pyruvate decarboxylase; E2, lipoate acetyltransferase; E3 lipoamide 
dehydrogenase) catalysis the irreversible conversion of the 3-carbon pyruvate 
metabolite to the 2-carbon acetyl CoA. Its regulation controls the relative rates of 
glycolysis and hence, the rates of complete oxidative phosphorylation of carbohydrate 
substrates. It is important to note that maternal insulin cannot pass across the 
placenta to the foetus therefore it cannot influence foetal glucose utilisation which is 
accomplished by foetal insulin. However it can be bound to the placenta and even 
degraded in both human (Freinkel and Goodner, 1960) and rat placentas (Goodner 
and Freinkel, 1959). Another important feature is the production of acetyl CoA 
resulting in a carbon loss, a non-recoverable state. Following this conversion 
gluconeogenesis cannot be performed. However, lipogenesis can be activated, since 
an accumulation of acetyl CoA, a precursor for lipid synthesis, will activate the acetyl 
CoA carboxylase enzyme in the adipose tissue sites under the correct metabolic state, 
controlled by insulin. Glycogen synthase and HMG CoA reductase, like pyruvate 
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dehydrogenase and acetyl CoA carboxylase, both increase in activity as insulin 
activities increase due to a high carbohydrate input. Phosphorylase kinase and 
triacylglycerol lipase both decrease in activity in the presence of high insulin 
concentrations, resulting in an elevation in glycogen and triacylglycerol. Hormonal 
regulation of these key regulatory enzymes determines the type of substrates oxidized 
in various nutritional states. 
1.8. Maternal insulin resistance during pregnancy. 
As previously mentioned, pregnancy exerts a state of insulin resistance on the mother. 
The extent and progression of this resistance has never been fully explained in the 
animal model, due to experimental restrictions, but such models have shed some light 
on this phenomena. Early studies by Knopp et al. (1970) showed that large doses of 
exogenous insulin did not increase glucose utilisation in late pregnant rats whereas, 
increases were seen in virgin rats suggesting a decreased response by maternal tissues 
to hyperinsulinaemic states. Further studies in humans and rats demonstrated in vivo 
insulin resistance by various tissues (Burt, 1956; Kalkoff et al., 1964; Costrini and 
Kalkhoff, 1971; Leturque et al., 1980). Leturque et al. (1984a), showed, by using 
euglycaemic-hyperinsulinaemic clamp techniques, that insulin insensitivity involves 
tissues which utilise glucose as well as those which produce it. This study implied 
a wide ranging tissue type sensitivity including skeletal muscle, adipose tissue sites 
and the liver. However depending on the technique used, opposing views on tissue 
sensitivity have been reported. A study by Rushakoff & Kalkhoff (1981) reported 
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decreased rates of insulin stimulated glucose uptake by perfused hind-limb in starved 
pregnant rats compared with starved virgin hind-limb. However, a similar study by 
Leturque et al., (1981a) using isolated rat soleus muscle showed no insulin 
stimulation of [U-"Clglucose uptake and utilisation. Studies on isolated adipose 
tissue (Leake & Burt, 1969; Knopp et al., 1970) reported the same situation where 
no differences were seen in insulin stimulated [U-j'Clglucose utilisation by the tissue 
in late pregnant and virgin rats. These studies suggested that pregnancy did not 
induce insulin resistance in these particular tissues. It has been suggested, that from 
the studies on isolated soleus muscle (Leturque et al., 1981), isolated adipocytes 
(Leturque et al., 1984) and isolated hepatocytes (Davidson, 1984), insulin resistance 
shown in vivo but absent in vitro could be accounted for by a loss of circulating 
factors inducing insulin resistance under normal gestational metabolism. During 
pregnancy hormones such as progesterone (Sutter-Dub et al., 1973) and placental 
lactogen (Shiu et al., 1973) are at an elevated level together with lipid fractions ie 
triacylglycerol and non-esterified fatty acids (Scow et al., 1964;, Knopp et al., 1973). 
Elevation of any one of these compounds is known to counteract the action of insulin 
(Kalkhoff et al., 1978) and therefore can be regarded as a contributory factor toward 
maternal insulin resistance. 
Insulin insensitivity by the various tissues during late pregnancy places the mother 
under a false state of "starvation" due to the reduced amount of glucose it can now 
utilise. This must therefore imply greater utilisation of other oxidisable substrates 
such as ketone bodies from fatty acid degradation in the liver but also from free fatty 
acids and amino acids. The nutritionally related metabolic changes of pregnancy are 
thought to be a mechanism by which the mother can accommodate sufficient 
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substrates for the exponential growth of the developing conceptus. By imposing onto 
itself a decreased capacity for glucose utilisation, the mother allows the foetus(es) to 
take advantage of the extra circulating glucose. If this is the case, glucose must be 
a preferred fuel substrate for foetal growth, possibly due to its ease of transport in the 
mother's blood, as well as across the synciotrophoblast and cytotrophoblast into the 
foetal blood. Alternatively, the enzyme systems for complete oxidative 
phosphorylation in the conceptus are better developed compared with systems 
requiring other substrates for the production of energy releasing phosphate rich 
compounds. Circulating glucose in the mothers extracellular pool is, therefore, 
indirectly diverted away from the mothers intracellular metabolic systems by the 
progressive insulin resistance developed by the various tissue types. Pregnancy 
therefore produces a situation similar to a starved state by decreasing the ability of 
the mother to use the otherwise abundant glucose. The decrease in maternal glucose 
utilisation is essential for the well being of foetal growth and development and can 
be seen to be vitally required when the rates of glucose utilisation in the conceptus 
is measured. A study by Leturque et al. (1986) set out to measure glucose utilisation 
rates of the conceptus and found that in a rat of 10 foetuses and 10 placentas the rate 
of glucose utilisation was 23% of the total maternal rate. These rates of utilisation 
are dependent on maternal and foetal glucose requirements, the K. of the carrier, 
foetal insulin levels [the foetal placenta is capable of secreting insulin at a very early 
stage of development (Girard et al., 1974)] and, during the early stages of gestation, 
maternal plasma glucose levels. Insulin sensitivity of the placenta is a matter of 
controversy but present knowledge indicates that in normoglycaernic conditions the 
insulin receptors of the placenta (Posner, 1974) are influenced by maternal insulin 
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levels. However, when blood glucose levels decrease, placental uptake is not 
compromised by exogenous insulin (Testar et al., 1985). Other studies involving 
different animal species have shown similar utilisation rates ranging of 30 % and 36 % 
in the sheep (Hay et al., 1983) and the rabbit (Gilbert et al., 1984), respectively. 
These studies enhances the idea that glucose is in fact a very important fuel 
requirement for the conceptus especially during the later stages of pregnancy. 
Decreased utilisation of glucose by maternal tissues reflects the increased circulation 
of ketone bodies cholesterol, triglycerides, free fatty acids, phospholipids and 
different lipoprotein fractions in the blood, producing a hypertriglyceridaemic state. 
Increases in both the very low density lipoprotein fractions (VLDL) and the high 
density lipoproteins (HDLP) fraction have been seen during the course of pregnancy 
(Knopp et al., 1986; FAhraeus et al., 1985; Warth et al., 1975). Elevation in the 
HDLP fraction is primarily due to the increase in the high density lipoprotein2 (HDI. 2) 
subfraction as well as the HDL3which are metabolised as an energy source for both 
mother and foetus as well as important for mammary milk production. These 
lipoprotein changes seen during gestation are not influenced by factors such as 
diabetes mellitus, hypercholesterolaemia, diet, obesity and body weight (McMurry et 
al., 1981; Warth and Knopp, 1977; Green, 1966) but thought to be controlled by the 
increases in progesterone and oestrogen. Increases in the plasma phospholipid 
fractions of sphingomyelin, lecithin and phosphatidylethanolamine have all been 
reported. However, lysolecithin plasma levels have shown marked decreases 
(Svanborg and Vikrot, 1965). By far the greatest increase in mobilisation is shown 
by the triglycerides which increase by 4.4 fold in normal pregnant individuals 
I 
Page 49 
(Svanborg and Vikrot, 1965). 
These two observations imply a gradual move of maternal tissues from carbohydrate 
to lipid utilisation. 
1.9. Pulpose of this study. 
Starvation in any physiological condition results in a degree of hypoglycaemia and an 
elevation in blood ketone body concentration (Felig and Lynch 1970). Blood glucose 
levels must be maintained above 2.2 mmol/l to adequately supply the brain with this 
essential oxidisable fuel substrate and hence starvation can be regarded as a life- 
threatening situation. Normoglycaemic conditions are maintained by degradation of 
hepatic glycogen stores under short term starvation. However during prolonged 
starvation, glycogen stores become depleted stimulating gluconeogenesis from protein 
derived amino acids together with increased fat mobilisation. During pregnancy 
glycaemic control is compromised. The mother must maintain sufficient control of 
glucose levels to provide her own needs together with the demands imposed by the 
foetus(es). As a consequence, maternal tissues tolerate prolonged periods of 
hypoglycaemia through maternal insulin resistance. This study set out to investigate 
the extent and progression of insulin resistance/glucose intolerance of various rat 
skeletal muscles as well as the heart, diaphragm and adipose tissue sites during the 
immediate absorptive and post absorptive phases. The studies discussed above have 
concentrated on only a very few muscle types and have not shown the comparison of 
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glucose uptake and phosphorylation by the various muscle types. Previous studies 
have concentrated on hind-limb muscles and a few adipose tissue sites but have not 
looked closely at the differences between oxidative and non-oxidative muscles and 
more importantly no studies have looked at the changes in the glucose utilisation 
capacity of the heart during the latter stages of pregnancy. The heart is by far the 
most important organ for consideration by virtue of its continual requirement for 
oxidisable fuels to maintain the high ATP levels required to sustain an ever increasing 
demand. For this simple reason glucose utilisation rates of the heart were measured 
during three stages of gestation along with the diaphragm, again a tissue with an 
obligatory high fuel requirement. 
If maternal nutritional supply is limited over prolonged periods during gestation, 
foetal development can suffer depending on the timing and extent of the food 
restriction. As restriction increases from day 1 of gestation net maternal and foetal 
weights decrease (Berg, 1965), resulting in infant mortality rates and disproportionate 
foetal development. Glucose utilisation rates were therefore assessed for pregnant 
rats placed on routine meal feeding regimes. This was to provide a potentially very 
interesting observation which could have further clinical applications. 
A major aim of this investigation was to perform the measurements of glucose 
utilisation on rats which were not under the influence of anaesthesia. Various studies 
previously mentioned have measured glucose utilization rates in different tissues in 
both the pregnant and non-pregnant states however, most of these studies have 
involved anaesthesia. The use of anaesthesia (sodium pentobarbitol) for glucose 
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utilization experiments has been shown to suppress uptake and phosphorylation by the 
diaphragm and soleus muscles (Penicaud et al., 1987). Therefore, in this study the 
glucose utilization rates in various tissues were investigated in un-restrained rats 
without the use of anaesthesia, during the experiment. The method employed required 
the catheterisation and surgical implantation of a specially designed cannula to the 
jugular vein of the rat. The procedure was performed so as to give no discomfort to 
the rat following surgery. The cannula was secured by various ties and channelled 
under the skin so as to emerge between the ears. This ensured no discomfort 
allowing un-hindered movement by the rat, as well as preventing the dislodgement 
of the cannula, see sections 2.1. & 2.2.. The rat provided an excellent model for 
pregnancy for a number of reasons. Firstly, the biochemical and physiological 
development of the foetus, and placenta have similarities to human. Secondly, there 
is a wealth of biochemical knowledge already associated with rat metabolism which 
can* be related to human. Thirdly, the rat shows similar eating habits during 
pregnancy to humans, where food is consumed erratically during the active hours. 
The two major differences between human and rat pregnancies are firstly the time 
scale involved for gestation where the rat can give birth within 21 days of conception 
compared with 9 months in humans. Secondly, the rat give birth to approximately 
12 off-spring, however humans give birth to on average just one. Both these 
differences imply the rat must regulate metabolic and physiological changes during 
pregnancy quicker to cope with extra nutrient requirements over a shorter space of 
time for a greater number of off-spring. Apart from these two differences the 
development of the foetus and placenta in the two models are very similar and so a 
good understanding of human pregnancy can be gleaned from rat studies. 
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CHAPTER 2. 
METHODS. 
2.1. Formation of cannulae (see figure 3). 
2.1.1. Tubing and equipment required. 
A= 20mm Portex ppIO non-sterile polyethylene tubing = "U-bend" [ID 
0.28mm, OD 0.61mml. 
B= 120mm Portex pp5O non-sterile polyethylene tubing = "Mainstern" [ID 
0.58mm, OD 0.96mml. 
C= l0mm Portex ppl. 00 non-sterile polyethylene tubing = "Half dumbell" [ID 
0.86mm, OD 1.52mm]. 
D= 50mm Portex ppI60 non-sterile polyethylene tubing = "Reinforced tubing" 
[ID 1.14mm, OD 1.57mml. 
E= 10mm PE60 (Becton Dickinson Intramedic) non-sterile polyethylene tubing = 
"Dumbell" UD 0.81mm, OD 1.37mml. 
F= 35mm Silastic (Dow Corning vivosil) elastic tubing [11) 0.12mm, OD 
0.25mml. 
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2.1.2. Method of formation. 
The "cannulae former" (Figure 2. ) was placed through tubing B. Onto the thin piece 
of wire (ID 0.27 mm) attached to the "former", tubing A was placed and pushed onto 
tubing B, over-lapping by 3-5 mm. Using a soldering iron, this area was gently 
heated to fuse the tubes together by squeezing the molten plastic between finger and 
thumb. Approximately 10-15 mrn below this area tubing B was gently heated and 
pushed from opposite directions so as to crimp the tubing. Tubing C was made into 
a "half dumbell" by allowing one end to be heated so that the tubing melted back 
upon itself, thus forming the dumbell shape. This tubings' internal diameter was 
increased by the use of a heated rod of diameter I. 1mm. Tube C was slid over the 
non fused end of B by 30 mm. Using a 2.0 mm diameter rod, tube D was enlarged 
at one end and then slid over tube C so as to make a tight seal. By starting at the 
dumbell end the tubings were heated until they went transparent and then fused by 
pressing and rolling with finger and thumb. This was repeated gradually all the way 
down to the end of tubing D, making sure that the different plastic tubings had melted 
completely and evenly over the "former". The "former" was removed and the fused 
tubings cleanly cut with a razor. Another piece of wire, covered with silicone fluid 
(Dow Corning 200/5CS), was inserted into tubing A and tube F slid firstly onto the 
wire and then onto tube A by approximately 4 mm. This was not heated as the seal 
is quite adequate. A dumbell was constructed with E in the same way as with tube 
C except this time both ends are treated. The dumbell was placed over the junction 
of A and F. A "U-bend" was produced by bending tube A around a nail set in a 
board, the tubingwas then placed into boiling water for 5 seconds and then into cold 
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water for 5 seconds. The cannulae were tested for leaks by injecting distilled water 
from a syringe through the reinforced end of the cannula while obstructing the 
passage at the silastic end. 
2.2. Method for atrial cannulation. 
N. B. All cannulations were carried out 5-7 days prior to the actual experiment, so 
as to allow sufficient time for recovery from the surgery. The meal fed group were 
cannulated in the same way. However, surgery was performed on either day 12 or 
13 of gestation at 16: 00 so as not to interfere with their meal feeding regime. 
Age-matched female albino Wistar rats maintained at 18-20 *C and constant humidity 
were housed on a 12h light/12h dark cycle. Rats were allowed free access to a 
standard chow diet (except the meal fed group) consisting of 52 % carbohydrate, 15 % 
protein, 3% fat and 30 % non-digestible residue. The RMF group were housed in a 
reverse light/dark room [light off 10: 00/light on 22: 001 and allowed free access to 
chow for 2h per 24h day (between 10: 00 and 12: 00) from day 9 of pregnancy. The 
rat was anaesthetised with an intramuscular injection of HypnormTI (1.0 mi/kg 
Janssen Pharmaceuticals Ltd., Grove, Oxford. ) [fentanyl citrate (0.315 mg/ml) and 
fluanisone (10 mg/ml)] followed by an intraperitoneal injection of Diazepam ([5 
mg/ml] Phoenix Pharmaceuticals Ltd. ] (1. Oml/kg). This type of anaesthesia takes 
effect within 5-10 minutes and lasts for approximately I hour. The anaesthetised rat 
was placed on a heating blanket maintained at 37"C and secured by its feet with 
masking tape. The skin was cut just below the thoracic cavity to a point parallel to 
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the left fore-limb, the inner body cavity wall was then carefully cut and the inferior 
jugular vein exposed by carefully pulling away surrounding tissue with curved 
forceps. The jugular vein was gripped with curved forceps and a small hole made 
with a blue needle (23G MOO mm). A cannula, which was filled with saline (0.9% 
NaCl w/v) and attached via an extension tubing (tube B see section 2.1.1. ) to a1 ml 
syringe also containing saline, was carefully inserted into the vein until all the silastic 
tubing had entered into the jugular vein and hence, the right atrium of the heart. A 
length of cotton (ca. 20 cm) was tied around the middle of the dumbbell, see section 
2.1.1., so as to leave two ends of cotton which are used for anchoring the cannula. 
Each end of the cotton was secured into muscle just below the area of cannulation. 
It was important to ensure that the cotton showed no slack to prevent the tubing from 
easing its way out of the vein. Another length of cotton was tied around the crimped 
area of the cannula and secured around muscle. The "U-bend" was positioned inside 
the thoracic cavity; this procedure requires the use of forceps to clear away tissue to 
producing room to position the "U-bend". The skin cavity was sutured (Ethicon 
thread) from the thoracic cavity downwards, leaving one stitch short to allow the 
"the borer" see figure 2., to be inserted between the skin and body cavity. The 
"borer" was pushed under the left fore-limb and then directed towards the back of the 
head. At a point between the ears the "borer" was forced through the skin, hence 
producing a hole. With the "borer" in position the cannula was disconnected from 
tube B and re-attached to the end of the "borer". The "borer" was gently pulled out 
through the opening between the ears to allow the emergence of the cannula through 
this opening. The cannula was reconnected to the syringe extension and tested for 
blood withdrawal. The small exposed area at the chest was then sutured. 
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l50xO. 57mmDIA 20X0.27mmDIA 
a) "Former" 
Cannula attached 
here 
Sharpened end 
to pierce skin 
b) "Borer" 
Total length = 200mr 
Maximum width =I 
Figure 2. Cannula lormer" and "borer". 
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Figure 3. Diagram of cannula. 
Reinforced 
tubing 
Total length = 100 - 120mm 
Crimped mainstem '**-A. 
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and U-bend 
Dumbbell 
77 
Silastic tubing 
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The half dumbbell (see section 2.1.2. ) was located under the skin and a small incision 
made so as to expose it. Two sutures were placed in front and behind the half 
dumbell so as to secure the cannula at this point. The incision was sutured and the 
cannula tested for blood withdrawal. A blue needle was cut from its base and both 
ends sealed, this was then placed into the end of the cannula to prevent blood 
escaping and/or air entering the cannula. 
The rat was placed back into the cage on top of a layer of tissue and the cage placed 
on top of a heating blanket until recovery from the anaesthesia. 
2.3. Glucose utilisation measurement in various rat tissues. 
2.3.1. Introduction. 
The method of glucose utilization is based on the method by Sokoloff et al. (1977) 
who measured glucose utilization rates in the brain by using the kinetic and metabolic 
properties of 2-deoxyglucose. This carbohydrate has been shown to behave in a 
similar fashion on contact with cell tissue as glucose. Uptake and phosphorylation 
of this compound, which represents the glucose utilization index, shows little 
discrimination compared with glucose and hence is a useful substrate when labelled 
either as 2-deoxy["'Clglucose or 2-deoxy['Hlglucose. The principles behind using 2- 
deoxyglucose lies in the fact that it is transported by the same carrier as glucose 
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(Kipnis and Cori, 1959; Olefsky, 1975; Rennie et al., 1983) and that phosphorylation 
is by hexokinase. There is, however, one important difference from glucose ie when 
it has been phosphorylated to 2-deoxyglucose-6-phosphate, metabolism goes no 
further. If concentrations of glucose-6-phosphatase (Lackner et al., 1984) are 
negligible, then the 2-deoxglucose-6-phosphate will be trapped within the tissue and 
its relative quantity measured after tissue digestion and scintillation counting. An 
index of glucose utilization can only be determined if the relative amounts of 
phosphorylated 2-deoxyglucose and the un-phosphorylated form can be differentiated, 
since simple uptake through carriers in the plasma membrane are no measurement of 
utilization. After the 2-deoxyglucose has been phosphorylated then the utilization of 
glucose by the particular tissue can be assessed. A method of separation of 2- 
deoxyglucose from 2-deoxyglucose-6-phosphate is by using the properties of 
perchloric acid and Ba(OH)2/ZnSO4 (Somogyi, 1945). The perchloric acid will not 
precipitate out either form of 2-deoxyglucose whereas the 'Somogyi reagent' 
(BaSO, /Zn(OH)2 Will only precipitate out the 2-deoxyglucose-6-phosphate. By 
counting the amount of radioactivity in both fractions the relative amount of 2- 
deoxyglucose-6-phosphate can be measured. Glucose utilization indices for various 
tissues can thus be quantified from the relative conversion rates of 2-deoxy PH] 
glucose to the metabolically stable 2-deoxy [IHI 6-phosphate with respect to the 
integral of labelled 2-deoxyglucose removal from the blood. An important 
consideration which has to be assessed before using this technique, is the relative 
discrimination between the two forms of glucose. Previous work on the 
discrimination between 2-deoxyglucose and glucose in various tissues have indicated 
that pregnancy shows no detrimental influence to the preference of tissues to the two 
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forms of glucose. Another important consideration is the relative amount of 2- 
deoxyglucose-6-phosphate hydrolysis by the various tissues under investigation. If 
these concentrations are quite high then the conversion of 2-deoxyglucose-6-phosphate 
back to 2-deoxyglucose will produce a significant mis-representation of the glucose 
utilisation rates. Studies have shown that skeletal muscles, adipose tissue (Ferr6 et 
al., 1985) and the diaphragm (Kipnis and Cori 1959) all have very low concentrations 
of glucose-6-phosphatase, hence, conversion back to 2-deoxyglucose can be thought 
of as being negligible. This does still put restrictions on looking at certain tissues like 
the liver and kidney, as both these organs have high glucose-6-phosphatase levels. 
2.3.2. Protocol for in vivo eXperiment. 
2.3.2.1. Animal preparation and its nutritional status. 
All experiments in the absorptive fed state (ie maximal gut carbohydrate availability) 
were started immediately after the light was turned on, post-absorptive fed state (ie 
gut carbohydrate availabilty depleted) experiments were started 4h after the last 
meal. Atrially carmulated rats included a control ad libitum, 22h starved 2h refed 
control; 10,15 and 20 day ad libitum pregnant groups (term = 21 days) and a 20 day 
pregnant RMF'group, see section 2.2 for RMF method. GUI measurements were 
carried out for both the absorptive and post absorptive states. 
Eight syringes were filled with 0.9% saline and blue Sabre needles attached, making 
sure that all air bubbles were removed (these were used for flushing the cannula of 
blood and initiating the removal of blood). Eight more syringes were also required 
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but remained empty (these were used for the removal of the blood sample). A 
syringe filled with saline (0.9% NaCl) and attached to tube B (40 cm) was attached 
to the carmula of the rat. Prior to administration of labelled glucose, 100 141 of blood 
was withdrawn from the cannula by withdrawing saline from the cannula until blood 
reached the syringe. At this point the saline filled syringe was removed and an empty 
syringe attached in its place. The sample was placed into a labelled Eppendorf tube, 
containing one drop of Heparin (Multiparin; 5000 units/ml). The tube was shaken 
and 50 IAI carefully pipetted into 2.51 % zinc sulphate (w/v) [ZnSO4.7H20 (250 pl)], 
this was then shaken and 2.63 % barium hydroxide (w/v) [Ba(OH), (250 141) - this was 
prepared fresh each week as barium carbonate is formed in the presence of COJ 
added, shaken and placed on ice. As soon as the blood sample was removed it is 
flushed with 500 pLI of heparinised saline [0.9% NaCI (w/v) + Heparin (5000 
units/ml) 60 IA11100 mll . The experiment was initiated by the injection of 200 ill of 
2-deoxy ['H] glucose (301AI) [ImCi/ml stock (Amersharn Ltd. ) diluted to 0.15 
mCi/mll. The stop clock was started immediately after the cannula was flushed with 
500 jil of heparinised saline. 
At time points 1,3,5,10,20,40 and 60 minutes, 100 Al blood samples were taken 
and processed as above. At 60 minutes, approximately I ml of blood was withdrawn, 
50til being processed as before, and a further 250 /il pipetted into I ml of 10% 
perchloric acid (w/v) for deproteinisation and hence, metabolite determination see 
sections 2.5., 2.6., 2. Z). The experiment was terminated by an over-dose infusion 
of sodium pentobarbital through the cannula. Cardiac arrest occurs almost instantly 
post-infusion allowing immediate removal of the tissues shown in table 2. Tissue 
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removal does not have to be too rapid since the amounts of circulating 2-deoxy ['Hj 
glucose after 60 minutes are relatively low and so continued uptake by tissues is 
small. Each tissue was immediately freeze-clamped in liquid nitrogen and wrapped 
in labelled aluminium foil. These frozen tissues can be stored at -196"C but are 
extracted within one week. 
After processing of all blood samples, the supernatant was recovered after 
centrifugation at full speed on a Hettich Rapid/K centrifuge for 5 minutes at VC. 
Table 2. Tissues investigated for GUT measurements. 
Muscles and tissues. 
Gastrocnemius 
Soleus 
Tibialis anterior 
Extensor digitorum longus 
Adductor longus 
Diaphragm 
Heart 
Placenta (0) 
Foetus (0) 
Adipos tissues. 
Parametrial white adipose tissue 
Mesenteric white adipose tissue 
Perirenal white adipose tissue 
Intrascapular white adipose tissue 
Subcutaneous white adipose tissue 
Brown adipose tissue 
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2.3.3. Protocol for in vitro tissue extraction. 
2.3.3.1. Methods. 
This procedure is used to extract the relative amounts of 2-deoxy [IHj glucose and 2- 
deoxy VHJ glucose-6-phosphate from the tissues freeze clamped and to produce an 
integral of glucose disappearance from the blood. 
Excised tissue was weighed (100-150 mg) and placed into a5 ml Alpha tube 
containing 0.5 ml of LOM NaOH. The samples were placed in a heating block set 
at 60"C and incubated for 45 minutes (or until all tissue had been dispersed) with 
occasional shaking to disperse surface digested tissue. The placentas and foetuses 
were treated slightly different in that 3 of each were weighed and placed into tubes 
containing I ml and 10 ml NaOH, respectively. Following digestion, tissues were 
neutralised with 1M HCI, at this stage the samples are stable and can be stored at - 
20"C. 
Two sets of Eppendorf tubes were prepared for each of the tissues, one set contained 
lml of 10% perchloric acid (w/v), and the other 0.5 ml of 2.51 %. ZnSO4.7H20 (W/V) 
plus 30 141 of universal indicator. Into each set of tubes 200 id of sample was placed. 
Into the ZnS04.71-120tubes, 0.5 ml of 2.63 % Ba(OH)2 (W/V)was added to form a 
precipitate with sulphate which conjugates with 2-deoxy VHJ glucose-6-phosphate and 
hence removes it from solution. All samples were mixed and centrifuged at 4"C for 
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8 minutes at full speed in a Hettich Mikro Rapid/K centrifuge. If the barium sulphate 
precipitated tubes were too acidic or alkaline, then they were neutralised with either 
NaOH or HCI (adjustment of the pH was usually not required). The supernatants 
were immediately transferred into another set of tubes following centrifugation. At 
this stage the samples were either stored at -20'C or counted for tritium. 
Sample radioactivity was measured as disintegrations per minute (D. P. M. ) by 
pipetting 800 IAI of the supernatants into plastic scintillation vials followed by 10ml 
of scintillation fluid (Optiphase "HiSafe"; Pharmacia Ltd. ) added. The samples were 
shaken and counted for 3 minutes in a Pharmacia Wallac 1410 scintillation counter. 
The de-proteinised blood sample supernatants (100 IAI) were counted for 2-deoxy [IH] 
glucose activity, and their glucose concentrations determined by a glucose oxidase 
method, see section 2.4.. 
2.3.3.2. Calculation of elucose utilisation index (G. U. I. ). 
The counts from each blood sample together with their respective glucose 
concentration were combined to give a value of D. P. M. /ng glucose. This value was 
plotted against time and the integral of the curve calculated. The integral represented 
the rate of glucose disappearance in the whole of the body and hence was the 
comparative value required when looking at specific tissues. 
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For each of the tissues, the two sets of counts were subtracted from one another to 
give a value of 2-deoxy VHJ glucose-6-phosphate. This value was then divided by 
the tissue weight (in mg. ) counted and then divided by the integral. 
(2-deoxyglucose-6-phosphate/wt. tissue sample)/ Integral (2-deoxyglucose 
uptake of body mass). 
G. U. I. = (dpm/mg tissue)/(dpm. min/ng glucose). 
2.4. Blood glucose determination for G. U. I. calculation. 
A glucose oxidase kit was used (Boehringer Mannheim Gmbh Diagnostica, cat. 
number 124 028) based on the conversion of glucose to gluconate and hence, the 
production of hydrogen peroxide which oxidises a coloured complex to produce an 
absorbance change. 
2.4.1. Reaction scheme. 
glucose+02+ H20---GOD-----P,. gluconate + 
H202 
H202 + ABTS ----POD ------ m. coloured complex + H20 
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GOD = glucose oxidase ý: 10 U/ml 
POD = peroxidase ý-- 0.8 U/ml 
ABTS = di-ammonium 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonate) 1.0 
mg/ml. 
Into 0.6 ml of the buffer (containing enzymes and coloured reagent) 50 pl of sample 
was added and incubated at room temperature for 45 minutes. A blank was set up, 
containing 50 IAI of distilled water (dd. H20), together with two sets of glucose 
standards [50 141 standard (0.505 mmol/1) and 25 1AI standard plus 25 jil dd. H201. 
After incubation of all samples for 45 minutes at room temperature, the optical 
densities were recorded on a PU 8610 spectrophotometer set at 610 nm. Plasma 
glucose concentrations were calculated on the basis of the standard O. D. readings. 
2.5. PlasMa Elucose detennination 
Plasma glucose determination was via phosphorylation of glucose by hexokinase 
[2.7.1.11 followed by. the non-equilibrium reaction by glucose-6-phosphate 
dehydrogenase [ 1.1.1.49] reducing the NADP' to NADPH, detected at 340 nm. 
Plasma samples must, be neutralised using NaOH. The glucose assay buffer was 
prepared fresh each day from 20 mg ATP (Boehringer 127 523), 17 mg NADPI 
(Boehringer 128 058) and 250 Al glucose-6-phosphate dehydrogenase mixed with 50 
ml of buffer containing 57.8 mmol/I Tris (Tris[hydroxymethyllaminomethane Sigma 
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T 6791), 10.7 mmol/I magnesium chloride (Sigma M 8266) at pH 8.1. Control, 
blank and standards (1 mmol/I glucose solution) were set up together with sample 
cuvettes (0.8 ml buffer + 0.1 ml sample). Absorbance at 340 nm was measured 
prior to and post addition of hexokinase. Incubation period at room temperature was 
45 mins.. 
2.5.1. Reaction scheme: 
CHO 
HCOH 
I 
HOCH 
I 
HCOH 
I- 
HCOH 
I 
L; H2L)H 
ATp4-__ 0. 
CHO 
I 
HCOH 
I 
HOCH 
I+ NADP+--l- 
HCOH 
I 
HCOH 
I 
CH20PO32- 
CHO 
I 
HOUH 
I+ NADPH, H' 
HCOH 
I 
HCOH 
I- 
UH2L)k'L)3' 
Glucose Glucose-6-phosphate 6-phosphogluconolactone 
2.6. Method of blood pyruvate. acetoacetate & 3-hydroxybutyrate detennination 
Blood samples were de-proteinised with 10% perchloric acid, see section 2.3.2.1.. 
The PCA extract was then neutralised with KOH, recording the weight of the sample 
before and after neutralisation to obtain the dilution factor. Results of pyruvate 
determinations not shown. 
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2.6.1.1! yruvate determination. 
Sample cuvettes, were set up containing 0.3 ml of phosphate/NADH buffer (this 
contained 5 mg NADH + 20 ml potassium phosphate buffer (0.1 M, pH 7.0)), 0.2 
ml ddH20 and 0.1 ml of sample. Blank readings were recorded at 340 nm on a PU 
8610 spectrophotometer after referencing to a blank. Lactate dehydrogenase [EC 
1.1.1.27] (10 Al) was added and the samples incubated at room temperature for 5 
minutes. Absorbance, readings were taken and repeated every 5 minutes until the 
readings remained stable. From the dilution factors of the samples and the extinction 
coefficient of NADH (e340. = 6.23 x 103 M-1cm-) the concentration of the samples 
could be evaluated. Results not shown however method required for acetoacetate 
determination. 
2.6.2. Acefoacetate & 3-Hydroxybutyrate determination (Ketone bodies). 
For acetoacetate determination the same cuvette samples as above were used and 10 
Al 3-hydroxybutyrate dehydrogenase [EC 1.1.1.301 (Boehringer Mannheim 737 054, 
2.5 mg/ml) was added and incubated for 30 minutes at room temperature. 
Absorbance readings were repeated until the optical density remained constant. 
For 3-hydroxybutyrate determinations a stock solution of 5 ml hydrazine hydrate 
(Sigma H-0883), 7 ml of Tris buffer (1 mmol/1) and 125 mg of EDTA (disodium salt) 
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was made up to 100 ml with distilled water at pH 8.5 and stored at 40C. A 20 ml 
aliquot of this buffer was mixed with 20 mg NADI and 0.3 ml pipetted into 3 ml 
cuvettes. Control and blank cuvettes were set up with the addition of 0.3 ml of 
distilled water whereas, sample cuvettes contained 0.2 ml sample and 0.1 ml distilled 
water. Cuvettes were mixed and optical densities recorded at 340 nm. 
Hydroxybutyrate dehydrogenase (10 jAl; 2.5mg/ml Boehringer 737 054) was added 
to all cuvettes, except the blank, and optical density readings taken following an 
incubation period of 45 min.. 
2.6.3. Reaction Schemes. 
2H' + CH3COCOO-+ 2NADH ---------- - --- P,. CH3CH(OH)COO- + 2NAD+ 
Pyruvate Lactate 
H 
2H' + CH3COCH2COO-+ 2NADH ---------- -- s- CH3CH(OH)CH2COO-+ 2NADI 
Acetoacetate 3-hydroxybutyrate 
I -lactate dehydrogenase. 
H- 3-hydroxybutyrate dehydrogenase. 
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2.7. Measurement of in vivo lipogenic rates in the liver and adipose tissue sites. 
2.7.1. Methods. 
2.7.1.1. In vivo eLiperiment and tissue removal. 
The rat was injected intraperitoneally with 4 mCi of tritiated water CH20 in 0.9% 
saline- 10 mCi/mI Amersham Ltd. ) and the rats' drinking water removed. The exact 
time of administration was recorded. After a period of approximately 55 minutes, 
the rat was anaesthetised with sodium pentobarbital (Sigma P 3761; 60 mg/ml/kg: 
body weight). The body cavity and wall were cut to reveal the gut which was 
displaced to one side. A blood sample was removed (ca. 1.0 ml) from the aorta 
using a syringe and blue Sabre needle by inserting the needle in the artery via a fat 
deposit above the kidney area. The blood sample was placed into a heparinised 
Eppendorf tube and placed on ice. The tissues (see table 3. ) were excised and freeze- 
clamped in liquid nitrogen as quickly as possible. As much of each of the tissues was 
removed to provide adequate sample size for processing. Tissues could be stored at - 
20*C at this stage. 
The blood sample was centrifuged in a Hettich Mikro Rapid/K centrifuge at full speed 
for 5 minutes at 4*C. The plasma was carefully transferred, with a glass pasteur 
pipette, into another tube. A volume of plasma was diluted ten times and 10 UI of 
this counted, in triplicate, for tritium in a Pharmacia Wallac 1410 scintillation counter 
after the addition of scintillation fluid (Optiphase "HiSafe"; Pharmacia Ltd. ). This 
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gives the total activity of tritiated water in I IAI of plasma. 
Table 3. Tissues investigated for lipogenic activiti. 
Liver. 
Parametrial white adipose tissue. 
Mesenteric white adipose tissue. 
(iv) Pefirenal white adipose tissue. 
(v) Subcutaneous white adipose tissue. 
2.7.1.2. In vitro extraction of tissues. 
Tissues were weighed (200-500 mg) [two samples of liver were weighed out for 
cholesterol and fatty acid determination], pl aced into 25 ml boiling tubes containing 
3 ml of 30% potassium hydroxide (KOH w/v). The tubes were incubated for 10 
minutes in a DriBlock (Techne, Cambridge Ltd. ) set at 80"C to digest the tissue. 
The tubes were cooled and 3 ml of absolute ethanol (95 % v/v) added followed by a 
further incubation of 3 hours at 80'C to saponify the fatty acids and cholesterol. The 
tubes were occasionally shaken to aid, the saponification process., 
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2.7.1.3. Extraction procedure for total lipids. 
Distilled water (3 ml) was added to dilute the ethanol and increase the volume of the 
acqueous layer. To obtain total fatty acid and cholesterol synthesis rates the samples 
were immediately acidified with 6M sulphuric acid and the lipids extracted by the 
following method. The solution was shaken with light petroleum ether [b. p. 40-60*C 
AnalaR grade], vented and the top organic layer recovered after separation of the two 
layers. This was repeated three times in total with the extracts being pooled together 
in the same tube [N. B. for each of the extractions 10 ml, 8 ml and 6 ml of ether was 
used, respectively. ]. 
2.7.1.4. Extraction procedure to obtain separate cholesterol and fatty aci 
synthesis values. 
In the case of the liver, where separate values for cholesterol and fatty acids were 
obtained, one of the liver samples was extracted for cholesterol first followed by the 
fatty acids. In this situation the solution was shaken with light petroleum ether [b. p. 
40-60*C AnalaR grade], vented and the top organic layer recovered after separation 
of the two layers. This was repeated three times in total with the extracts being 
pooled together in the same tube [N. B. for each of the extractions 10 ml, 8 ml and 
6 ml of ether was used, respectively. ]. Following cholesterol extraction, the solution 
was acidified as above and re-extracted for fatty acids by following the same above 
Page 73 
procedure. 
All extracts were washed three times with d. H20 (5 ml) to remove any tritiated water 
and aqueous components that may persist. The aqueous layer was removed by 
aspiration and the petroleum ether extracts poured into pre-weighed scintillation vials. 
The extracts were dried down in a fume cupboard (1-2 days). The vials were re- 
weighed to give the dry weight of the lipid extracted from the tissue and 10ml of 
scintillation fluid (Optiphase "HiSafe"; Pharmacia Ltd. ) added. After extensive 
shaking the extracts were counted in a Pharmacia Wallac 1410 scintillation counter. 
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2.7.1.5. Method of calculation. 
I ml plasma Assuming: 1g H20 1g plasma 
Then: x dprn in 1 jil plasma x dpm/1 mg 
H20 
--I) 
Each molecule of H20 has I atom of 'H 
I lAg atom IH 18 jAg H20 0.018 mg'H20 
Therefore, 1/0.018 lAg atom 'H I mg H20 ...... 2) 
Substitute 2) in 1), 
x dpm x dpm. 0.018/lig atom IH. 
1/0.0181Ag atom 'H 
Counts-in tissue 
-xxI jAg 
atom IH/h/g. 
Counts in plasma x 0.018 wet wt. time 
m gmoIH20 eH +'M/h/g 
N. B. It must be noted that plasma will contain appreciable amounts of protein which 
has not been taken into consideration for the purposes of the calculation. It has also 
been assumed that the plasma specific activity of 11-1, following instant mixing with 
the blood, is equivalent to the total tissue water specific activity for 1H. 
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2.8. Preparation of arylamine acetyltransferase (AAT). 
2.8.1. Introduction. 
2.8.2. Method. 
Pigeon liver acetone powder (10 g) [Sigma L-83761 was placed in a conical flask and 
100 ml of cold distilled water added. The contents were homogenised at high speed 
(Polytron Tissue Homogeniser; large probe; position 6) for 3 minutes on ice. The 
homogenate was distributed into high density polyethylene - centrifuge tubes and 
centrifuged at 13 000 rpm for 15 minutes at 4"C in a MSE Europa 24M Centrifuge. 
The supernatants (ca. 70 ml) were pooled into a 250 ml conical flask and placed on 
ice, the -ice being further cooled with the addition of ammonium chloride (BDH 
27149). Into the gently stirring flask, cold acetone (40ml) [AnalaR grade] was slowly 
dripped from a separating funnel to precipitate protein out of solution. The 
supernatant was transferred into polypropylene centrifuge tubes and carefully 
balanced., The tubes were centrifuged for 15 minutes at 13 000 rpm and at -10"C. 
The supernatants were pooled and re-extracted and centrifuged, as above, but with 
25 ml of cold acetone and an operating temperature of the centrifuge at -20*C. 
Following centrifugation, the pellet was kept and the supernatant extracted for the 
final time with the dropwise addition of 50 ml of cold acetone. The solution was 
centrifuged as above at -200C. 
The pellet from the last spin was retained and re-suspended in as small a volume as 
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possible of 10 mmol/l potassium phosphate buffer [dipotassium phosphate titrated with 
potassium dihydrogen phosphate obtaining pH 7.01. The pellet from the third 
centrifugation was also resuspended in the phosphate buffer. The two sets of pooled 
pellets were transferred to I ml Eppendorf tubes and spun at half speed in a Hettich 
Mikro Rapid/K centrifuge at VC for 2 minutes. The supernatants were carefully 
recovered, this contained the arylamine acetyltransferase which was assayed for 
activity, see section 2.10.3.. The AAT was stored in aliquots of 250 pI at -20"C. 
2.9. Measurement of pyruvate dehydrogenase activity (active form). 
2.9.1. Introduction. 
The complex consists of three enzymes which catalyse the conversion of pyruvate to 
Acetyl CoA during aerobic respiration on the inner mitochondrial membrane. The 
three enzymes are pyruvate dehydrogenase, dihydrolipoamide acetyltransferase and 
dihydrolipoamide reductase which collectively carry out the following reaction. 
2.9.1.1. Reaction scheme. 
Pyruvate + CoA + NAD - ------ - -- - ---- io. Acetyl CoA + NADH + C02 
For this reaction to reach completion other factors are needed in conjunction with 
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three enzymes, these are: thiamine pyrophosphate (TPP), lipoic acid coenzyme A, 
FADH2 and NAD+- The pyruvate dehydrogenase (or pyruvate decarboxylase) 
converts the pyruvate to hydroxyethylthiamine pyrophosphate and the 
dihydrolipoamide acetyltransferase then transfers a two carbon component from the 
thiamine pyrophosphate and to CoA to form acetyl CoA. The dihydrolipoamide 
reductase then oxidises, the reduced form of lipoic acid to form FADH2 followed by 
NADH. 
2.9.1.2. Control of the pyruvate dehydrogenase complex- 
Control of this enzyme system- relies on the phosphorylation state of the complex. 
Phosphorylation of PDH is catalysed by pyruvate dehydrogenase kinase (PDH kinase) 
and this form of the enzyme is inactive. De-phosphorylating the PDH complex with 
pyruvate dehydrogenase phosphatase activates the complex so that pyruvate 
conversion to acetyl CoA can be carried out. The relative amounts of active and 
inactive quantities of the PDH complex determine the relative activity of that 
particular tissue under investigation. Control of the two regulatory enzymes which 
phosphorylate and dephosphorylate the PDH complex is dependent on several factors, 
the most important of which are the ratios of ATP/ADP, acetyl CoA/CoA, 
NAD'/NADH and Ce' levels. For example, if there is a relatively high 
concentration of acetyl CoA or ATP around, then the PDH kinase would be activated 
to switch the PDH complex off, whereas, with high concentrations of NAD' or Ca? ' 
the opposite occurs. Due to the very delicate balance between activation and 
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inactivation of the PDH complex, it is very difficult to get an accurate measurement 
for tissue activity unless tissues are assayed on the same day of extraction. 
The method of assaying the activity of the PDH complex relies on the transfer of acyl 
groups onto a coloured compound called aminophenylazobenzene sulphonic acid 
(AABS). Acyl groups, produced by the pyruvate dehydrogenase complex, are 
transferred to the AABS via -SH groups of cysteine residues. This reaction is 
catalysed by the enzyme arylamine acetyltransferase which involves the formation of 
an acylthioenzyme: - 
E-SH + CH3COS-CoA E-SH. CH3COS-CoA ---- ,. E-S-COCH3 +CoA 
E-S-COCH3+ RNH2 
Where RNH2 = AABS. 
P. E-SH + RNHCOCH3- 
The pyruvate dehydrogenase complex, discussed in section 2.10.1., is very easily 
inactivated once metabolic conditions are drastically altered. Due to this, it is vitally 
important that, when the tissues were extracted, they were done so as quickly as 
possible. It is impossible to assay every tissue as in the glucose utilization experiment 
due to the rapidity of PDH inactivity and therefore, only a couple of tissues can be 
used per rat which must be removed before any other tissue. 
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2.9.2. Methods. 
2.9.2.1. Chemicals. 
1.0 mmol/l KH2PO4 (stored at VC). 
1.0 mmol/l K2HPO4 (stored at VC). 
0.2 mmol/l EDTA-K' {Add dropwise 30% KOH to dissolve the salt at its correct 
pHj stored at VC. 
0.2 mmol/l EGTA-KI {Add dropwise 30% KOH to dissolve the salt at its correct 
pHj stored at 4"C. 
1.0 mmol/l Tris Buffer pH 8.0. 
0*1 MM0111 MgC121 
Dithiothreitol (DTT) (Boehringer 708 992). 
Pyruvate (Boehringer 128 147). 
Tosyl-Lysine-Chloromethyl Ketone (TLCK) (Sigma t-7254). 
Leupeptin 5 mg/ml (Sigma 1-2884). 
Benzamidine (Aldrich B200-4). 
Triton X 100 (25 %). 
p-(p-aminophenylazo) benzene sulphonic acid (AABS) (Img/50ml d. H20; stored at 
4"C). 
Mercaptoethanol. 
NADI. 
Co-enzyme A (Sigma C-3144). 
Cocarboxylase [Thiamine Pyrophosphate Chloride (TPP) (Sigma C-8754). 
Arylamine acetyltransferase (AAT) (Extracted from Pigeon Liver Acetone Powder 
and stored at -20'C 
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2.9.2.2. Solutions. 
PDH Assay buffer A: Extraction Buffer B: 
50ml LOM KH2pO4 (50MM)- 17.5ml PDH Assay Buffer A 
50ml LOM K2HP04 (5OmM). 30.7mg DTT (2mM) 
25ml 0.2M EDTA (5mM). 11.1 mg TLCK (0.3mM) 
50ml 0.2M EGTA (lOmM). 100ul 5mg/ml Leupeptin (IOAM) 
15.7mg Benzamidine (ImM) 
II Orng Pyruvate (0.1 mM) 
pH 7.5 and made up to 100ml 
Extraction Buffer C: 
Identical to B except, 20 ml of 25% "Triton X-100" was added. 
2.9.2.3. Method of extractio 
In order to obtain maximal enzyme activity rates, the tissue was removed from the 
rat and immediately freeze-clamped in liquid nitrogen. Pyruvate dehydrogenase 
activity was assayed on the same day as excision, with the tissues stored in liquid 
nitrogen until required. 
Extraction buffers B and C were made up fresh each day and kept on ice. 
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Approximately 100-200 mg of tissue was weighed into a liquid nitrogen cooled 
scintillation vial and ice-cold extraction buffer B added (0.5 ml/100 mg tissue). The 
tissue was homogenised using a Polytron Tissue Homogeniser (PT 10 probe; position 
3 for 5-10 seconds) to disperse and increase the surface area of tissue. Ice-cold 
extraction buffer C was added (0.5 ml/100 mg) to the honiogenate and homogenised 
for a further 1-2 seconds to solubilise the cell membranes. The homogenate was 
transferred into an Eppendorf tube with a pin-hole in the lid, and then frozen in liquid 
nitrogen. The mitochondrial membranes were then disrupted by a process of freeze- 
thawing the homogenate three times, ie frozen in liquid nitrogen followed by a 
gradual thaw at 300C in a water bath. Insoluble material was removed by 
centrifugation at full speed in an Eppendorf 5415 C centrifuge for 30 seconds. The 
fibrous pellet and the supernatant was re-frozen in liquid nitrogen until required for 
the assay. 
2.9.3. Active form pyruvate dehydrogenase activity assay. 
2.9.3.1. Solutions 
Assay buffer A. 
100 ml Tris buffer pH 8.0 (LOM) 
10 ml magnesium chloride (0.1M) 
2.5 ml EDTA-KI (0.2M) 
Made up to I litre and pH=7.8. 
Assay buffer B. 
50 ml Assay buffer A 
I ml AABS 
15 jil Mercaptoethanol 
Equilibrated at 30*C 
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NCT solution 
30.7 mg NAD' 
10 mg Co-enzyme A 
48 mg TPP 
Dissolved in I ml dd. H20 
Made fresh each week. 
2.9.3.2. Assay Method 
Assay buffer 
0.75 ml Assay buffer B 
7.5 jul 
NCT solution 
7.5 pl IOOmM Pyruvate 
5.0 IAI AAT 
Micro-cuvettes containing assay buffer C were mixed by inversion and placed in a 
Philips PU 8610 spectrophotometer set at 460 nrn and containing a cell temperature 
controller, set at 30'C. A PM 8521 chart recorder was set at a rate of I cm/min. 
The absorbance change produced by this blank should be relatively negligible, 
however in the case of a non-steady state, caused by trace acetate contamination, the 
reaction mixture was allowed to equilibrate until a steady base-line was achieved. 
The sample was thawed at 30'C and 20-100 IAI (ie. smaller volumes for tissues with 
greater PDH activity, like the heart) swiftly added to the reaction cuvette, inverted 
twice and placed into the spectrophotometer cell temperature controller. The rate of 
absorbance decrease at 460 nrn was recorded on the chart recorder with a suitable full 
scale deflection. 
2.9.4. Calculations for pyruvate dehydrogenase actiVity. 
The trace obtained from the chart recorder gave the relative rate of pyruvate 
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dehydrogenase activity and hence, the gradient of the trace represented OD change 
(mm) / time (cm). 
This value was multiplied by the below factor, giving the enzyme activity in terms 
of mUnits/ml. 
Multiplying factor fsd x assav volume x UP 
PW X E460 X SV 
Where: 
fsd = full scale deflection of chart recorder (OD) 
assay buffer = total volume of reaction mixture 
(IAD 
pw = chart recorder width 
E4111 
= Extinction coefficient of AABS [6.5 M-'Cm-'] 
sv = sample volume 
By knowing the weight of the sample and the volume of extraction buffers used, the 
concentration of tissue assayed can be calculated and combined with the above value 
to produce a value in terms of mUnits/gm wet weight. 
The value obtained from the above calculation was specific to each individual tissue 
extracted since different tissues have differing amounts of the PDH complex in their 
mitochondria. Therefore, the only way to quantify the relative amount of PDH 
complexes was to compare the activities with a tissue constant. For this purpose the 
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citrate synthase activity was calculated from the tissue samples. The relative number 
of citrate synthase molecules compared to PDH complex macromolecules is fairly 
constant in different tissues. The PDH activity rate is therefore divided by the 
respective citrate activity. This produces an activity of the pyruvate dehydrogenase 
complex activity termed as a function of citrate synthase activity. 
2.10. Determination of citrate synthase [EC 4.1-3-71 activity 
Samples prepared for the pyruvate dehydrogenase assay in section 2.10.2. were used 
for this assay. Citrate synthase, unlike pyruvate dehydrogenase is relatively stable 
and can therefore be stored at -20"C until required. 
Samples were defrosted and diluted as in table 4. 
Micro-cuvettes were set up as below: 
1.5 ml 100 mM Tris buffer, pH 8.0 
20 jil 10 mM *DTNB 
30 jAl 10 mM Acetyl CoA 
201AI diluted sample 
*DTNB = 5,5 -Dithio-bis(2-nitrobenzoic acid) [a sensitive sulphydryl reagent; Sigma 
D 81301. 
A total of five blank readings were taken in a PU 8610 spectrophotometer at 412 nm 
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to produce an average. Citrate production was initiated by the addition of 20 jAl of 
75 mM oxaloacetate. The samples were immediately shaken and placed back into the 
spectrometer. Five readings were taken sequentially to obtain an average rate. 
Activity rates were expressed in terms of Units/ml. 
2.10.1. Reaction Scheme. 
CH3COSCoA + HOOCCOCH2COO 
acetyl CoA Oxaloacetate 
- --------- CH2COOH + DTNB-CoA 
I 
QOH)COOH 
I 
U112COOH 
Citrate Coloured 
complex 
Table 4. Dilutions used for citrate synthase activity. 
TISSUE SAMPLE VOLUME 100mM TRIS VOL. 
pH 8.0. 
Heart, 20 yl 480/Al 
Brown adipose tissue. 
Diaphragm. 20, gl 180 Al 
Liver, Gastrocnernius, 20 pl 80 pl Soleus, Tibialis anterior, 
Extensor digitorum longus. 
Adductor longus. 50, ul 50 pl 
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2.11. Method for hepatic glycogen guantitation 
2.11.1. Glycogen extraction protocol. 
Approximately 50-100 mg. of frozen liver was weighed into a pre- "liquid nitrogen 
cooled" glass scintillation vial. The liver was homogenised with 0.03 mmol/I HCI 
(5 ml) for 5-10 seconds with a Polytron PTIO Tissue Homogeniser [large probe; 
position 5). The homogenate (0.5 ml) was transferred to a 10 ml centrifuge tube and 
0.03 mmol/I HCI added. At this stage 3 triplicate standards were made up: - 
0 (a) 1.0 ml 0.03M HCL 
0 (b) 0.5 ml glycogen stock solution (Sigma G-8876) 
[0.3 mg/ml 0.03M HCIJ + 0.5 ml, 0.03M HCL 
0 (C) 1.0 ml glycogen stock. 
All samples and standards were placed into a water bath at 100"C for 5 min. The 
tubes were removed and 0.1 ml of I mmol/I NaOH added. After mixing, the tubes 
were returned to the water bath for a further 10 min. The tubes were allowed to cool 
down and 0.1 ml of 1.5 mmol/I acetic acid pipetted into the samples, the samples 
were mixed thoroughly and 2 ml of 0.1 mmol/l acetate buffer added [4. Ig sodium 
acetate + 2.86 ml glacial acetic acid made up to 1 litre; pH 4.7 and stored at VC]. 
After mixing, the samples were centrifuged in a MSE Mistral 3L at 5000 rpm for 5 
mins. at VC. Supernatants (0.5 ml) were collected into labelled Eppendorf tubes 
ready for glycogen digestion with amyloglucosidase. 
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2.11.2. Glycogen digestion protocol. 
A solution containing amylo-1,6-glucosidase was freshly made with the following 
components- 
20 mg Bovine serum albumin (Sigma A 6003) 
10 mg Amylo-1,6-glucosidase (Boehringer Mannheim Gmbh. 208 469) 
10 ml Tris [Tris(hydroxymethyl)aminomethane (Sigma T 6791) 
buffer (20 mmol/I ; pH 7.5 stored at VQ 
To both samples and standards a 0.1 ml aliquot of amylo-1,6-glucosidase solution was 
added and mixed by gentle inversion. The samples were incubated at room 
temperature for 2h. 
2.11.3. Reaction scheme: 
Amylo-1,6-glucosidase catalyses the release of glucose subunits between branches of 
glucose chains in the glycogen macromolecule. The ct-1,6 linkage is broken down 
releasing approximately 7% of the total glucose subunits. Therefore use of this 
enzyme does not constitute the complete release of all glucose subunits but the value 
obtained is a measure of total glucose on the assumption that glycogen molecules 
closely resemble one another. Released glucose was measured by the 
hexokinase/glucose-6-phosphate dehydrogenase method, section 2.5.. 
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2.11.4. Calculation of glycogen. 
Glycogen was calculated from the relative amount of glucose released by the 
debranching enzyme. From the optical densities of the glycogen standards the weight 
of glycogen (mg) per gram of tissue assayed was calculated. 
Total liver weight assayed Dry wet weight of sample 
384 
Total glycogen content 
following digestion OD x [standard]. 
ODsUndud 
Where OD = optical density 
[] = concentration assayed. 
2.12. Statistics. 
Statistical significance of differences between means was assessed by Student's 
unpaired t test. All results are given as means ± SEM for n=6 rats unless otherwise 
stated. 
Page 89 
CHAPTER 3. 
RESULTS. 
Rat weight. tiver weight. heart weight and chow intake during the period 
of gestation. 
From the results shown in table 5 it can be seen that rat weights increase steadily 
during pregnancy. Up to day 10 of pregnancy the increase is almost linear, after 
which the rate of increase is more exponential. Just prior to giving birth, the mother 
gains almost 50% more weight within a space of just 3 weeks, reflecting the extent 
of the physiological change brought about during pregnancy. To cope with the extra 
foetal -demand chow intakes are also shown to increase substantially compared with 
the virgin condition. On day 20 of pregnancy, chow consumption increases to 
approximately 33 g. Chow intake represented a net increase of 84% during late 
gestation as against day 3 of gestation, this far exceeds the net rat weight increase 
implying enhanced metabolic growth systems being promoted in the conceptus. From 
a diurnal food consumption study it was revealed that approximately 30% of the total 
daily food intake was consumed during the final 3h of the dark phase just prior to 
sampling. Approximately 80% of total food intake was consumed in the 12 h dark 
phase, independent of pregnancy. 
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Table S. 
Changes in rat weights and food intakes during the course of 
gestation in the Wistar rat. 
Day Rat Weight ± SEM (g). Daily Food Intake ± SEM 
2 215.42 5.91 (13) -- 
3 227.20 4.85 (16) 18.33 2.04 (7) 
4 231.48 6.57* (12) 21.23 1.37 (8) 
5 229.48 4.26* (23) 19.50 2.11 (8) 
6 232.79 3.45** (38) 21.55 1.68 (16) 
7 240.19 4.65*** (39) 22.69 0.81 (25) 
8 233.74 ± 3.58"** (32) 22.78 ± 0.63" (22) 
9 238.85 ± 3.10*** (32) 23.73 ± 1.14" (22) 
10 240.15 ± 3.86*** (33) 24.22 ± 1.09'. 1 (19) 
11 253.30 ± 5.62**** (30) 23.99 ± 1.35" (16) 
12 256.23 4.50**** (41) 25.37 0.77' (18) 
13 262.83 3.55**** (54) 26.03 1.15""" (27) 
14 264.59 3.02**** (47) 27.80 0.96"'1 (33) 
15 268.95 3.92*** (37) 28.88 1.32"' (21) 
16 278.73 4.58**** (32) 27.79 1.3(Y"" (19) 
17 290.93 ± 5.08**** (27) 30.49 ± 0.92""" (19) 
18 289.67 6.29**** (28) 28.18 1.5410" (17) 
19 300.22 8.48 **** (19) 31.24 2.3(Y (10) 
20 319.35 + 11.70**** (10) 33.80 + 1.96"0" (10) 
Numbers in brackets represent the number of rats in each group. Statistical 
significance between the means of age-matched virgin rats for increases in rat weight 
are represented by *P<0.1; **P<0.2; ***P<0.01; ****P<0.001. Significant 
differences between food intakes during gestation compared with age-matched virgin 
rats are represented by "P<0.05; ""P<0.02; "I"P<0.01; ""'P<0.001. 
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In chapter 1, organ weights were said to increase during pregnancy as the demands 
on them also increased. From table 6., liver weights increased by 45 % and the heart 
by a modest 8% at 20 days. The hearts weight increase was relatively small and not 
really apparent until approximately day 15 of pregnancy, this being the period of 
enhanced foetal growth. This was not expected, especially with the very substantial 
increase in the uterine system and the liver, both implying a greater blood flow 
requirement. 
Tabk 6. Changes in heart and liver weights during the course of gestation in th 
Wistar rat. 
Heart wt. (g) Liver wt. (g) 
Virgin 0.778 0.028 (12) 10.21 0.36 (13) 
10 days 0.754 0.038 (6) 12.58 0.821 (4) 
15 days 0.828 0.024 (11) 13.70 0.82"" (7) 
20 days 0.842 0.024* (6) 14.82 0.33"" (5) 
Statistically significant differences to the virgin weights are represented by *P<0.1; 
'P<0.02; "*P<0.01; """P<0.001. Numbers in brackets represent the sample size. 
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3.2.1. Effects of pregnancy on the glucose utilisation capacity of various 
tissues durine the immediate fed period fabsoicptive state). 
From table 7 it can be seen that as gestation progresses the relative degree of 
hypoglycaemia increases. At 10 days of gestation glucose concentrations were 
already significantly reduced from virgin values ie. 5.81 ± 0.23 to 5.00 ± 0.18 
mmol/l (P<0.05). By days 15 and 20 of gestation blood glucose levels were 3.68 
± 0.18 mmol/I and 3.37 ± 0.10 mmol/l (P<0.001), respectively. These values 
represent decreases of 37% and 42%, respectively. 
From the results in table 7 andfigures 4&5 significant effects of pregnancy can 
begin to be seen in most tissues (except the soleus) as early as day 10 of gestation. 
As pregnancy progresses to days 15 and 20 the effects are very apparent, with the 
greatest changes shown by the normally high glucose utilising tissues of the heart, 
diaphragm and soleus muscles. The skeletal muscles can be grouped into two, the 
first being the working oxidative muscles (soleus and adductor longus) and the 
second, the non-working muscles (tibialis anterior (TA) and extensor digitorum longus 
(EDL). Both sets of tissues show their most significant declines during the latter part 
of the gestation period with the non-working muscles showing the greatest degree of 
suppression in GUL On day 15 of pregnancy the glucose utilisation rates of the non- 
working muscles were reduced by 51-61 %, whereas the working muscles reduced by 
27-37%. By day 20 of gestation the working muscles showed reductions of 58%. 
However, the non-working muscles decline even further by 76 % and 80 %, in the TA 
and EDL, respectively. 
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The reductions shown in the various tissues can be seen to be progressive through the 
course of pregnancy. The stage of pregnancy therefore, depicts the relative degree 
to which the tissues reduce their capacity to utilise glucose as their preferred fuel 
substrate. As pregnancy progresses so does the decline in glucose uptake and 
phosphorylation by the tissues. The heart and diaphragm both expend large amounts 
of energy due to their constant rhythmic contractions and hence are expensive utilisers 
of the maternal free circulating glucose pool. Significant reductions in GUI values 
of 34% were seen on day 10 of pregnancy in both heart and diaphragm. As gestation 
progressed to 15 days the suppression increased to 46% in the heart, however no 
further reduction in GUI was observed in the diaphragm. The greatest suppression 
was shown on day 20 of pregnancy where the heart reduced to a value of 160.0 ± 
35.6 nmol/min/g which is 51 % lower than the 15 day value and 74 % lower than the 
control virgin value. The diaphragm showed a reduction from the 10 day pregnant 
and virgin values of 59% and 73%, respectively. The most significant decrease in 
glucose utilisation by these two tissues were seen between 15 and 20 days which 
coincides with the most rapid developmental stage of the conceptus, shown by the rat 
weight increase (table 5. ), which during this period increased by almost 30%. 
Page 94 
3.2.2. Effects of pregnancy on the glucose utilisation capacity of various 
tissues during the post-absol: ptive fed period. 
Blood glucose concentrations show a marked difference to the corresponding values 
in the immediate absorptive state, compare table 7 and table 8. Glucose 
concentrations in non-pregnant rats reduce from 5.81 ± 0.23 mmol/l to 4.68 ± 0.13 
mmol/I in the post absorptive state. Unlike the absorptive state significant reductions 
in glucose concentrations during pregnancy are not seen until day 15. The value 
obtained on this day of gestation is 14% (P<0.01) lower than the non-pregnant 
values however, in the absorptive state the value is 37% (P<0.001) lower than the 
corresponding non-pregnant value ie. 3.68 ± 0.18 mmol/l. By day 20 of pregnancy 
glucose concentrations reduce to 3.37 ± 0.38 mmol/l which is similar to the 
corresponding absorptive state. 
From the results in table 8 andfigures 4&5 it can be seen that performing glucose 
utilisation measurements 4 hours after the light is switched on shows a reduction in 
the tissues' ability to utilise glucose in the virgin rat. This is expected since during 
the light phase the rat would be resting and hence, in a state of starvation, reducing 
the tissues' need to utilise glucose. The GUI values for the different stages of 
gestation show the same pattern of suppression as in the absorptive state but values 
are slightly lower due to the post-absorptive nutritional status. The greatest 
suppression of glucose uptake and phosphorylation is once again shown on day 20 of 
gestation. The heart and diaphragm show a decline of 74 % and 51 %, respectively, 
from the virgin post-absorptive state which is similar to values obtained for the 
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absorptive 20 day pregnant state. This would imply that the limit of glucose 
utilisation suppression has been reached. Despite this suppression in GUI during the 
latter stage of gestation there was no significant suppression during the early stages 
of gestation although values were lower. The two working muscles (soleus and 
adductor longus) showed reductions of 40% and 78%, respectively, on day 20 of 
gestation these values are greater than the corresponding absorptive values. Non- 
working muscles on day 20 of gestation showed a similar suppression as the 
absorptive state of 38% in the tibialis anterior and 18% in the EDL. On day 10 of 
gestation, values were similar to the virgin post-absorptive values; however, by day 
15 of gestation they had fallen by 38% and 18% in the tibialis anterior and EDL, 
respectively. 
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GUI Values During Pregnancy During The 
Absorptive & Post-Absorptive States. 
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GUI Values During Pregnancy During The 
Absorptive & Post-Absorptive States. 
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Virgin 10 days 15 days 20 days 
3.2.3. Hepatic glycogen. lip id fuels. ketone bodies and insulin concentrations 
during pregnancy in the abso Eptive state. 
From table 9 it can be seen that despite increased food intakes, free access to food 
and measurements being made in the absorptive state, significant increases in total 
ketone bodies and non-esterified fatty acids (NEFA) occur. Largest increases of 
480% and 135% were seen in ketone body and NEFA plasma concentrations, 
respectively. Triacylglycerols also increased but to a lesser degree. The large 
increases in ketone body and NEFA concentrations were only seen on day 20 of 
gestation, this is despite the increase in blood plasma vascularity, see section 1.3.3.. 
Hepatic glycogen levels indicate that the progression of pregnancy does not affect 
levels. However, on day 20 of gestation slightly lower glycogen levels of 58.8 ± 4.5 
mg/g *compared with 72.6 ± 8.2 mg/g in the non-pregnant group were seen The 
insulin concentration decreased from 26.2 ± 2.2 IA-units/ml to 14.1 ± 3.1 IA-units/ml 
by day 20 of gestation, a reduction of 46% which is comparable to the plasma 
glucose reduction of 42% in the absorptive state. This implies that the insulin 
response by the mother is unaffected during gestation. 
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Discussion. 
A study by Leturque et aL (1986) showed no difference in glucose utilisation rates 
by the diaphragm and soleus muscles of anaesthetised rats in the post absorptive state. 
In a later study by P6nicaud et al. (1987) the effect of anaesthesia on glucose 
utilisation was shown. Pentobarbital anaesthesia has the effect of reducing the 
capacity for tissues to utilise glucose hence, under-estimating in vivo glucose 
utilisation. In the above study the rats were unrestrained and conscious and showed 
clear suppression in glucose utilisation rates by the various muscle types investigated. 
This study has shown the extent of glucose intolerance by the various skeletal muscles 
irrespective of their fibre composition. It is apparent that the extent of suppression 
of glucose utilisation is dependent on the duration of gestation and the nutritional 
status- of the rat. The GUI capacity of the various muscles were maximally reduced 
on day 20 of gestation, however in the immediate absorptive state significant 
reductions were observed 10 days into pregnancy. Greatest suppressions in GUI were 
shown by the heart which by 20 days of gestation, in both the absorptive and post- 
absorptive states, were significantly reduced to values normally seen in 24 h starved 
virgin rats (Holness and Sugden, 1990). Non-working muscles and oxidative 
working muscles all showed vast reductions in glucose uptake and phosphorylation 
during the latter stages of pregnancy in the rat. It is interesting to note that even 
when carbohydrate is readily available, as in the absorptive state, GUI values were 
at levels resembling virgin post-absorptive values, except the heart and diaphragm 
which resembled higher degrees of starvation. 
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This study shows the extent by which maternal blood glucose is diverted away from 
the mothers' intracellular metabolic pool, presumably for use by the developing 
foetus(es). All the muscle fibre types investigated showed significant degrees of 
suppression in their capacity to utilise glucose. The post-absorptive study 
demonstrated the accelerated response to food withdrawal during pregnancy. Once 
again the response to food withdrawal by the various tissues was highly dependent on 
the duration of gestation, the greatest suppressions shown by the 20 day pregnant 
groups. In general the GUI values by all the working and non-working muscles 
showed a decrease in their ability to utilise glucose in the post-absorptive state 
compared with the corresponding absorptive state. This was not true for the heart 
which had GUI values which were very similar in both nutritional states. This is 
despite the free availability of glucose in the immediate absorptive state and would 
suggest that as gestation progresses the heart has the greatest susceptibility to the 
imposed glucose intolerance. The heart, even during the absorptive state, must be 
using other oxidisable substrates such as ketone bodies and lipids to meet its demands. 
The fact that there was no difference between the two nutritional states at any of the 
three time points during pregnancy seems to imply that the heart has been "targeted" 
as an expensive glucose drain. The control virgin GUI values indicate this point. 
Fortunately the heart has the capacity to utilise other oxidisable substrates depending 
on the physiological condition imposed, see section 1.4. 
Despite the relatively high glucose concentration in the post-absorptive state, which 
is very comparable to the absorptive 20 day pregnant state, the mother is restrained 
from utilising glucose. Reducing the capability of the mother to utilise the circulating 
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glucose imposes a large energy deficit which has to be met by other fuels such as 
lipids and ketone bodies both of which are shown to increase substantially, see table 
8a. Both these fuels can substitute for carbohydrate substrates especially in the 
oxidative tissues and the brain. Considering the extent of suppression of glucose 
utilisation by the various tissues it may be expected that concentrations of NEFA and 
ketone bodies would steadily increase during gestation to compensate for the reduced 
maternal glucose utilisation. However, from table 8a it is clear that plasma 
concentrations of these substrates are not seen to increase until day 20 of gestation 
in the post absorptive state. A possible explanation could be the increased utilisation 
of these fuels, especially by the heart. This would have the net effect of decreasing 
the plasma concentrations which would otherwise be seen to increase ie. increased 
utilisation of these fuels is directly met by increased mobilisation therefore, producing 
no net-effect on concentrations. It must be noted that NEFA plasma concentrations 
are seen to decrease slightly during the first two trimesters of pregnancy which could 
reflect the increased utilisation of this fuel. 
An important observation was the decrease in insulin levels in late pregnant rats. A 
reduction in insulin would imply reduced glucose utilisation by the mother. Hence, 
it could be thought that the glucose intolerance is not secondary to insulin resistance 
but to other factors such as a reduction in numbers of tissue or pancreas glucose 
receptors etc. -A study by Leturque et al. (1984) showed, using a euglycaernic 
hyperinsulinaernic clamp on anaesthetised pregnant rats, that pregnancy does 
constitute an insulin resistant state. It was shown that insulin concentrations causing 
half maximal utilisation of glucose in virgin rats was 200 pU/ml and in 19 day 
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pregnant rats was 500 jzU/ml. However, in this same study insulin levels during 
pregnancy were shown to be slightly higher compared with age-matched virgin rats. 
This contradicts the changes seen in this study where insulin levels reflect the degree 
of glycaemia of the rats, anaesthesia could therefore be influencing insulin secretion. 
However, studies on pregnant women have shown steady increases in the levels of 
plasma insulin during gestation (Freinkel, 1980). Insulin resistance must therefore 
be assessed by euglycaemic hyperinsulinaemic clamp studies on unrestrained 
unanaesthetised rats to resolve this discrepancy. 
3.3. Effects of pregnancy on the lipogenic rates of the-liver and white adipose 
tissue sites. 
3.3.1. Liver 
Glucose uptake and phosphorylation by the various muscle types has been shown to 
be greatly suppressed as gestation progresses. Fuel demands of the mother however, 
still must be met. The most likely oxidative substrate candidates are the lipid derived 
fuels such as FFAs and ketone bodies. These are supplied by the liver following 
triglyceride oxidation. Tables 9& 10 and Figures 6&7 show the lipogenic rates 
during the course of pregnancy in the liver and five different adipose tissue sites. 
The liver shows an exponential increase in its lipogenic activity. This increase 
however, is mainly due to the contribution of newly synthesised fatty acids rather than 
cholesterol. Cholesterol synthesis rates remain relatively constant throughout 
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pregnancy. However, there is a slight increase but its significance is difficult to 
assess, as this increase could be the result of increased hormone production. Total 
lipid synthesis rates increase by 190% towards the end of gestation which again 
reflects the similar increase in fatty acid synthesis. The increased fatty acid synthesis 
will have two benefits for the "fuel" starved mother. Firstly, the fatty acids can be 
exported out of the liver packaged with apolipoprotein to be used as fuel in peripheral 
tissues or stored in adipose tissue. Secondly, in the fasting periods the liver will 
breakdown fatty acids to release ketone bodies into the maternal blood. Ketone 
bodies, as previously discussed, are far more easily transported both inter and 
intracellularly compared with either FFA or lipoprotein fractions. 
3.3.2. - Adipose tissues. 
The various adipose tissue sites show a similar lipogenic response to pregnancy as the 
liver. Significant changes can be seen from day 15 onwards in all the adipose tissue 
sites investigated. By day 20, the parametrial and perirenal white adipose tissues 
increased to a value 180% higher than virgin fed controls, the mesenteric increased 
by 125% and the subcutaneous to a greatly enhanced level which was 305% higher 
than the non-pregnant condition. The response by the adipose tissue sites to gestation 
reinforces the idea that the mother has the potential to use lipid derived fuel substrates 
when utilisation of glucose is suppressed. Lipids play a significant role in supplying 
the mother with oxidisable substrates allowing the developing foetus(es) to utilise 
what seems to be the preferred substrate, glucose. The rates of lipid synthesis in both 
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the liver and adipose tissue sites can be seen to increase exponentially towards term, 
this directly coincides with the growth pattern of the foetus(es) which show their 
greatest development in the latter stages of gestation. 
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3.4. Effects of routine meal feeding during pregnancy on GUT. 
Results and discussions. 
3.4.1. Effects of 10 day meal fed pregnant rats on GUI values during th 
absoi: ptive phase. 
From the information obtained in this current study glucose uptake and 
phosphorylation, by the otherwise glucose intolerant tissues during pregnancy, have 
been "re-stimulated". Direct comparison of pregnant meal fed rats and control virgin 
22h starved 2h refed rats (table 11 andfigure 8,9 & 10) shows increases in glucose 
utilization indices (GUI) of 54% and 97% in soleus and adductor longus (ADL), 
respectively, showing the effect of conditioning the animal over a period of meal 
feeding. The non-working muscles namely the gastrocnemius, tibialis anterior and 
EDL show a different variation; with the posterior hind-limb muscles gastrocnemius 
and EDL showing increases of 225% and 40%, whereas the TA shows a modest 
decline of 21 %. The two cardiothoracic muscles investigated showed opposing 
changes with the diaphragm increasing its utilization of 2 deoxyglucose by 91 %, 
whereas, the heart remains low at 156.7 nmol glucose. min-'. g` which is half the 
control value but exactly the same as fed pregnant control rats. 
The greatest effect which meal feeding has on pregnancy can be seen when the GUI 
results are compared with normal fed 20 day pregnant rats. The previous study 
(section 3.2. ) showed a very substantial suppression of glucose uptake and 
phosphorylation by both the working and non-working muscles with the most 
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significant reductions by the two cardiothoracic muscles. This type of decline was 
seen for all other skeletal muscles investigated and is thought to be the result of the 
glucose insensitivity brought about by the insulin resistant state induced by pregnancy 
onto tissues (Hauguel et al., 1987; Leturque et al., 1980). However, from the RMF 
study it can be seen that meal feeding has actually enhanced glucose uptake and 
phosphorylation in the tissues investigated, except the heart. On comparison with fed 
virgin rats it can be seen that the GUI values for the pregnant meal fed rats have 
increased to almost normal fed values, except in the heart. Meal feeding these 
otherwise glucose intolerant rats has increased the capacity for all tissues (except 
heart) to utilize C6 substrates. Pallardo and Williamson (1989) observed increased 
lipogenic rates within the liver of meal fed rats: however glycogenic rates were 
similar to control ad libitum chow fed rats. The former observation was reinforced 
by Holness and Sugden (1989) showing hepatic pyruvate dehydrogenase activities 4- 
fold higher in a meal fed group when compared with rats fed ad libitum. Due to the 
inability of skeletal muscle to perform lipogenesis it is reasonable to assume that the 
bulk of this glucose is taken up and assimilated as glycogen, especially in the non- 
working muscles, or passed to the pyruvate dehydrogenase complex for complete 
oxidation to replenish energy stores after the 22h starvation period. 
Glucose utilization of the heart however, remains at surprisingly low levels when 
compared with the response by the other insulin sensitive tissues during meal feeding. 
Meal feeding pregnant rats produces a GUI value in the heart of 156.7 ± 29.4 nmol 
glucose. min-'. g-I which is exactly what would be expected in normal late pregnancy 
(Holness et al., 1991). The heart, a powerfully contracting muscle, under normal 
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physiological conditions relies substantially onC6substrates to maintain its continuous 
demand for energy. However, it has the ability to use other oxidisable substrates 
during states of starvation and differing physiological conditions such as pregnancy. 
Pregnancy induces a greater demand on the heart to pump a greater volume of blood, 
up to 40% more, to the ever increasing uterine blood system and other organs such 
as the liver. This implies a greater utilization of fuel, but as previously shown during 
late pregnancy does not involve the increased use of glucose. Meal feeding causes 
no influence on the heart, unlike the other tissues, to once again utilize the glucose. 
The heart remains a conserved area for the minimisation of glucose utilisation which 
is vitally required for the conceptus growth during its most rapid developmental stage 
of the third trimester. 
The diaphragm, also a continuallY contracting muscle, has a glucose utilization 
requirement of half the value of the heart which makes it a significant glucose drain. 
The control pregnant GUI value of the diaphragm is 97.2 ± 25.0 nmol glucose. min- 
whereas, in the meal fed condition it increases to 306.7 ± 50.6 nmol 
glucose. rnin-'. g-1; an increase of 215% and comparable to virgin control values of 
358.3 ± 40.6 nmol glucose. min-'. mg-'. 
The soleus and adductor longus show increases of 73 % and 91 % respectively, when 
compared with control pregnant values. These increased values are almost 
comparable to virgin controls being approximately 19-29% less. The non-working 
muscles; gastrocnernius, tibialis anterior and extensor digitorurn longus all increase 
to vastly enhanced levels, equivalent once again to virgin control values. The tibialis 
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anterior increased 380% and the EDL 800% compared with pregnant controls both 
of which are very substantial increments. Enhancements of glucose utilization at the 
levels seen in the non-working muscles compared with working muscles is most 
probably associated with elevated glycogen synthesis of which the non-working 
muscles have a greater capacity compared with working muscles (soleus and ADL), 
a consequence of meal feeding (Pallardo and Williamson 1989). Absorptive state 
glucose utilization in meal fed pregnant rats is, therefore, producing values which far 
exceed those seen in pregnant control rats, with the greatest enhancements seen in the 
two non-working muscles, EDL and TA, and to a lesser extent the two working 
postural muscles, soleus and ADL. The constantly contracting muscles, as previously 
discussed, show differing responses; the diaphragm increased to almost fed virgin 
values with the heart remaining at the greatly suppressed value, normally seen in 
pregnancy. 
3.4.2. Effects of 10 day meal feeding of pregnant rats on the GUT values durin 
the post-absorptive phase. 
The enhanced starvation status which late pregnancy induces has been shown in both 
the absorptive and post-absorptive states (Holness et al., 1991), with the post- 
absorptive state showing a further reduction from the absorptive pregnant state. 
During the post-absorptive phase shown in table 12, the meal fed pregnant heart has 
a value of 296.7 ± 72.8 nmol glucose. min-'. g-I which is directly comparable to the 
control value of 317.8 ± 66.1 nmol glucose. min-I. g-I and a relative increase of 89% 
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of the absorptive state. From this data it does seem that the heart does have the 
capability to increase its utilisation of glucose in the meal fed condition, but its 
responsiveness to the higher glycaemic conditions is obviously not as fast as the other 
insulin sensitive tissues. The heart is the only tissue to display this response in the 
post-absorptive state, the other tissues investigated have a varied suppression from the 
initial fed condition. 
The other muscle types investigated showed the expected decrease in GUI values 
while in the post-absorptive state. The diaphragm is reduced to a value equivalent 
to the control virgin but 27% higher than the control pregnant value. The two non- 
working muscles (TA and EDL), show declines of 85% and 86% respectively, from 
meal fed absorptive levels indicating the accelerated starvation state which pregnancy 
has on the mother after food withdrawal. Despite this dramatic decrease from the 
absorptive meal fed values they still remain higher than control pregnant post 
absorptive values by 45 % in the TA and by 84 % in the EDL. It is interesting to note 
that the rate of decrease from the two nutritional states is 3-5 times more in the meal 
fed pregnant group and yet the GUI values still remain higher than the control 
pregnant group. The soleus and ADL have very much smaller reductions of 27% and 
35% respectively, compared with the absorptive values which reflects in the 145% 
and 470% relative increases from the control post absorptive pregnant rat. 
Meal feeding pregnant rats, as with normal fed pregnant rats, shows the expected 
decline in glucose utilization from the absorptive to the post-absorptive states due to 
the developing starved status imposed by carbohydrate removal. However, the 
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relative rates of suppression in GUI values between the two nutritional states can be 
seen to be very different in different tissue types. The non-working muscles all 
decrease to levels which are approximately 85% less than their absorptive values, 
whereas the working muscles reduce to a rate equivalent to control pregnancy. The 
non-working muscles show an enhanced starvation pattern, during the fed period these 
tissues are rapidly assimilating and utilizing the circulating glucose for replenishing 
the glycogen stores for the subsequent 22h starved period. Once circulating blood 
glucose levels start to decrease from the fed state glycogen synthesis in these muscles 
is relatively switched off. The 10 day meal feeding regime seems to be sufficient to 
cause an enhancement by the non-working muscles to utilize the glucose for glycogen 
synthesis in preparation for the forthcoming starved period. 
3.4.3. Effect of administering controlled food amounts on the GUT values Of 10 
dav meal fed 19 dav Dreenant rats. 
Control 19 day pregnant rats eat approximately 28.7g of chow in a 24h period 
whereas the same time-mated 10 day meal fed pregnant rat will eat approximately 
11.0 g. Despite this substantial reduction in total chow intake the values for glucose 
utilization as have already been shown are very much greater than in the normal 
pregnant condition in the two nutritional states mentioned. If the chow allowed is 
then restricted to the equivalent amount eaten by a 22h starved 2h refed virgin control 
rat ie approximately 8.2g, representing 73 % of the total meal fed intake, a dramatic 
reduction in the GUI of all the insulin sensitive tissues looked at occurs. 
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GUI values were therefore measured at 12: 00h immediately after the controlled 
quantity of chow had been given. The response by the tissues to the reduced 
carbohydrate availability on the GUI was dramatic (table 13), showing reductions of 
approximately 70% in all the tissues. However, in the two non-working muscles, 
tibialis anterior and EDL, values still remained higher than control pregnant values 
by 63 % and 320 %, respectively. The heart was reduced to a value of only 47.8 nmol 
glucose. min-I. g-1. The fact that the two non-working muscles remained higher than 
control pregnant rats may suggest that carbohydrate levels at lower concentrations can 
be utilized at relatively high rates by these tissues and that glycogen synthesis is, 
therefore, one of the mechanisms enhanced during a sustained period of meal feeding. 
3.4.4. ' Effect of 10 day meal feeding pregnant rats on GUI values in absorptive- 
post absoriptive states in various adipose tissue sites. 
The physiological condition imposed by pregnancy has been shown to suppress the 
use of glucose by the mother (Holness et aL, 1991). This condition can be reversed 
by meal feeding pregnant rats for a relatively short period of time of only 10 days 
causing enhanced utilization of glucose in most tissues. Since meal feeding is 
associated with increased lipogenic, glycogenic (Pallardo and Williamson 1989) and 
pyruvate dehydrogenase activities (Holness and Sugden 1989), the GUI of various 
adipose tissue sites was investigated in the 10 day meal fed 19 day pregnant rat. 
Very few studies have been conducted on glucose utilization by different adipose 
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tissue sites, especially during pregnancy. It has previously been shown in that during 
the initial stages of pregnancy fat storage is enhanced, reflecting the increased glucose 
conversion in adipose tissue sites. As pregnancy reached the third trimester, glucose 
conversion to maternal fat stores was substantially reduced as the tissues' insulin 
responsiveness declined (Knopp et al., 1973). 
Table 14 shows the glucose utilization values of five different white adipose tissue 
sites; the parametrial, mesenteric, perirenal, subcutaneous and interscapular. The 
meal fed pregnant rats show a vast enhancement for the utilization of glucose in the 
three nutritional conditions imposed on the pregnant rat ie. absorptive meal fed; 
absorptive meal fed restricted last meal of 8g and post-absorptive meal fed when 
compared with respective controls. The greatest enhancement shown is by the 
perirenal adipose tissue which has a value of 168.3 nmol glucose. min-'. g-I in the 
absorptive state, this represents an increase of 24 times the value of 22h starved 2h 
refed virgin controls. The interscapular increases by 7.3 times, the mesenteric and 
subcutaneous by 4.5 and the parametrial by 3.2 times. The total glucose utilization 
of these tissues represents a value of 476.7 nmol glucose. min-'. g-1, clearly a major 
glucose expender. This vast enhancement by the adipose tissues to utilize the 
circulating glucose must be a consequence of increased lipogenic rates by the tissue 
cells. As previously discussed meal feeding rats increases hepatic lipogenic rates to 
substantially higher rates. Pallardo and Williamson (1989) showed increases in the 
rates of fatty acid synthesis of nearly 10 fold in a meal fed group on refeeding, 
whereas the control 21h starved 3h refed group showed no significant increase in 
lipogenic rates. These results suggest that glucose must therefore be a very important 
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substrate for fatty acid and cholesterol synthesis in the white adipose tissue sites 
during pregnancy, together with the possible utilization of lactate and amino acids. 
Previous studies on glucose utilization rates in white adipose tissue sites have shown 
no real change during pregnancy (Leturque et al., 1986) together with normal insulin 
sensitivity (Leake et aL, 1969; Knopp et al., 1970). This present study suggests that 
even during late pregnancy lipid synthesis in these tissues must be greatly increased 
to produce enough energy reserves for the following 22 hour starvation period to 
which the rat has become accustomed to. 
During the post-absorptive state as with the other peripheral tissues discussed, the 
glucose utilization still remains much higher than control 22h starved 2h refed rats. 
The perirenal, once again, remains at the highest value when compared with its 
control (218% increase) but the mesenteric has the highest index. Restricting the 
amount of chow allowed by the rat to the control amount of 8g still produces an 
enhancement in the utilization by the various adipose sites but the values are greatly 
suppressed from the ad libitum meal fed group. The greatest suppression is found in 
the mesenteric, this tissue falls to just over half of the control value, this maybe due 
to it requiring a higher concentration of carbohydrate before lipid synthesis will 
occur, otherwise due to its close proximity to total carbohydrate intake, lip id synthesis 
would constantly be switched on. 
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GUI Values For Virgin, Pregnant ad libittim 
& Pregnant RMF In Working & Non-Workinu tn t., TiSS'Lle Types During The Absorptive State. 
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Absorptive GUI Values For Virgin, PregnaQ W libHum 
& Pregnant RMF In Cardiothoracic Museles 
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3.5. General discussion. 
The initial studies in this chapter on the effects of pregnancy have demonstrated the 
glucose sparing ability by the mother, so as to conserve the circulating glucose levels 
for the development of the conceptus. Despite increased food intakes and decreased 
utilization of glucose by the mother, glucose levels of near term rats decrease to 
hypoglycaemic levels (Holness et al., 1991). This can be looked upon in two ways; 
firstly it could be due to the haemodilution effect caused by the increased blood 
circulation to the conceptus, and other organs, whose blood capacity has increased 
(Clapp, 1978) like the liver, for example (Tindall, 1975). Alternatively, it could be 
due to the increased glycaemic requirements of the rapidly developing conceptus 
(Spellacy, 1975; Adam and Felig, 1978). Glucose utilization by otherwise insulin 
sensitive tissues is decreased substantially, with the heart showing the greatest 
reduction in glucose uptake and phosphorylation. From the results obtained in the 
latter study, the insulin resistant state of late pregnancy has been overcome by placing 
the rats on a routine meal feeding regime. Tissues which would otherwise have a 
diminished response to a high carbohydrate challenge show the complete opposite 
effect, glucose utilization by these tissues is enhanced to levels far exceeding those 
normally expected during near term pregnancy, resembling values more like control 
virgin rats. The increases in GUI is despite the substantial reduction in the total chow 
intake when compared with normal pregnant rats at the same gestational stage. It 
could be argued that the increase in GUI of the individual tissues is due to the 
refeeding of the rat as might be expected in a 24 h starved 2h refed pregnant state. 
However, a comparable study by Holness and Sugden (1993) reported GUI values 
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in 24 h starved 2h refed late pregnant rats of 84.4,81,1 and 28.3 nmoles/min/g in 
the EDL, TA and gastrocnemius, respectively. In contrast, this study produced GUI 
values of 115.6,102.2, and 76.1 nmol/min/g wet wt. in the RMF late pregnant group 
in the same tissues, respectively. These values represent increases of 37%, 26% and 
169% in the EDL, TA and gastrocnemius muscles. This further implicates the 
method of meal feeding as producing significant changes in glycaemic control by the 
otherwise glucose intolerant muscles. During the absorptive phase the two non- 
working muscles (TA and EDL) show the greatest significant change from control 
pregnant values, this, no doubt, is due to glycogen being rapidly synthesized. After 
food removal, during the post-absorptive phase, the non working muscles become 
greatly suppressed from their original fed values, while the postural working muscles 
(soleus and ADL) remain significantly enhanced. The various white adipose tissue 
sites show a similar response to the meal fed conditions with significant increases in 
glucose utilization in all five sites studied. Meal feeding has produced a concerted 
response by energy storage tissues to accumulate and utilize as much, as possible, of 
the free glucose available during the re-feeding state. The food regime has enhanced 
intracellular storage mechanisms to protect the mother and conceptus for the long 
fasting period. A large proportion of the circulating glucose must, therefore, be 
converted to high energy storage compounds such as glycogen and fatty acids. 
The heart, however during the routine meal feeding regime, unlike the other tissues 
investigated, shows very little change in its glucose utilization when compared with 
normal pregnancy. Glucose utilization indices remained greatly suppressed in the 
meal fed condition giving values of exactly the same as control pregnant rats. The 
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heart is a very significant utilizer of glucose and is probably targeted very heavily as 
a source of glucose conservation during pregnancy. Randle et al. (1964) showed that 
if the heart is being perfused. by high concentrations of fatty acids and ketone bodies 
then the glycolytic rate of the heart will be suppressed. During pregnancy this is in 
fact the case and could be the special reason for the heart to remain insensitive to a 
glucose challenge in the meal fed pregnant state. 
The heart seems to be a very important regulatory control organ for the glycaemic 
state of the rest of the body. It has a capacity to utilize other oxidisable substrates 
more easily, and with the heart being a major energy requiring organ, this allows free 
glucose to be utilized else where. During pregnancy this is even more important with 
the welfare of the conceptus, being a primary concern. With this in mind, it must be 
pointed out that during meal feeding since the mothers capacity to utilise glucose has 
been restored what then is the consequence of the glucose utilisation of the conceptus? 
Since gestation channels glucose toward the conceptus, is the process of this severe 
meal feeding affecting normal metabolism of the foetus(es)? 
Administration of controlled amounts of food to meal fed pregnant rats was studied 
to evaluate whether a certain amount of carbohydrate intake is required to promote 
enhanced glucose utilisation. From table 13 it can be seen that controlled feeding 
severely reduces the majority of the tissues glucose utilisation capability. 
Interestingly, only two tissues, the tibialis anterior and EDL had higher GUI values 
than control 20 day pregnant rats. All other tissues investigated were oxidative 
working tissues and had very much suppressed GUI values compared to control 20 
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day pregnant rats. This may suggest increased glycogen deposition in the non- 
working muscles rather than glucose oxidation and maybe the key influence of meal 
feeding during pregnancy. Reductions in GUI values, even in the heart which is 
severely suppressed during normal pregnancy, may suggest a carbohydrate level is 
required to trigger enhanced peripheral tissue glucose utilisation as well as the 
conditioning that meal feeding promotes onto the due to nutrient availability. 
The findings in this study have implications for mothers with a high risk of 
complications of eclampsia and intrauterine deaths during pregnancy caused by 
abnormal glucose intolerance. These mothers (approximately I% of all pregnancies) 
develop gestational diabetes mellitus and up to 24-50% of these mothers develop 
NIDDM postpartum (O'Sullivan 1988). The method of routine meal feeding 
illustrated in this thesis has been conducted at extremes to show the effects during 
pregnancy. However, on a more clinical line of thought a similar method of 
controlled food intake could be adopted by mothers at risk of GDM or to those with 
a history of non-insulin resistant diabetes mellitus. This study does suggest that food 
intake patterns could be used as a precautionary measure for high risk mothers, 
however further studies are needed to evaluate the effects on the conceptus as well 
reducing the severity of controlled feeding shown by this study. 
3.5. PDH activities and other aspects of pregnancy. 
Activities of PDH were extensively investigated for the heart, diaphragm and liver 
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during the various stages of gestation. However, despite conducting numerous 
experiments consistency was not achieved. This was attributed to the a number of 
reasons. Firstly, the metabolic state which pregnancy exerts upon the mother 
promotes an "accelerated starvation" state, which has previously been discussed. This 
makes analysis of the PDH complex extremely difficult on account of its tight control 
on carbohydrate oxidation. Holness and Sugden (1989) demonstrated the extent of 
PDH inactivity over a 48 h starvation period and showed dramatic declines of 68% 
in cardiac PDH activity following 3-4 h of food withdrawal, this was despite hepatic 
glycogen concentrations being 70% of the fed value. As has been demonstrated, 
cardiac GUI values in the fed state on day 20 of pregnancy resemble those obtained 
following a 24 h starvation period in the rat. With this in mind it can be assumed 
that immediately following food withdrawal, the PDH complex would be in a rapid 
transition to becoming inactive. The technique for measuring PDH activity would 
have to be very swift and consistent between the groups. Unfortunately, when 
experiments were conducted it was assumed that PDH activities remained constant for 
3h following food withdrawal, as is the case in the virgin state (Holness and Sugden, 
1989). This obviously is not the situation during pregnancy, where the PDH complex 
is targeted quicker during periods of short term starvation. Since PDH activity and 
carbohydrate are tightly linked it must be assumed that during late pregnancy, even 
in the fed state, PDH activities must reflect a greater degree of starvation compared 
to the actual nutritional status. The assumption that three hours of starvation during 
pregnancy does not significantly affect activities of the PDH complex caused the 
inconsistency within the groups studied. During the period of tissue excision, the 
PDH complex was already rapidly becoming inactive. The inactivity of the complex 
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is compounded by the fact that elevations in fatty acids seriously suppresses PDH 
activity (Randle et al., 1964, Holness et al., 1989). During late pregnancy the 
circulation of fatty acids and triglycerides are substantially elevated hence contributing 
to the inactivation of the PDH complex. 
A study by Holness and Sugden (1993) investigated the relative changes in PDH 
activity by fast-twitch muscles during late pregnancy. The tissues studied included 
the gastrocnemius, tibialis anterior and EDL all of which are non-oxidative and have 
quite low GUI values in the fed state compared to muscles such as the'heart, 
diaphragm and soleus. It was revealed that during the fed state there was no 
difference between late pregnant and virgin rats in all three of the tissues investigated. 
Differences were only noted following a 24 h period of starvation and refeeding, 
where PDH activities were significantly lower compared with virgin 2h refed rats, 
which had already re-established fed PDH values. During starvation of pregnancy 
non-oxidative tissues rely heavily upon lipid fuel oxidation, following refeeding these 
substrates still play an important part in the energy requirements of these tissues. 
Interestingly, fed PDH values were unaffected by late pregnancy, however GUI 
values were substantially suppressed to 15 % (EDL) of virgin fed values, see above. 
This raises questions concerning carbohydrate control during late pregnancy in non- 
oxidative muscles. If GUI values decrease and lipid fuel plasma circulation increases 
during the fed state, PDH activities would be expected to be suppressed, but this was 
not shown (Holness and Sugden, 1993). If this is the situation, then the glucose 
intolerance shown by these muscles could be correlated to membrane glucose 
transport processes. Glucose transport has been observed to be mediated by a 
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combination of different GLUTs all of which are tissue specific and are not coupled 
to ATP or H' gradients. Despite the close homology of all these proteins they are 
all independently expressed as specific genes and have varied kinetic capabilities. 
The role of GLUTs in glucose homeostasis is self-evident, widening the possibilities 
of understanding physiological states which impose glucose intolerance. Studies on 
the glucose transporters (GLUTS) (Gould and Holman, 1993) could reveal changes 
which are relevant to the apparent glucose intolerance shown by skeletal and 
cardiothoracic muscles. By far the most interesting tissue for investigation would be 
the heart which undergoes a substantial shift away from glucose utilisation to other 
forms of oxidative substrates such as ketone bodies and other lipid derived substrates. 
GLUT 4 and GLUT 1 are the predominant transporters in the heart and it is proposed 
that either one or both of these transporters are severely depleted as gestation 
progresses. If the total membrane protein of these glucose transporters are 
diminished, this would account for some of the glucose intolerance seen during late 
pregnancy. A study by Kraegen et al. (1993) has shown that following 48 h of 
starvation GLUT I levels were severely reduced, implicating an insulin responsive 
role of the transporter. Glucose intolerance during pregnancy may be attributed to 
several metabolic factors including hormonal action (eg. placental lactogen which is 
diabetogenic agent) increased lipid circulation, glucose transport systems and insulin 
responsive aspects of tissues. It is difficult to assess the various contributions of these 
factors and whether the change in one of the factors is directly related to another and 
hence is just a direct consequence of the new metabolic state. The trigger mechanism 
for the glucose intolerance/insulin resistance requires defining. 
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CHAPTER 4. 
Nudear mametic resonance spectroscopy 
4.1. Brief history 
The phenomenon of nuclear magnetic resonance (NMR) was first detected in 1946 
independently by Purcell et al. and Bloch et al.. Since its discovery it has provided 
a tool primarily for proton detection in the chemical laboratory for the analysis of 
composition and structure of organic compounds. The first magnets used were 
extremely large, weighing several tons and consisted of large electromagnets which 
required very high current to produce the necessary field strength. The power 
supplied was stored in large oil filled capacitors contained in a vacuum, this made the 
application of NMR a risky business especially in the event of a breakdown when the 
capacitors had to be discharged manually. It was not until the late 1950's, when 
improvements to the design of the magnet and data processing started to develop, that 
its application could be widened to other nuclei (Lauterbur, 1957; Lauterbur, 1958; 
Holm, 1957). However, at this early stage in its development only relatively pure 
compounds in homogenous solutions could be analysed. For its use as a biochemical 
and clinical tool better magnets were required. The advent of super-conducting 
magnets in the late 1960's eliminated a lot of the power problems associated with the 
electromagnets and produced far greater field strengths, a pre-requisite for better 
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resolution. The principle of the super-conducting magnet relies on the property of 
certain alloys which exhibit zero resistance at very low temperatures. This allows a 
closed loop of this alloy wire to absorb electrical current without any heat loss, due 
to resistance of the wire, which can then remain indefinitely so long as the wire is 
constantly being cooled at the correct tempeiature. For this purpose the magnet 
contains coils consisting of either niobium-titanium or niobium-tin which are 
immersed in liquid helium (-269*C). Loss of helium is minimised by various vacuum 
chambers and by cooling with the cheaper cryogen, liquid nitrogen. However, there 
is always the inevitable loss of these two cryogens and hence, the magnet must be 
regularly topped up. The magnet is energised by slowly increasing the current from 
the power supply until the correct field is obtained, the magnet is isolated from the 
power supply via a special switch thus producing a magnet with constant current and 
zero potential difference at the required field strength. 
Following the advances in the "hardware" of the spectrometer and the advances borne 
from Fourier transformation NMR (see later), a new era in applications emerged. 
Spectrometers were no longer just vertical small bore magnets for chemists to insert 
small sample tubes into, but developed into horizontal wide bore, high field systems 
capable of producing high resolution images and chemical shift spectra of whole 
animals and humans. A rapid exploitation into the in vivo non-invasive aspect of 
NMR followed. For the biologist the ability of monitoring metabolic pathways 
involving several metabolites was an exciting prospect especially in exogenously 
perturbed systems. The first productive metabolic study of intact cells was reported 
by Moon and Richards (1973) who showed that by using phosphorus spectroscopy of 
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red blood cells, 2,3 diphosphoglycerate, inorganic phosphate and the three phosphorus 
ATP components could be resolved. Furthermore by monitoring the chemical shift 
difference between the inorganic phosphate and ci-ATP resonance, the intracellular 
pH (pH) of the cell could be assigned. Studies then graduated to muscle metabolism 
where muscle biopsies and single muscle preparations of hind limbs of rats and frogs 
were placed into the magnet (Hoult et al., 1974; Dawson et al., 1977). As well as 
phosphorus, carbon was gaining the recognition of being an important nucleus in 
studies defining metabolic end products (Cohen et al., 1979; Cohen et al., 1979a). 
These early experiments provided a foot-hold required for the advancement of NMR 
application to biological systems. Most recent work has involved a plethora of 
applications to the heart, liver, muscle, brain and kidney, using a varied array of 
nuclei (possessing non-zero spin). Nuclear magnetic resonance provides an elegant 
method for metabolic studies providing information on organs with the minimum of 
abnormal manipulation. The work in this thesis has utilised the advantages of both 
carbon and phosphorus NMR for in vivo assessment of control of hepatic glucose 
utilisation, glycogen synthesis and gluconeogenesis. 
4.2. Basic principles of nuclear magnetic resonance spectroscopy. 
As the name suggests the principle process involves the resonance of specific nuclei 
whilst in a homogenous and directional magnetic field. Different nuclei resonate at 
different frequencies (their natural resonances, as in a tuning fork) in a given 
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magnetic field, hence information on the nuclei in question can usually be gained 
without the participation of other nuclei, which have their own natural resonance in 
the same field strength. Nuclear magnetic resonance involves the interaction of 
electromagnetic radiation with matter which upon perturbation will emit a similar 
radiation, in the form of a resonance, which can subsequently be detected. It is 
important to note that only a certain species of nuclei are NMR visible, these include 
nuclei with an odd mass number and hence, have a half integral spin, and those which 
have an even mass number but an odd atomic number and hence, have an integral 
spin. Those-nuclei which have an even mass number and an even atomic number 
have zero spin and are not NMR visible. In the case of biological systems the most 
relevant nuclei include hydrogen (11-1), carbon ("C), phosphorus CIP), sodium (Na) 
and nitrogen ("N and "N). Since the technique is critically dependent on the natural 
abundance of these isotopes certain nuclei are easier and quicker to detect. From 
table 15. proton and phosphorus nuclei are shown to be amongst the most prevalent 
naturally occurring isotopes and hence, their extensive use in spectroscopy and 
imaging. 
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Table 15. NMR Properties Of Biologically Important Nuclei. 
Nucleus Spin quantum 
number 
Resonance 
frequency at 
5T (MHz) 
Natural 
abundance 
*Relative 
sensitivity 
111 1/2 213.0 99.985 100.0 
13C 1/2 53.5 1.108 1.6 x 10-' 
31 P 1/2 86.2 100.00 6.6 
'Na 3/2 56.3 100.00 9.3 
14 N 1 15.4 99.63 1.0 x 10-1 
ineoreticai iNmK sensitivity ot nuciei at constant neia pi) reiative to inat oi: an 
equal -number of 'H, multiplied by the percentage natural abundance. (Gadian, 1982) 
Carbon however, has a natural abundance of only 1.1% but this property can be 
exploited by developing tracer-like experiments which follow the metabolic 
consequences of a bolus administration of a "C-enriched compound in the system. 
Another important aspect of detection is the relative sensitivity of the isotope which 
reflects the net magnetisation of the nuclei. From table 15. it can be seen that 
relative to the proton, phosphorus and carbon, have relatively poor sensitivity values 
and therefore weaker magnetisation. Sensitivity and natural abundance of the nuclei 
are intrinsic factors which determine the detection ability of NMR with respect to 
time and signal intensity. To obtain spectra with good signal to noise various factors 
must be considered, these are outlined in table 16. 
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Table 16. Important considerations for acguiring NMR spectra. 
1. Absolute sensitivity of nucleus. 
2. Abundance of nuclei. 
Volume of sample. 
4. Magnetic field strength of magnet. 
5. Homogeneity of static magnetic field. 
6. Number of acquisitions ie number of averages making up one spectrum. 
7. Longitudinal relaxation time of the nucleus (TI). 
8. The splitting/width of the spectral lines (T2 influenced) and spin-spin coupling. 
9. Pulse sequence used to acquire spectrum. 
10. Configuration and size of coil relative to the sample. 
The variables in table 16 must all be addressed to obtain the best spectral resolution 
and signal to noise ratio, see below. 
Signal to Noise Ratio = 2.5 x signal height 
peak to peak noise 
To completely understand the concepts involved in NMR a thorough knowledge of 
quantum mechanics is required. Fortunately, to grasp an outline of the theory a 
simpler model can be applied. This illustrates by classic physical phenomena how 
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nuclei respond to induced changes during the NMR experiment. When a nucleus is 
placed in the magnetic field the spin and charge of the nucleus try and prevent 
orientation around the field and so they precess around the BO axis (Z-axis), rather 
like a spinning gyroscope, setting up a net magnetic moment Mz. As can be seen in 
figure 11 the rotation of the nucleus resembles a cone in shape (as would that of a 
gyroscope viewed from above) and this is called the Larmor precession and the 
frequency of the precession, the Larmor frequency. The frequency of the oscillation 
is dependent on the magnetic field strength, see equation 1. 
Equation 1. 
wo = y. Bo where w,, = frequency. 
-y = gyromagnetic 
ratio of nucleus. 
%= field strength. 
Page 141 
x 
Figure 11. Precession of nuclei about the z axis setting up 
a net magnetisation 
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B07. 
y. 
x. 
Figure 12. Tilting of magnetisation towards the xy' plane 
following the B, pulse. 
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At this point in the discussion the "rotating frame" concept must be introduced in 
which an orbiting satellites' view of the earth must be imagined. If the satellite is 
travelling at a velocity which allows the same continuous view of Britain, then the 
earth will appear stationary and at a fixed angle to the vertical perspective. If this is 
then applied to the precessing nuclei, in which the observer is rotating at the same 
Larmor frequency as the nucleus, then the net angle of the nucleus to the Z-axis can 
be visualised as infigure 11. Since the sample will contain a population of different 
spinning nuclei, depending on their chemical environment, phasing and direction of 
spin (nuclei can spin either clockwise or anti-clockwise), further simplification can 
be achieved by representing the spinning nuclei as a coherent net magnetic moment 
ft as in figure 12. It must be emphasised however, that the spin population is 
completely random, there is no coherence in the phasing of the spins and so it is this 
property which is exploited in NMR. Introduction of another magnetic field (B, ) in 
the direction of X', as is the case of NMR experiments, causes a perturbation in this 
net magnetic moment towards the X'Y' plane (Mx. r), shown infigure 12. The B, 
field is applied perpendicular to the BO field and has the same frequency as the 
Larmor frequency of the nucleus under observation and can therefore be represented 
on the 'rotating frame' scheme. The B, field is provided by a coil placed next to the 
sample which is pre-tuned to the correct radio frequency (r. f. ) (ie the Larmor 
frequency), it produces two opposing fields of the same frequency, one electric and 
one magnetic, the latter being important. Typically the r. f. field (B, ) is applied in 
short pulses (microseconds) and depending on the length of the pulse determines to 
what extent the angle of magnetisation of the nuclei to the Z axis has increased, see 
equation 2. 
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Equation 2. 
Bj. -y. ý 
Therefore an r. f. pulse producing a 90* tilt can be expressed as: 
Equation 3. 
, r/2 =BI., y. ý where: 
duration of pulse. 
B, r. f. field 
0 angle tilt with respect to Z 
Prior to the r. f. pulse, the spins are randomly phased ie precessing randomly about 
BO, then immediately after the pulse the spins become coherently phased, producing 
a net component of magnetisation (Mx. y) separate from either BO or B, but rotating 
about BO at a frequency wo. This component of magnetisation induces an 
electromotive force (e. m. f. ) in the detecting coil at frequency wo, however as Mx, r 
decays due to the resonance provided by B, being no longer applicable, the spins 
become randomly phased and eventually produce no net signal due to the loss of spin 
coherence reflected by Mrr. The exponential time course associated with this decay 
in a homogenous static field is called the spin/spin relaxation time (T2). This 
parameter is a measure of signal duration or line width produced by the perturbed 
nuclei and is determined by the interactions of energy transfer by other nuclei. Since 
no magnet is completely homogenous this value in practice is smaller due to 
dephasing occurring quicker to that in a perfectly homogenous static field. A second 
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exponential time constant associated with Mrr is the longitudinal (spin-lattice) 
relaxation time T,, this determines the rate at which the spinning system returns to 
the Z-axis totally de-phased, producing no induced e. m. f. This parameter determines 
the duration required between pulses when the nuclei have returned to the resting 
equilibrium about BO. As the Mx-r magnetisation disappears so does the induced 
e. m. f. producing a signal referred to as a "free induction decay" (FID), seeflgure 
13. This oscillating signal contains information about various different species of the 
nuclei concerned within the sample. Nuclei within a sample will have a variety of 
chemical environments depending on the type of bonding associated with its 
neighbour and the type of nuclei it is bonded to. The chemical environment of the 
nucleus will determine the electron cloud composition surrounding it and hence will 
slightly shield the nucleus (aB) from an applied magnetic field. This gives rise to 
a local magnetic field to which the applied r. f. field induces an electronic orbital 
angular momentum producing a small additional field 3B such that: 
Equation 4. 
B+ 6B = B(I - a) ........ Total local fidd. 
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Time 
Figure 13. Free induction decay - FID. 
It is this shielding effect which will produce a slight variation in the induced e. m. f. 
to the applied Larmor frequency and hence the precise resonance of the nuclear spins 
will depend on its particular chemical environment (resulting in variations in both the 
time and frequency domains). The shielding effect is different for every type of 
chemical environment within a molecule and so shieLding constants (a) for particular 
nuclear species can be calculated. The slight variation to the Larmor frequency 
applied produces a different induced frequency called the chemical shift. Therefore 
when a FID is obtained it will contain a multitude of component frequencies 
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depending on the molecular basis of the sample. To the human eye it would be 
extremely difficult to differentiate between the frequencies obtained and a more 
convenient method of interpretation is applied in the form of Fourier transformation 
(Cooley and Tukey, 1965; Ernst and Anderson, 1966) which employs an, algorithm 
for conversion. This process is computer aided and converts the free induction 
decay, which is a function of time, into its component frequencies with respect to 
their relative intensities. The Fourier transformed representation of the FID is 
measured in parts per million (ppm), this scale does not depend on B. as it is 
dimensionless. This scale allows a universal comparison of spectra obtained from 
various field strength magnets to be achieved, therefore it can be regarded as a 
standard normalisation procedure. 
4.3. The r. f. coil. 
Generation of the r. f. field and the detection of the induced e. m. f. are both usually 
accomplished using the same coil. In high resolution vertical bore magnets the coil 
surrounds the sample tube. However, for in vivo spectroscopy a wide range of coil 
designs is implemented. In order to obtain spectra restricted to the tissue or organ 
of interest, such as the heart and liver coils are designed specifically. Fortunately, 
probe construction is relatively simple and so the size and shape required can usually 
fit the experimental protocol. The design, however, must account for the volume of 
sample to be examined in order to obtain the best sensitivity from the coil. The most 
frequent type of coil is the sur fiace coil which is flat and usually one or two turns 
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which can be placed directly on the tissue/organ of interest. The major disadvantage, 
or advantage depending on the experiment, of the surface coil is the inhomogeneous 
B, field which is produced, this however is not the case with either the saddle or 
solenoid coils. As you move axially away from the coil the B, field drops slightly. 
However the further away you are the greater the drop in field strength which results 
in the reduction in signal intensity. This produces an array of flip angles, ranging 
from the r. f. pulse angle down to zero, inducedinto the sample dependent on the 
distance from the coil surface, hence surface coils are capable of a limited amount of 
localisation by choosing correct pulse widths. The degree of localisation will depend 
on the size of the coil, the r. f. pulse power and the volume of the sample. This 
introduces an important consideration when using surface coils on multiple tissue 
systems that the signal produced is solely from the tissue of interest and not from the 
surrounding tissue which may have different metabolic properties. It is important to 
note that a B, field is induced above and below the coil in an elliptical fashion. 
In the studies illustrated in this thesis, two types of surface coils were used, both of 
which were "home-made". The phosphorus coil consisted of a single turn of 
insulated wire whereas the carbon coil consisted of one single turn coil and a 21h turn 
coil (the former tuned to decouple protons and the latter tuned to IIQ . Depending 
on the nuclei of concern the coils were developed and tuned to the. respective Larmor 
frequency for the static field strength of the magnet used. Tuning is accomplished 
by simply applying the correct capacitance across the coil and matching it to 50 0. 
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4.4. Advantages and disadvantages of NMR. 
Nuclear magnetic resonance spectroscopy is a relatively new tool for biochemical and 
medical analysis. Its elegance lies in its non-invasive and non-destructive attributes 
and is rapidly gaining rightful recognition as its potential is understood. There are 
many advantages in using this technique, the most important of which is that it allows 
the analysis of metabolic perturbations in whole body living systems, without the need 
for elaborate surgery. Conventional metabolic studies usually require many samples 
to be obtained to provide adequate time courses of the metabolism under question, 
therefore producing lengthy and laborious studies. With NMR it is possible to follow 
the time course of perturbed systems of one individual subject over long periods of 
time. This reduces the number of subjects required considerably and produces a 
wealth of other synchronous information, not possible with conventional 
methodologies. In the work presented in this thesis information has been gained on 
various aspects of hepatic glycaemic control using anaesthetised rats (without the need 
for laborious chemical assays). (If studied closely enough, information on substrate 
availability and enzymatic control can be gained. ) However, in order to gain 
maximum sensitivity and less spectral contamination from other surrounding tissues 
it usually necessary to expose the rat livers directly against the coil itself. This is one 
disadvantage of NMR in that it lacks sensitivity and anything which can be done to 
improve this helps in the resolution of the spectra. In this situation NMR is no longer 
non-invasive but can still be regarded as non-destructive to the organ of interest. 
Developments in pulse sequences are overcoming this problem producing localisation 
techniques which allow the study of various organs such as the liver (Cox et aL, 
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1988), brain (Bottomley et al., 1983), heart (Blackledge et al., 1987), kidney Que et 
al., 1987) and muscle (Taylor et al., 1983); Narayana et al., 1988; Pan et al., 1988) 
from the intact body and hence its application to human metabolism is becoming more 
prevalent. Unfortunately, there is a trade off in a decreased sensitivity of a nucleus 
when localisation techniques are applied (due to a smaller volume producing less 
overall signal whereas, the coil has a bigger volume capability which would produce 
a greater signal). Since NMR has an inherent lack of sensitivity [ie detection has to 
be in the millimolar range; > 0.2 mmol/l at 100 % natural abundance (Cohen et al., 
1987b)], localisation. exacerbates this which inevitably increases experimental times, 
a major disadvantage with the technique. When obtaining NMR spectra, 
considerations must be made for the relaxation times of the metabolites under 
examination as well as the population of mobile to immobile metabolites since only 
those which are mobile are detected. The latter consideration is realised in vitro 
where higher concentrations of particular metabolites are seen, suggesting tight 
binding to divalent metal ions and other macromolecules (Brown et al. 1973; Lawson 
and Veech, 1979) eg. ATP binding to MgI producing different chemical shifts 
compared with in vitro analysis. The other disadvantages are purely financial, in that 
the machinery is expensive which reduces its availability and makes machine time a 
precious commodity. However, the advantages far outweigh the disadvantages in the 
flexibility and information obtainable using this technique. No other technique has 
the capability of producing a vast amount of information regarding anatomy and 
biochemical processes of the intact organ or tissue of interest. 
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4.5. Previous in vivo studies tSine 13C and 31p nuclei. 
4.5.1. '3C-Nuclei. 
Carbon has a special role in NMR with regard to biochemical studies. This nucleus 
is ubiquitous in metabolism and yet 11C, the stable NMR visible isotope, has a very 
low natural abundance and sensitivity. Experiments can be designed, however, to 
partly overcome and in some cases take advantage of these properties. As briefly 
mentioned previously, bolus administration of an enriched source of "C, such as I- 
"C glucose, can give information on end products containing this enrichment, such 
as IYC glycogen. By using specific carbon labelling various pathways can be 
studied, Placing two "C nuclei together in a molecule is highly informative since the 
point of chemical cleavage of these carbons can be verified in a pathway if the I'CYC 
coupling disappears. Carbon spectra have a very large chemical shift range of 
approximately 200 p. p. m. (IH = 10 p. p. m.; IT = 25 p. p. m. ) which enhances the 
ability to distinguish between structurally similar compounds. Unfortunately carbon 
is almost always attached to a proton, and depending on the carbon-proton species of 
a neighbouring carbon-13 (ie -CH2,, -CH3. -CHO etc. ) multiple resonances around the 
definitive chemical shift will occur; this is due to heteronucleur spin-spin coupling 
which produces a different shielding effect and hence a variation in the magnetic 
moment and therefore splitting of the resonance line according to the n+ 1 rule, where 
n= number of protons. To overcome this problem the protons are continuously 
irradiated at the proton Larmor frequencies which makes all proton species the 
"same" and the carbon spectra can therefore be obtained totally decoupled from the 
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protons ie. proton splittings are eliminated. This process will also increase the peak 
magnitude and allow different 11C species to be assigned one specific chemical shift, 
see table 16a. Constant irradiation simplifies the spectra obtained but also enhances 
further the signal intensity by a factor up to 3-fold, caused by the nuclear Overhauser 
effect (nOe) (Campbell and Dobson, 1979), by altering the relative populations of the 
"C spin states. It is therefore important, when obtaining quantitative spectra, that the 
signal intensities are corrected for nOe effects. 
A wide range of applications to cells, tissues, animals and humans has been 
investigated but in this synopsis "C relevance to animal hepatic metabolic studies will 
be discussed. 
A study by Alger et al. (1981) was one of the first in vivo experiments to be carried 
out exploring the ability of "C-NMR as a tool for glucose/glycogen metabolism. 
Several experiments on rats and humans provided carbon spectra prior to and after 
a bolus intubation of "C labelled glucose. The hepatic studies on fasted rats showed 
that the "C-enriched glucose resonances could be detected 45 min. after 
administration. Furthermore, PIC glycogen could be resolved after 75 min.. The 
enrichment shown was very small but detectable even at the low field strength of 1.89 
T. It suggested that studies could be carried out to further understand this pathway 
in various physiological states, including diabetic states and that it could be an 
important tool for characterising nutritional fat deficiencies and abnormalities by 
examination of the fatty acid resonances, most prevalent in hepatic "C-NMR. Prior 
to this study various perfused liver experiments had been carried out (Cohen et al., 
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1979; Cohen et al., 1980; Cohen and Shulman, 1980; Bailey et al., 1981) together 
with rat liver cell experiments showing the conversion of 1,3-"C-glycerol to the 
various a and B anomers of glucose (Cohen et al., 1979a). Metabolic pathways have 
been followed by the recognised technique of "C tracer experiments. These 
experiments require the quenching of metabolic processes to prevent complications 
in interpretation followed by laborious tissue extractions. Use of "C eliminates these 
problems since various components of metabolic pathways can be monitored in vivo. 
A study by Cohen et al. (1981) compared the merits of I'C and 'T and it was 
concluded that the results from both techniques were highly comparable (experimental 
errors between the two groups after analysis of specific metabolite labelling ranged 
from ±2% to ±7%). However, IIC proved to be a more versatile probe of 
metabolism compared with its 'T counterpart on the simple basis that a wide ranging 
number of pathways could be measured from the one experiment. The one major 
disadvantage of I'C metabolic studies is the relatively large quantities of label 
required to produce sufficient enrichments for NMR detection. A liver perfusion 
study by Sillerud and Shulman (1983) suggested that all the hepatic glycogen is NMR 
visible, except particle molecules of W and 10' molecular weight. This was 
achieved by monitoring real time glycogen synthesis rates after incubation of 30.6 
mmol/I 1YC glucose and hepatic glycogen extraction. By this method, cycling of 
glucose to the triose phosphates followed by glucose re-formation was seen due to the 
appearance of 6J'C glucose showing the power of "C-NMR even at enzymatic levels. 
A series of experiments by Cohen et al. (1987,1987a and 1987b) set out to determine 
the effects of diabetes and fasting on carbohydrate metabolism in the perfused rat 
liver by using 3-"C alanine and 2-11C pyruvate. Measurements of the rate of flux 
Page 154 
through the pyruvate kinase enzyme [E. C. 2.7.1.401 were made by comparison of the 
gluconeogenic rate (which is at non-steady state in these physiological conditions) and 
the distribution in label caused by pyruvate kinase activity (Cohen et al., 1987a). 
Increases in alanine, aspartate, acetate, lactate and carbamyl aspartate are all 
indicative of pyruvate kinase flux. In the insulin dependent diabetic model, large 
increases in the activity of hepatic pyruvate kinase were measured upon administration 
of 7 nmol/l of insulin which were comparable to values in 24 hour fasted control 
livers, in the absence of insulin there was no detectable flux through pyruvate kinase. 
This study shows the application of "C-NMR as a tool to provide information on the 
fate of a label by non-destructive means and more importantly in real time. In a 
sequel to this study Cohen et al., 1987b looked at the metabolism of pyruvate in the 
Krebs cycle together with the utilisation of pyruvate and ethanol during lipogenesis 
in the fasting and diabetic perfused rat livers. Estimation of pyruvate entering the 
Krebs cycle via the pyruvate dehydrogenase complex [E. C. 4.1.1.1., 2.3.1.12, 
1.6.4.3.1 and pyruvate carboxylase [E. C. 6.4.1.1.1 were estimated by monitoring the 
"C-enrichments of glutamate after perfusion of "C-3 alanine [C-2 and C-3 labelling 
indicate pyruvate carboxylase activity whereas, C-4 labelling indicates PDH activity]. 
The relative activities of these two enzyme pathways give an indication of the 
physiological state of the animal since carbohydrates entering the system at the level 
of pyruvate can either enter the Krebs cycle to be completely oxidised (PDH) or 
synthesised to fatty acids, or be carboxylated to oxaloacetate for the conversion to 
phosphoenol pyruvate and therefore, gluconeogenesis. In the study, the relative flux 
through the two pathways was similar in the fed livers, however in the 24 hour fasted 
and streptozotocin induced diabetic livers relatively more of the pyruvate entered the 
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Krebs cycle as oxaloacetate, this correlated with higher rates of gluconeogenesis 
(Cohen et al., 1987). A further experiment was also carried out to show the 
application of "C-NMR to the study of fatty acid synthesis by using PIC acetate. 
It was possible to distinguish the different carbon elongations produced and hence a 
determination on the flux of lipogenesis could be achieved. It was also interesting to 
note that "C labelling from acetyl CoA only occurred with the co-addition of ethanol 
implying additional reducing equivalent requirement to supplement those produced by 
the pentose phosphate pathway. Ethanol can be oxidised via three separate pathways 
in the liver which produces NADH see figure 14. The synthesis of one molecule of 
palmitate requires 14 molecules of NADPH implying ethanol involvement for 
NADPH production. However, NADPH production is indirectly made from NADH 
produced by alcohol dehydrogenase via the production of pyruvate by malate 
dehydrogenase, see figure 14. 
Fivure-14. NADPH derivation from the oxidation of ethanoL 
1. CH3CH20H + NAD+ - CH3CHO + NADH + H' 
Oxaloacetetate + NADH + H' i malate + NAD+ 
Malate + NADP+ , Pyruvate + NADPH + C02 + H+ 
I. -alcohol dehydrogenase. 
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An in vivo study by Kalderon et aL, (1987) used 11C-2 acetate to determine the 
amount of metabolic exchange that may occur with the oxaloacetate pool 
(concentration too small for "C-NMR visibility) in synthesising glucose in fasted rat 
livers. It was concluded that the percentage of labelled carbon in newly synthesised 
glucose amounted to only 7% of that originating from the oxaloacetate pool and 
therefore, the metabolic exchange at this level is only 7%. Further to this study 
Shulman et al. (1987) freeze clamped livers from previously conscious rats (24h 
starved) which had been intraduodenally infused with [1-"C]glucose to determine the 
route of glycogen synthesis. It was estimated that direct conversion of glucose to 
glycogen accounted for 34 % of the glycogen synthesised whereas, approximately 55 % 
was formed from the indirect route from alanine and lactate. These values were 
estimated following assumptions regarding the relative dilution that occurs as labelled 
pyruvate flows through to the oxaloacetate pool taking into account the anaplerotic 
flux through glutamate and glutamine. However, the dilution may be affected by the 
physiological state of the animal making this estimation difficult to assess accurately. 
Further to this study, Shalwitz et al. (1989) administered, by intraduodenal infusion, 
IYC glucose and 3-"C alanine to 18 h fasted rats and monitored the relative 
contributions of the direct and indirect pathways to hepatic glycogen repletion. From 
in vivo data, the direct pathway accounted for approximately 30% of total glycogen 
formed, however dilution of the label into the oxaloacetate pool. was not assessed. 
Active glycogen synthesis from V'C alanine occurred over a longer period of time 
compared with PIC glucose which reflected the lower hepatic levels of VIC alanine. 
However, the rate constant for glycogen synthesis from VIC alanine was Mold 
higher than from IYC glucose implying a greater efficiency of glycogen synthesis 
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from the indirect route. It was therefore concluded that the glucose phosphorylating 
capacity of the liver is limited. 
Other typical studies have looked at the metabolic pathways for hepatic ketone body 
production by using "C-multilabelled fatty acids (Pahl-Wostl and Seelig, 1986) and 
the effects of long term feeding of various fats (non-enriched) to the carbonyl and 
olefinic regions of hepatic carbon spectra in rats (Barnard et al., 1993). As well as 
the liver, metabolic processes have been investigated for the heart (Sherry et al., 
1988; Laughlin et al., 1988; Neurohr et al., 1983; Malloy et al., 1988; Malloy et al., 
1990), brain (Cerdan et al., 1990; Kauppinen et al., 1994), brain tumours (Navon et 
al., 1989; Ross et al., 1988) and kidneys (Jans and Willem, 1989) using a variety of 
"C-labelled precursors. 
4.5.2. "P-nuclei. 
Surprisingly, there have been relatively few liver metabolic studies using `P as the 
nucleus of choice. One of the reasons for this could be the relatively poor amount 
of information obtained from the phosphorus spectrum, compared with carbon and 
proton spectroscopy. The hepatic phosphorus spectrum consists of broad components 
of the phosphomonoesters (glycerol I-phosphate, glucose-6-phosphate, fructose-6- 
phosphate, AMP, phosphocholine, phosphoethanolamine), phosphodiesters 
(phosphoenolpyruvate, glycerophosphory1choline and glycerophosphorylethanolamine), 
inorganic phosphate (HPO41- and H2PO; ), -y-ATP (y-phosphate of MgATP and 8- 
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phosphate of MgADP), a-ATP (ci-phosphates of MgATP and MgATP and NADH) 
and B-ATP (8-phosphate of MgATP). Subtle changes within the broad resonances 
cannot be distinguished and in vitro analysis invariably has to be carried out. Another 
problem associated with in vivo hepatic phosphorus NMR is the co-resonance with the 
above metabolites and the phospholipid components of plasma membranes, between 
30 and -30 ppm. This broad resonance produces a large hump, seeflgure 26, which 
makes quantitation by integration very difficult and hence, integrals must be obtained 
after removal of the phospholipid component by r. f. saturation techniques, specialised 
computer programs or by cutting and weighing each spectrum. As briefly mentioned 
previously, the problem of NMR visibility of certain metabolites must be considered. 
A good example of this are the contributions of ATP, ADP and Pi visibility in the 
"P-NMR spectrum. From in vivo and in vitro studies it is widely acknowledged that 
ATP is almost 100% visible in the in vivo spectra, however ADP and Pi are thought 
to be only partially visible (Iles et al., 1985). The reason for this invisibility could 
be compartmentation within the mitochondria (representing approximately 15 % of 
hepatocyte volume) or binding to other macromolecules (following in vitro extraction 
techniques these would liberate the residual ADP and P). It is interesting to note that 
the extent of invisibility of ADP within the liver is similar to that found in other 
tissues like the muscle, brain, kidney or even heart, which has an extremely large 
quantity of mitochondria. With the assumption that ATP is almost totally visible, 
phosphorus spectra are quantitatively referenced to the B-ATP resonance which 
contains only nucleoside triphosphates due to the resonance of the middle phosphate, 
see section 6. LL. 
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Various groups have used 'T NMR to measure pH in various cell types such as 
tumour cells (Navon et al., 1977), muscle (Dawson et al., 1977), perfused heart 
(Garlick et al., 1979), kidneys (Sehr et al., 1977) and liver (Iles et al., 1980; 
Cunningham et al., 1986). Studies involving hepatic IT NMR have included isolated 
rat hepatocytes (Cohen et al., 1978), perfused isolated mouse and rat livers 
(McLaughlin et al., 1979; Salhany et al., 1979; Iles et al., 1980) and liver of the 
anaesthetised rat (Griffiths et al., 1980). The study by Griffiths et al. (1980) 
overcame some of the initial problems of localisation of the liver by adopting a simple 
surgical procedure to place a surface coil directly on top of the liver. However 
Gordon et al. (1980) used a process of field profiling and rapid pulsing (topical 
magnetic resonance TMR) to obtain liver spectra from the intact anaesthetised rat. 
The technique of field profiling produces a small volume of BO homogeneity around 
the position of interest together with an inhomogeneous % field else where. Since 
this technique there have been other methods of localisation to obtain liver spectra of 
humans (Sauter et al., 1987; Segebarth et al., 1987; Bailes et al., 1987; Ross & 
Barker, 1988a; Dagnelie et al., 1992), see section 6.1.1., which include rapid pulsing 
techniques which take advantage of the relatively short T, times of liver metabolites 
(thought to be due to the presence of paramagnetic ions in the tissue) compared with 
the surrounding muscle tissue. It is easy to assess the degree of localisation using IT 
since a good protocol will produce spectra which have the phosphocreatine (PCr) 
resonance absent or very low, characteristic of the liver. The presence of PCr would 
indicate spectral contamination from underlying muscle. Phosphocreatine is present 
within muscle where short burst activities (due to muscle contractions) require quick 
replenishment of ATP concentration prior to reaching a steady state rate of glycolysis. 
Page 160 
The liver does not require quick adjustments to ATP levels since its activity is more 
constantly controlled compared with muscle. However, it must be mentioned that the 
brain also contains PCr which may be regarded as a protection mechanism since the 
brain does not carry out any physical activities. 
Most hepatic work has been on the isolated perfused liver since this provides a more 
controlled metabolic environment which can easily be perturbed by exogenous 
additions to the perfusate, medium. Cohen (1987) used this technique to obtain IT 
spectra of 24h fasted and diabetic rats over a total perfusion time of 4.6h after the 
addition of "C-alanine and "C-ethanol. This study also showed the existence of two 
P, species which were slightly shifted from one another in the phosphorus spectrum, 
this suggested that cytosolic and mitochondrial P, could be resolved using NMR due 
to the slightly different pH of the two compartments. Earlier studies concentrated on 
the energy status of the liver by following the effects of fructose metabolism (Iles et 
al., 1980). The effect of fructose perfusion showed the expected increases in the 
PME region associated with the rapid phosphorylation of fructose to fructose 1- 
phosphate, together with decreases in ATP, P, and pH. Pre-fructose ATP levels were 
never re-established due to the probable degradation of the adenylate pool to uric 
acid. 
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4.6. Human studies using 13 C and MP NMR. 
The problems associated with in vivo NMR spectroscopy, whether it be phosphorus 
or carbon, are inherent with the technique. In 1983, Canioni et al. used TMR 
(developed by Gordon et al., 1980; Hanley and Gordon, 1981; Gordon et al., 1982), 
see section 4.5.2., to obtain natural abundance 11C spectra of rat livers by totally non- 
invasive means. It was concluded that the localisation used was by no means perfect 
as contributions from adipose tissue sites contaminated the spectral analysis of the 
liver, however this would not interfere with glycogen monitoring. In humans the 
liver is much larger and hence contamination is reduced but probe size and design 
determines spectral resolution (Hoult, 1978). 
Carbon has the additional complication of requiring proton decoupling to simplify and 
enhance sensitivity, however this produces a heating component, due to continuous 
irradiation. Carbon-13 NMR has a very important role to play in providing answers 
to hepatic carbohydrate abnormalties found in diseased states such as diabetes mellitus, 
and cirrhosis of the liver. Most human "C NMR studies have been carried out in the 
last 5 years of which the bulk of the studies have examined muscle tissue of the arm 
or leg Que et al., 1989 and 1989a; Shulman et al., 1990; Beckmann et al., 1990). 
These studies have concentrated on direct observation of glycogen repletion through 
natural abundance or after administration of [P'C] glucose. The work by Jue et al. 
(1989) compared hepatic glycogen repletion rates in 30 h starved individuals pre and 
post meal showing repletion rates 3.8 times greater in the post meal state compared 
with the fasted basal rate. A study by Shulman et al. (1990) used hyperglycaemic- 
Page 162 
hyperinsulinaemic clamps to compare muscle (gastrocnemius) glycogen synthesis of 
healthy subjects to those with NIDDM. Glycogen synthesis in the NIDDM subjects 
was 2.3-fold lower than the healthy subjects implying a suppression of muscle 
glycogen synthesis in this insulin resistant state. Hepatic gluconeogenesis in healthy 
subjects and those with NIDDM was investigated by Magnusson et al. (1992). This 
study used an elaborate technique for assessing total glycogenolysis and glucose 
production of the liver. Following infusion of VH glucose and liver imaging (to 
calculate its volume), gluconeogenesis in the NIDDM subjects was found to be 60 % 
greater than control subjects and accounted for 88% of the total glucose production 
compared with 70% in the normal subjects. It was suggested, therefore, that 
increased gluconeogenesis accounted for the increase in whole body glucose 
production in overnight fasted NIDDM subjects. A study by Beckmann et al. (1993) 
administered [1_13C] glucose (99% enrichment) intravenously, but was only able to 
detect hepatic glycogen formation after prolonged infusion times of 60 minutes. In 
the same study volunteers were given an oral dose of 99% enriched [1_13C] glucose 
which was detected in the liver within 20 mins together with the C-1 resonance of 
glycogen; glucose enrichment of 6.6% allowed detection after 45-60 mins. It was 
concluded that the glucose uptake and glycogen formation of the liver was similar to 
more invasive techniques used to measure these metabolites. 
One of the first IIP-NMR studies of the human liver was carried out on newly born 
children which were found to have hepatic neuroblastomas, (Maris et al., 1985). A 
surface coil, with an optimised pulse length for localisation, was employed. 
Unfortunately, contamination from surrounding tissue was a problem, however 
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': 'C-glucose metabolic studies during pregnancy. 
5.1. Not study to assess the incoi: poration of 13 C-glucose into the hepati 
glycogen moiety using NMR. 
5.1.1. Introduction, 
The purpose of this study was to set up a working NMR protocol which could be 
applied to the various pregnant conditions investigated in chapter 2 to determine 
hepatic glycaernic control. Glucose uptake and utilisation cannot be assessed using 
the 2-deoxyglucose protocol discussed in chapter 2 due to high concentrations of 
glucose-6-phosphatase. Following uptake of 2-deoxyglucose by the liver 
phosphorylation can occur; however, 2-deoxyglucose-6-phosphate can then be 
converted back to 2-deoxyglucose by glucose-6-phosphatase. This would under 
estimate the rates of glucose utilisation by the liver. It is therefore necessary to 
employ other means for the assessment of hepatic glucose uptake and utilisation such 
as the application of NMR. 
For this pilot study, rats were placed on a4 week meal feeding -regime where food 
was restricted to two hours per day. As previously discussed (see section 1.6.4. ), 
rats which are meal fed show some profound changes associated with carbohydrate 
and lipid metabolism (Pallardo and Williamson 1989). It was decided to investigate 
the potential of infusing a bolus quantity of IIC-glucose to observe in vivo changes in 
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ot and 8 1-11C glucose levels and "C-1 incorporation into the glycogen 
macromolecule. An investigation was thus set up to evaluate the carbohydrate status 
of the liver of 4 week meal fed rats prior and post feeding following a bolus 
administration of glucose (Changani et al. 1994(a)). High resolution IIC-NMR 
spectroscopy was also carried out to substantiate the findings of the in vivo study. 
This investigation provided substantial proof on the method of glycogen repletion in 
vivo of meal fed rats. 
Initially, a bolus of 1.39 mmol/kg (250 mg/kg) was injected intraperitoneally, 
however very little "C-glucose signal was obtained from the exposed liver. It was 
thought that the amount of infused glucose was too low to disturb the metabolic pool 
of the whole rat, due to the dilution effect caused by haemodilution. This left the 
choice of either considerably increasing the glucose administration, hence placing the 
rat under a new metabolic condition (effectively placing all rat models closer to the 
same nutritional status), or infusing the bolus IYC glucose closer into the liver. The 
second option was decided upon since the bolus amount used could be quantified as 
equivalent to an average human subject eating a small bar of chocolate. This would 
not have the effect of grossly altering the metabolic status of the subject and hence, 
different physiological conditions could be more closely compared. 
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5.1.2. Methods. 
5.1.2.1. Development of a proton-decoupled carbon NMR coil for in vivo 
purposes. 
Initial experimentation with a commercially available proton decoupled carbon probe 
made it apparent that a custom built probe was required. The commercial probe 
consisted of two sets of coils, the carbon tuned coil positioned within the proton tuned 
coil, encapsulated with thick poly-tetrafluoroethylene. Unfortunately, the encasement 
extended from the coils to the capacitors producing a very bulky product making 
central positioning of the coils onto the organ difficult to assess. In order to try and 
obtain the best possible localisation of the organ it was necessary to push the probe 
as far-into the chest area as possible, this had the consequence of exerting undue 
pressures on the diaphragm and liver which inevitably led to either respiratory or 
circulatory hinderance to the rat. An additional problem due to the encasement was 
the vertical distance between the coils and the surface of the organ, this resulted in 
even poorer sensitivity of the coil to carbon-13. 
A new coil was therefore designed to be smaller than the commercial coil to allow 
un-hindered positioning on top of the liver. The coil was based on the commercial 
one so that it could be attached to the same tuning and matching rods, however both 
the proton and carbon coils were reduced in diameter by one fifth, seefigure 15. 
[The coils were produced from teflon covered silver base wire of 1.3 mm diameter. ] 
This resulted in a proton single turn coil diameter of 3.2 cm and a carbon 31h turn 
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diameter of 1.6 cm with the distance between the two coils of 0.8 cm. The resultant 
coil was not encapsulated which reduced the total diameter of the coil area by over 
I cm compared with the commercial coil. Reduction of the proton and carbon coils 
meant a change in the capacitance required to tune the coils to 200 MHz and 50 
MHz, respectively, this was achieved by trial and error, after working out the rough 
capacitance required, by using an oscilloscope with a frequency spike generator. 
The coil allowed the easy positioning of the carbon coil directly on top of the liver 
without the need to exert any unnecessary pressures. The spectra obtained were far 
more detailed, picking up vital resonances between 50 and 100 ppm, seefigure 17a, 
contamination from other tissues could be avoided due to the easy manipulation of the 
liver and coil within the abdominal cavity. The one problem resulting from not 
encapsulating the capacitors was a gradual dephasing and diminishing of the signal 
due to sequestration of blood around the capacitors, which essentially de-tuned the 
carbon coil. This problem was resolved by covering the whole probe with cling-film 
and placing a4 mm plate of silicone rubber [Poly dimethyl siloxane (Dow Corning 
Ltd. )] between the capacitors and the rat body. Justification for the development of 
the smaller coil came from the higher resolution spectra obtained as well as a survival 
rate of nearly 90%, opposed to 60% using the commercial probe. 
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5.1.2.2. General animal preparation and cannulation procedure for in vivo NMR 
studl. 
5.1.2.2.1. Anhnal feedinE reeimes. 
Ten age matched female Wistar rats (185-200g) were housed in a reverse light/dark 
room [light off 10: 00/light on 22: 00] and allowed access to a standard chow diet (see 
section 2.2. ) for 2 hours per day for 4 weeks [10: 00 to 12: 001. Due to animal and 
NMR preparation times all experiments started I hour after removal from the animal 
house. The experiments were carried out on 5 pre (23 hour starved) and 5 post meal 
(1 hour after the end of feeding) rats. After obtaining a blood sample from the 
jugular vein, proton-decoupled carbon spectra were obtained at 50.309 MHz using a 
4.7 Tesla, 33 cm horizontal bore SISCO system, over a period of 65 min. (see 
section 5.1.2.3. ). Following spectral analysis a further blood sample was taken. 
5.1.2.2.2. Removal of blood sample via the inferior Jugular vein. 
Rats were anaesthetised using an intraperitoneal injection of 60mg/ml/kg body weight 
sodium pentobarbital dissolved in distilled water. Commercial equivalents such as 
Sagatal were not used as they contain ethanol which is utilised solely by the liver. 
The rat was weighed. A blood sample was removed by making a small incision near 
the neck of the animal and exposing the inferior jugular vein by cutting away 
surrounding tissue. A lml syringe with a blue needle (23G, 0.600mm) was inserted 
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through a fat pad and then into the vein. Approximately 3501AI of blood was removed 
and transferred into a heparinised Eppendorf. The blood (250pl) was then 
deproteinised in 10% perchloric acid (v/v) (I. Oml) and stored at -70*C for future 
blood glucose determinations. See section 2.3.2.1. for blood preparation and section 
2.5. for glucose assays. 
5.1.2.2.3. Cannulation of hepatic portal vein. 
A transverse abdominal incision was made extending laterally so as to expose as much 
liver as possible, without hinderance. The coronary ligament was carefully cut with 
round nosed scissors, to prevent damage to the diaphragm. The triangular ligament 
was cut to allow greater accessibility of the liver when positioning the proton-carbon 
probe. The cannula used was a straight version to that described in section 2.1. ie. 
no "U-bend" was introduced into tube A and tube F was cut to 20-25mm depending 
on the rat size. 
The small intestine and stomach were pushed to one side exposing the hepatic portal 
vein. Cotton was tied around the dumbbell of the cannula see section 2.1.2. and one 
end threaded through a curved surgical needle. The cotton was threaded under the 
hepatic portal vein through the surrounding fat deposits. The hepatic portal vein was 
held gently with rounded forceps distal to the liver, slight pressure was applied to 
reduce blood flow to the liver and a hole made into the vein with bent blue needle 
(23G 0.600mm). The cannula attached to a line containing saline (0.9% NaCI w/v) 
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was immediately inserted into the hole, it was imperative that as little blood as 
possible was lost. If done quickly enough blood loss was minimal. The cotton 
threaded under the vein was then knotted to the free end of the cotton and secured 
around the dumbell of the cannula. 
Successful carmulation was assessed by perfusing 100-200/A of saline, if some of the 
liver lobes discoloured to a creamy/red appearance,, the cannula was correctly 
inserted. The cannula was then attached to 2 metres of tubing B see section 2.1.1. 
containing D-11C-1-glucose 75mg [200mg/ml] (MSD Isotopes 6260). 
5.1.2.3. In vivo proton-decoulaled carbon spectroscopic protocol. 
The magnet cradle, seefigure 16, was lined with cotton wool and a hot gel pad, used 
to prevent heat loss from the rat, placed in the cradle. The cannulated animal was 
placed on top of the hot gel pad and a dual tuned proton/carbon surface coil (see 
section 5.1.2.1. ) positioned directly on to the liver. The probe was covered in cling 
film to prevent blood coming in contact with both the coils and the capacitors, this 
would lead to a change in the loading of the capacitors and hence a de-tuning of the 
probe would occur. The M. R. S. machine used was a 4.7 Tesla, 33cm horizontal 
bore SISCO system. After tuning the proton and carbon channels, the magnet was 
shimmed for greatest field homogeneity. Proton-decoupled carbon-13 spectra were 
acquired at 50.309MHz using a decoupling power of 120w and a decoupling 
mudulating frequency of 580OHz. An acquisition time of 0.205 secs., a pulse delay 
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of 0.1 secs., a pulse width of 701As and a spectral width of 12kHz were used to 
produce 25 array elements consisting of 512 averages (ie. 1 spectrum = 2.5 mins for 
accumulation of 512 averages). These parameters did not allow the absolute 
quantitation of metabolites due to partial saturation effects caused by the very short 
pulse delay. However, this was not a requirement of the study since sequential 
spectra were compared to the pre-infusion spectrum which cancelled out the partial 
saturation effects. After acquiring two base-line carbon spectra, "C-1 glucose was 
slowly infused as D-glucose- 1_13C [75mg; 20mg/min]. Subsequent to infusion, the 
spectra were referenced to C-1,8-glucose at 96.60ppm and C-1 u-1,4 glycogen 
appearance observed at 100.48ppm, see table 16a. 
After spectroscopy a final blood sample was removed (300pl) from the inferior vena 
cava. The blood sample was treated as in section 2.3.2.1.. The liver was quickly 
excised and freeze clamped in liquid nitrogen for future high resolution N. M. R. 
analysis (see sections 5.4 and 5.5) and glycogen quantitation (see section 2.12. ). 
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Table 16a. 
Chemical shifts of metabolically hnportant carbon compounds. 
Compound. Chemical Shift (ppm. ) 
C-3 Alanine 17.5 
C-3 Lactate 20.8 
-CH2CH2CO- 25.6 
-CH=CHCH2CH=CH- 26.32 
-CH2CH2CH = CH- 28.0 
-(CH)-fatty acyl 30.1,30.5 
Malate 43.5 
Citrate 46.0 
3-hydroxybutyrate 47.2 
C-2 Alanine 51.9 
C-2 Glutamine 55.6 
C-2 Glutamate 56.0 
C-6 ci, B Glucose, Glycogen 61.4 
C-1, C-3 Glycerol (ester) 62.6 
C-6 Glycogen 8 1,6 67.9 
C-2 Lactate, Glycerol (ester) 69.7 
C-4 Glycogen 8 1,6 70.0 
C-4 ci, 3 Glucose 70.3 
C-2 Glycogen a 1,4,8 1,6 72.2 
C-3 a Glucose 73.4 
C-3 B 1,6 Glycogen 73.5 
C-3 a 1,4 Glycogen 74.0 
C-3, C-5 8 Glucose 76.5 
C-4 a 1,4 Glycogen 77.7 
C-2 0 Glucose 79.9 
C-1 a Glucose 92.7 
C-1 6 Glucose 96.6 
C-1 B 1,6 Glycogen 99.2 
C-1 a 1,4 Glycogen 100.5 
-CH=CH-CH2-CH=CH- 128.7 
-CH=CHCH2CH2- 130.4 
-CH2-CH2-CO- 172.4 
-CO-OR 173.8 
Assignments accrued from numerous papers. 
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5.1.2.4. Intei: pretation and guantitation of in vivo carbon spectra. 
Typical proton decoupled carbon spectra of the liver can be seen infigure 16a. 
Glucose and glycogen quantification from the spectra involved computer aided base- 
line correction and integration across the glucose resonances at 97.00 - 96.00ppm for 
8-glucose; 91.150 -93.50ppm for ct-glucose and 98.50 - 103.00ppm for the glycogen 
resonance, seefigure 16a and 17. Lipid extraction measurements (section 3.3. ) have 
shown that total hepatic lipid concentration remains constant at 67.2 ± 3.7 mg/g wet 
weight of liver tissue, therefore, the glycogen signal was expressed as a function of 
the total -CH2and CH3 integrated areas. 
5.1.2.5. Method for agueous extraction of liver for in vitro "C-N. M. R. analysis 
5.1.2.5.1. Extraction Drocedure. 
Approximately Ig of frozen liver tissue was ground to a powder in a pestle and 
mortar (cooled in a bath of liquid nitrogen) while under liquid nitrogen. The ground 
tissue was transferred to a liquid nitrogen cooled glass scintillation vial and its exact 
weight measured. The tissue was homogenised for 1-2 min (Int. Lab. Appl. Gmbh; 
Type X 1020; position 5) in 10% perchloric acid (2 ml/gm tissue) to deproteinise the 
sample. Once a suspension had been obtained the precipitated protein was centrifuged 
to a pellet at 50OOrpm for 5 min at VC in a MSE Mistral 3L centrifuge. The 
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supernatants can be stored at -70*C at this stage. 
Prior to Iyophilisation the samples were neutralised at VC with solution containing 
1.5M potassium hydroxide [KOH]; 0.3M potassium chloride [KCII and 0.1 M sodium 
phosphate [Na3PO4]. The samples were centrifuged at VC for 10 mins. at 5000rprn 
to pellet the perchlorate precipitate. The supernatant was transferred to a pre-weighed 
tube and freeze-dried for 36h in a freeze dryer (Edwards-Modulyo). The freeze dried 
extract was weighed and stored at -70*C until required for high resolution N. M. R. 
analysis. 
5.1.2.5.2. Preparation of freeze-dried sample for high resolution N. M. R. 
analysis. 
Deuterium oxide (0.5ml) was added to the sample together with 50111 of IOOmM TSP 
(3-(trimethylsilyl)propionic acid Sigma T 5762). Some perchlorate crystals may 
persist in which case the sample was spun at 50OOrpm for 20 mins. at VC. The 
clear supernatant was transferred to a5 mm N. M. R tube (Goss Instruments Type 
507-HP) and analysed quantitatively on a JEOL GSX500 N. M. R. spectrometer 
operating at 50OMHz and 11.75 Tesla. Proton-decoupled carbon spectra were 
obtained using an acquisition time of 0.544s a pulse width of 15 jAs and a pulse delay 
of 6s. 
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Igure 17. Base-line subtracted spectra. 
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5.1.2.6. Method for lipid extraction of liver for in vitro "C-NMR analysis. 
5.1.2.6.1. Extraction procedure. 
The frozen liver sample (I g) was weighed and was crushed under liquid nitrogen in 
a pestle and mortar. The powdered liver was transferred to a 50 ml boiling tube 
containing chloroform: methanol [(2: 1) 20 ml/I g tissue] and homogenised briefly 
using a tissue homogeniser [Inter. Lab. App. Gmbh, Type X 1020; small probe; 
position 5] to allow greater surface area for lipid extraction. The solution was left 
shaken every 10 minutes for 1 hour after which the tissue was homogenised 
thoroughly for 3-5 minutes (position 7). Saline (20 ml) was added and tube gently 
inverted several times, the lipid and aqueous layers were then allowed to settle. The 
top methanol/saline layer was discarded and the clear, slightly yellow, bottom layer 
transferred into a pre-weighed scintillation vial to be dried down under a continuous 
stream of nitrogen (3 -4 hours). The resultant dry lipid extract was weighed and 
stored under nitrogen at -700C. 
5.1.2.6.2. Preparation of lipid extract for high resolution NMR analysis. 
On the day of NMR analysis the lipid extract was dissolved in 0.6 ml deuterated 
chloroform together with the addition of tetramethylsilane (Sigma T 3759) as use as 
a reference and transferred to 5 mm NMR tubes (Goss Instruments Ltd., Type 507- 
HP). The lipid samples were run on a JEOL GSX 500 N. M. R. spectrometer 
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operating at 500 MHz and 11.75 Tesla. Proton-decoupled carbon spectra were 
obtained with an acquisition time of 0.544s a pulse width of 15 us and a pulse delay 
of 6s. 
5.1.2.7. Statistics. 
Statistical significance of differences between means was assessed by Student's 
unpaired t test. All results are given as means ± SEM for five rats. 
5.1.3. Results and discussion. 
It is important to note that the 4 week routine meal fed group had similar food intakes 
as the ad libitum fed rats (ie. 17.5 ± 2.4 g for 4 week meal fed rats and 18.3 ± 2.0 
g for ad libitum fed rats over a 24 h period). 
Figure 18 shows typical carbon spectra prior to glucose infusion, followed by 
sequential spectra post infusion. The three main broad components of the hepatic 
carbon spectra are from fatty acyl chains which include the -CH2 and -CH3, between 
14 - 35 ppm, the olefinic carbon region, between 125 - 130 ppm, and the carbonyl 
region between 170 - 185 ppm (all chemical shifts are approximate due to the inherent 
lack of resolution seen in in vivo spectroscopy). The spectra show clearly the 
appearance at 92.68 and 96.60 ppm of ci and 8 glucose (ratio of 1: 2, respectively) 
'following infusion of 13C_glucose. From figure 19 and table 17 it can be seen that 
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hepatic 1-"C glucose utilisation/assimilation/removaI declines at approximately the 
same rate in both pre and post meal groups with no significance between the two. 
Plasma glucose concentrations prior to and 60 mins. post lJ'C glucose administration 
within the two groups were the same, however values were slightly higher in the two 
groups at 60 mins. post administration. Fromfigures 19 and table 17, "C-1 glycogen 
incorporation, seen at 100.48 ppm, increases to a maximum approximately 30 mins 
post "C-glucose infusion (P<0.02) in the pre-meal group. As early as 10 min post 
"C-glucose infusion, there was a significant difference between the two groups 
(P < 0.05), with the pre meal group showing enhanced I'C incorporation into 
glycogen. The rate of incorporation is seen to be considerably faster than rats either 
fed ad libitum or starved for 22 h and refed for 2 h. The post-meal group shows 
little net incorporation of "C-gIucose into glycogen implying that either maximal 
glycogen levels had been reached or synthesis was occurring preferentially from the 
unlabelled pool of 3 carbon precursors. From in vitro NMR studies conducted on the 
livers following in vivo analysis (see diagram 20), it can be seen that the pre-meal 4 
week RMF group show a broad resonance at 100.48 pprn corresponding to the C-1 
of glycogen. This resonance was noticeably diminished or absent in all of the post- 
meal 4 week RMF group, despite normal fed hepatic glycogen levels in this group, 
see below. This would suggest direct incorporation of "C-1 glucose into the C-I of 
glycogen, since glycogen from naturally abundant "C-1 glucose (1.1% natural 
abundance) is very difficult to detect with the spectroscopic parameters used. This 
is despite the fact that the post-meal group has a glycogen concentration of 63.1 ± 
6.4 mg glycogen/g wet wt.. There were no differences between in vitro lipid 
extracts, in particular there was no enrichment in the glycerol moiety (see diagram 
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21). The signal to noise ratios in the aqueous extracts were consistently poor due to 
the very low I'C enrichments used for this study. 
Upon refeeding 24 h starved ad libitum fed rats maximum glycogen levels are not 
achieved until 6-7 hours after the start of refeeding (Holness et al., 1988). In routine 
meal fed rats, glycogen levels reach a maximum following 3h of refeeding, 
indicating the enhanced capability for the conversion of glucose. A major question 
arising from glycogen synthesis studies is the relative contribution Of C3 intermediates 
to the glycogen molecule compared with the direct conversion of glucose to glycogen. 
The latter method provides a quick method of glycogen repletion however, it is 
thought that ad libitum fed rats undertake both processes with a ratio of 60: 40% in 
favour of the indirect gluconeogenic pathway (Shulman et al., 1985). This line of 
thought is not conclusive as other studies report glucose as the major glycogenic 
precursor (Scofield et al., 1985). 
Pallardo and Williamson (1989) found that the rates of hepatic glycogen synthesis on 
re-feeding 10 day meal fed rats were identical to those in rats fed ad libitum (approx. 
30jAmol of glycosyl units/h per g of liver) however hepatic lipogenic rates were 
enhanced. It was suggested that in the meal fed group direct conversion of exogenous 
glucose to glycogen occurred. However, a study by Sugden et al. (1993) 
systematically looked at the glycogen concentrations of 4 week meal fed and virgin 
rats following refeeding over a9h period. It was noted that the meal fed group had 
a much faster capacity to replenish hepatic glycogen levels compared with control ad 
libitum fed rats. Control rats showed maximal glycogen levels approximately 6-9 h 
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following refeeding, however, the meal fed group reached maximal values 
approximately 4h after food provision. The differences between these two groups 
can be accounted for by the duration of the meal feeding regimes employed, Pallardo 
and Williamson studied 10 day meal fed rats whereas, this most recent study looked 
at long term food restriction (4 week meal feeding). In conjunction with increased 
glycogen disposal patterns in long term meal fed rats, increased rates of disposal were 
observed in both 10 day and 4 week meal fed rats which were attributed to increased 
PDH activities supplying acetyl CoA subunits for lipid synthesis. The results shown 
in this thesis show high rates of IJIC glucose incorporation into glycogen C-1 in the 
meal fed rats when compared to rats fed ad libitum (see section 5.3.3.1. ) and support 
the view that glucose is directly converted to glycogen in long term meal fed rats. 
The rates of glycogen repletion shown in table 17 and figure 19 compare very 
favourably with the repletion rates shown by Sugden et al. (1993). This study 
showed a gradual increase in total glycogen to a maximum of 67.8 ± 10.9 mg/g wet 
wt. within 3 hours following food administration. The study shown here show 
gradual increases in incorporation of "C-glucose into the C-1 of glycogen in the pre- 
meal 4 week RMF group, this incorporation reaches a maximum at 30 min post 
glucose infusion indicating "C-glucose units have been "removed" from circulation. 
From 30 - 60 min. post-infusion no "C-1 glycogen degradation was seen. The post- 
meal group, showed no net incorporation of 'IC into the C-I of glycogen. Taking 
into account that the actual time following food provision is 3 h, due to animal and 
magnet preparations, it must be assumed that maximum glycogen levels have been 
reached. From in vitro glycogen measurements this was the case, with the post-meal 
glycogen levels resembling fed values of 63.1 ± 6.4 mg/g wet wt. compared with 8.1 
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± 2.7 mg/g wet wt. in the pre-meal 4 week RMF group. 
One of the earliest studies on meal feeding was conducted on obese mice (Tepperman 
and Tepperman 1957) in which increased absorption of glucose from the gastro- 
intestinal tract was noted. This was an interesting observation in light of this present 
study which suggests that glucose is rapidly assimilated by the liver and directly 
converted to glycogen. If glycogen repletion was via the indirect gluconeogenic 
pathway of C3 substrates (and the glycolysis of glucose followed by carboxylation to 
oxaloacetate) then a large amount of the label on the C-1 of glucose would be 
expected to be lost at the level of oxaloacetate and hence loss through intermediates 
of the Krebs cycle and other anaplerotic pathways associated with this flux. Loss of 
"C could also be attributed to the relative pools of dihydroxyacetone and 
glyceraldehyde 3-phosphate where an equilibrium exists between the two and glycerol 
phosphate. Of course, the bulk of substrates used via the gluconeogenic pathway 
would primarily be lactate or amino acids from extra hepatic metabolism, but the 
above just illustrates the possibility of the futile cycle involving glucose breakdown 
and subsequent synthesis of glycogen. 
This study provides further evidence that glycogen synthesis during long-term food 
restriction in rats can primarily be accounted for by the direct conversion of glucose 
subunits. From the study by Pallardo and Williamson (1989), increased lipogenic 
rates were seen in the meal fed groups and it was suggested that lipogenesis and 
glycogenesis occur simultaneously albeit with different substrates. It would appear 
that lipid synthesis is primarily achieved through carboxylation0f C3 precursors. 
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Figure 20. High resolution proton decoupled carbon spectra 
of liver aqueous extracts of 4 week RMF rats pre 
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Table 17. Comparison of "C-glycogen deposition between pre-meal and post - 
meal 4 week routinely meal fed rats. 
Time 
(mins) 
Pre-meal 
n=5 
S. E. M. Post-meal 
n=5 
S. E. M. 
0 0.021 0.0020 0.016 0.0053 
5.2 0.027 0.0029 0.019 0.0069 
10.4 0.032 0.0023 0.017* 0.0055 
15.6 0.037 0.0025 0.021* 0.0065 
20.8 0.041 0.0053 0.021* 0.0064 
26.0 0.046 0.0054 0.019** 0.0058 
31.2 0.049 0.0075 0.022* 0.0065 
36.4 0.048 0.0080 0.018** 0.0056 
41.6 0.048 0.0072 0.021* 0.0065 
46.8 0.047 0.0062 0.018*** 0.0055 
52 1 0.046 0.0062 0.013*** 0.0016 
Time point 0 mins. represents baseline levels prior to IJIC glucose infusion. Rat 
weights for both groups were 216.6 ± 2.6 g. The mean glucose concentrations in 
pre and post meal jugular vein samples prior to PIC glucose administration were 
4.560 ± 0.449 mmol/I and 4.569 ± 0.263 mmol/I and 60 mins. after 1YC glucose 
administration were 5.184 ± 0.705 mmol/l and 6.146 ± 1.440 mmol/l. Values 
which were significantly different between pre and post meal are indicated by 
P<0.05; **P<0.02; ***P<0.001. 
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5.2. Assessment of NMR protocol for in vivo hepatic metabolic studies. 
The results demonstrate the ability of "C-NMR to monitor both the decay of lYC 
glucose and incorporation into glycogen simultaneously, in real time. In theory it 
should also be possible to investigate the degree of "C recycling via 3-carbon 
intermediates e. g. lactate, and gluconeogenic intermediates, by observing enrichment 
in the C-6 position of glycogen. However, there is either insufficient resolution 
and/or signal in vivo and in vitro. Following this study a new coil, as described in 
section 5.1.2. L, was built but with the specific requirements of the protocol in mind 
and used for all subsequent experiments. Although the commercial probe provided 
the necessary information required for the pregnant study it was by no means 
perfectly adapted to the physical constraints of the rat model, reflected in the high 
mortality rates. This was due to the coil being large and bulky which regularly 
obstructed the movement of the diaphragm as well as placing extreme pressures onto 
the liver, possibly causing ischaemia and hence hypoxia. It was hoped that with the 
new coil design these problems would be eliminated and that higher resolution "C 
spectrum could be obtained, which could detect fluctuations other than the resonances 
of C-1 glucose at 92.68 and 96.60 ppm and the C-1 glycogen at 100.48 ppm. 
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5.3. In vivo hepatic glycogen sInthesis rates during late gestation in the rat. 
5.3.1. Introduction. 
As shown in chapter 2, glucose intolerance by most tissues is dependent on the 
progression of pregnancy and the mothers nutritional status; late gestation shows the 
greatest suppression of uptake and phosphorylation. The insulin resistant state shown 
during late gestation can apparently be reversed upon placing the rat under a short 
term course of routine meal feeding, see section 3.4.. 
Since the liver controls glucose homeostasis, increased knowledge on the pathogenesis 
of insulin resistant states like pregnancy and non-insulin dependent diabetes mellitus 
can be gained from hepatic glucose metabolic studies. A study by Davidson (1983) 
explored the role of the liver during late pregnancy. However, this study used 
isolated hepatocyte preparations from which no correlation between pregnancy and 
insulin resistance was observed. A subsequent study by Leturque et al. (1985) 
revealed that isolated peripheral tissues do not exhibit insulin resistance, otherwise 
shown in vivo. It was also suggested that the liver does exhibit a degree of decreased 
sensitivity to insulin during late gestation, shown by infusing low doses of insulin 
which did not produce rapid glucose clearance rates as seen in virgin rats. It is 
imperative therefore, when conducting studies on the insulin resistance of tissues that 
they are conducted in vivo. Measurements of glucose utilisation rates using the 
methods illustrated in chapter 2 can not be preformed on the liver due high levels of 
hepatic glucose-6-phosphatase [EC. 3.1.3.9]. This enzyme catalyses the conversion 
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of glucose-6-phosphate to glucose and hence phosphorylated 2 deoxyglucose-6- 
phosphate can be converted back to 2 deoxyglucose producing inaccurate 
measurements of the GUI. In vivo `C-NMR has therefore been employed to 
elucidate the liver's glucose utilisation/disposal during pregnancy of rats fed ad 
libitum and those on the strict meal feeding regimes. In vitro analysis of freeze 
clamped liver extracts were assessed using high resolution "C-NMR spectroscopy, 
see section 5.1.2.5. and 5.1.2.6.. 
As well as investigating the consequences of late pregnancy on the glycaemic control 
by the liver, the study was extended to early pregnancy, ie. day 10 of gestation. This 
study was set up primarily to investigate the role of the liver during gestation to 
equate results to the changes shown in the glucose utilisation capacity of the skeletal 
and cardiothoracie muscles. A further purpose was to evaluate the possibilities of 
NMR in a more clinical role for detecting abnormalities in the glucose homeostasis 
of the liver during disease states. 
5.3.2. Methods. 
5.3.2.1. Animal feeding regimes. 
The methods of cannulation and NIVIR set up have fully been discussed in section 
5.1.2., the following is a synopsis of the animal feeding regimes employed. Four 
groups of age-matched female albino Wistar rats were time-mated. The RMF group 
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were housed in a reverse light/dark room [light off 10: 00/light on 22: 00] and allowed 
access to chow for 2h per day from day 9 of pregnancy. The early pregnant group 
was started on the RMF regime from day I of gestation. The ad libitum groups had 
free access to food. Two control groups were studied which were age-matched ad 
libitum virgin controls and 22 h starved; 2h refed controls. Immediately after the 
last meal on either day 10 or 20 of pregnancy (term = 21 days), the pregnant rat was 
anaesthetised with sodium pentobarbital (60 mg/ml/kg). The liver was exposed and 
the hepatic portal vein cannulated to a line containing D-glucose-l-"C(99atom % 1, C) 
[200mg/mll. Spectra were obtained as in section 5.1.2.3., the infusion of "C-1 
glucose took place after acquisition of the second base-line spectra over a period of 
2 min. during the first time point (5.2 min. ). 
5.3.3. Results. 
5.3.3.1. "C-glucose inco[poration into the glycogen macromolecule durin 
late pregnancy. 
From table 18 andfigure 22 it can be seen that very little incorporation of "C-glucose 
into glycogen was detected in 20 day pregnant ad libitum and control fed virgin rats, 
whereas the 20 day pregnant RMF group had a very much enhanced incorporation 
rate, in an approximately linear fashion. The same incorporation rate was shown in 
the 20 day pregnant; 22 h starved 2h re-fed group up to 20 min. post infusion, 
however no further net increase in incorporation was seen after this. In this group 
there was reduction in the total net incorporated IIC 20 minutes post "C-glucose 
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infusion ie. there appears to be no further incorporation into hepatic glycogen 
indicating a gradual reduction in the 13C_glycogen stores. This would indicate the 
rapidity by which newly synthesised glycogen can be almost immediately broken 
down as the rat moves into a post-absorptive nutritional status. During the same time 
scale the 20 day pregnant RMF group continues to incorporate the administered 13C_ 
glucose into glycogen macromolecules in an unhindered fashion. Approximately 50 
min. post infusion the net incorporation is at a level approximately 2.3 times the 
maximum incorporation levels shown in the 20 day pregnant; 22 h starved 2h re-fed 
group. The increase in '3C incorporation slows down 25 min. post infusion, however 
the increases still continue but in a slower linear fashion. From flgure 23 it can be 
seen that "C-glucose levels in the 20 day pregnant ad libitum group disappeared very 
rapidly and by 15 min. post infusion the label had returned to pre-infusion levels. 
Compared with the virgin rat, label declined at a much slower rate and was at half 
maximal levels at 15 min.. "C-glucose levels remained very much higher and for a 
longer period of time in the 20 day pregnant RMF group. In this group levels of "C- 
glucose were equivalent to virgin levels 15 min. post-infusion. However, from this 
time point onwards the "C-glucose remained at an elevated level over the virgin 
condition. By 40 min. post-infusion "C-glucose resembled pre-infusion levels in the 
20 day pregnant ad libitum group whereas, in the RMF group the levels remained at 
of approximately one third of the total infused label. Between 20 and 50 min. post- 
infusion there was very little decline in the label. 
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5.3.3.2. "C-Oucose incorporation into the ellcogen macromolecule during 
early pregnancy. 
Table 19 andfigure 24 show the relative amounts of 11C incorporation into the C-1 
of hepatic glycogen in 10 day pregnant rats compared with late pregnant rats. Food 
restriction during the first 10 days of gestation produced a large increase in glycogen 
labelling compared with any other group shown. Compared with the 20 day pregnant 
rat, restricted in the last 10 days of pregnancy, and the 10 day ad libitum group, 
increases of 2.4 and 4.3 fold were seen, respectively. Maximal increases in the 10 
day ad libitum group occurred at 25 min. post "C-glucose infusion after which 
incorporation declined. However, in the 10 day RMF group glucose incorporation 
increased linearly for 30 min. post infusion and plateaued out for the period of the 
experiment (60 - 70 min. ). 
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Hepatic Glucose Disposal In ad libitum 20d Pregnant 
& Virgin Control & RMF 20d Pregnant Rats. 
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Glucose integral values represent net hepatic IT infitsed 
glucose. All integrals are normalised to the CH, 
integrated area. For clarity the results from one 
experiment are shown, 4 other experiments showed 
similar results. 
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5.3.4. Discussion 
This study has been the first to investigate in vivo hepatic carbohydrate metabolism 
using "C-NMR in the pregnant rat. It has revealed the possibility that carbon 
spectroscopy can be used as an investigative tool for physiological and pathological 
conditions which show adaptations to normal glucose metabolism, such as late 
pregnancy, NIDDM, liver cirrhosis, etc.. It is apparent that glycogenesis can occur 
using one of two pathways, either direct synthesis of glucose subunits to glycogen or, 
indirectly viaC3gluconeogenic precursors such as amino acids and lactate (Shulman 
et aL, 1985). The relative contributions of these pathways to glycogen repletion may 
be determined by physiological changes and pathological abnormalities. It is 
therefore important for studies such as these to be carried out in order to characterise 
changes seen in vivo rather than in vitro, since contributory metabolic factors may be 
lost as a consequence of in vitro methodologies. This study was devised to 
investigate the glucose homeostatic control of the liver in pregnancy and reflect any 
changes seen to the extensive suppression in glucose uptake and phosphorylation in 
skeletal and cardiothoracic muscles (see chapter 3). 
The results show marked changes in hepatic glycogenesis during pregnancy and upon 
meal feeding pregnant rats. The changes between the groups in "C-glucose 
"disappearance" reflect quite closely the degree of incorporation into glycogen. The 
20 day pregnant RMF group showed an enhanced degree of IIC incorporation into the 
glycogen macromolecule together with an apparently greatly reduced dissipation of 
glucose from the liver. Dissipation of hepatic glucose could be the result of hepatic 
Page 204 
oxidation due to glycolysis and the Krebs cycle or via flux through the pentose 
phosphate pathway (for generation of NADPH, important for fatty acid, cholesterol 
and steroid synthesis). It could also be due to direct incorporation into glycogen or 
the simple diversion away to other glucose requiring peripheral tissues. It would 
appear that during late pregnancy very little of the administered glucose is converted 
to glycogen. Consequently, it may be diverted away from hepatic vascularity to fuel 
the development of the foetus(es) rather than requirements of maternal tissue, due to 
the significant degree of glucose intolerance shown by these tissues, see chapter 3. 
The rapidity in which the glucose dissipates from the liver is remarkably high and it 
could be argued that this may caused by the haemodilution effect due to increased 
vascularity and/or a greater glucose turnover rate. However, bolus infusions of 
glucose were administered in accordance to the rats weight prior to the experiment. 
The specific activity of the blood was investigated. However, due to the small bolus 
infusions of IYC glucose administered it was impossible to distinguish between the 
groups. Clearly pregnancy is having an effect on hepatic glucose homeostasis. 
Glucose absorption/retention by the liver is somehow being compromised during 
pregnancy, allowing circulating glucose to be channelled towards the foetus(es). It 
would therefore be useful to evaluate the role of hepatic glucose transport systems and 
insulin receptors during late gestation. The latter has previously been investigated 
and was shown to be unaffected by pregnancy (Soman, 1979). The method of 
glycogen repletion during late pregnancy may be a mechanism of preserving plasma 
glucose levels for the requirement of the foetus(es). If glycogen is predominantly 
being repleted by the indirect gluconeogenic pathway this would allow glucose to be 
diverted away from the liver. It is evident during pregnancy that higher levels of C3 
Page 205 
intermediates are prevalent due to the increased mobilisation of fatty acids (oxidised 
by peripheral tissues) and ketone bodies together with the consequence of increased 
glucose utilisation by the foetus generating pyruvate and lactate which can re-enter 
the maternal blood stream. During pregnancy these intermediates may act to buffer 
the reduced rates of glycogenesis from glucose. Consistent with the findings in 
chapter 3 routine meal feeding late pregnant rats encourages greater glucose 
absorption by the liver and consequently is diverted to glycogen repletion. Compared 
with other short-term meal feeding regime studies (Pallardo and Williamson 1989), 
pregnancy accelerates the adaptation to food availability. The study by Pallardo and 
Williamson (1989) used 10 day non-pregnant meal fed rats to demonstrate the 
increase in lipogenic rates of the liver. However, they did not see changes in 
glycogen repletion rates which is evident during long-term meal feeding regimes, see 
sectiýn 5.3.4.. This could be due to the fact that these studies were not designed to 
evaluate the relative contributions of the direct and indirect method of glycogenesis. 
Although "C-glucose incorporation into hepatic glycogen was significantly higher in 
the 20 day pregnant RMF group it did not compare to the levels of incorporation seen 
in the 10 day pregnant RMF group. This group showed a greatly enhanced ability 
to incorporate glucose directly into glycogen, a response which cannot easily be 
explained. It must be noted however, that in the 10 day pregnant ad libitum group, 
rates of hepatic "C-glucose incorporation into glycogen were comparable to that 
found in the 20 day pregnant RMF group. Therefore initially, there are greater levels 
of direct glycogenesis during early gestation and the effects of routine meal feeding 
enhance the total level of incorporation into glycogen. As well as significant changes 
between the two nutritional regimes, early and late gestation also show definite 
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changes in hepatic glycaernic: control when ad libitum and RMF groups are compared 
directly. These changes are despite the fact that plasma glucose concentrations are 
relatively constant in all groups, except the 20 day pregnant ad libitum group, see 
table 20. 
It appears from the results in chapter 3, and those discussed above, that routine meal 
feeding dramatically alters maternal glycaemic control during pregnancy. More 
glucose is being utilised by maternal tissues, including the liver. This raises one 
important question concerning the nutritional status of the foetus(es). If more glucose 
is being phosphorylated by skeletal tissues as well as being assimilated as glycogen, 
does this compromise the development of the foetus(es) with respect to its glucose 
requirement. Litters from mothers placed on routine meal feeding regimes showed 
approximately 20% reduction in weights compared with normal pregnant pups 
immediately following birth. However, these pups grew into normal sized animals 
with no observable malformations. 
This study illustrates the importance that particular feeding regimes have on glucose 
utilisation by the mother. Benefits could be gained by mothers who have a high risk 
of developing gestational diabetes or who are diabetic prior to pregnancy. Since 
pregnancy diverts glucose away from maternal tissues, mothers which already have 
a degree of tissue insulin resistance may be at greater risk of developing conditions 
such as eclampsia, which is recognised by acute increases in blood pressure and blood 
lipids, and the occurrence of intrauterine deaths. Although this study has shown 
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benefits to the mother in utilising glucose, the extent of the feeding regime is 
extremely severe. Further studies are required which would extend the periods of 
feeding to allow correct daily food consumptions to be achieved. If simply altering 
the frequency of feeding can influence the fate of glucose then this study could be 
modified to high risk mothers who are diabetic or are prone to acquiring diabetes post 
partum. The acquisition of these conditions could directly be related to the erratic 
consumption of food during a 24 hour period in the 20 day pregnant rat. Results not 
tabulated show that during the 3h periods starting from when the light was switched 
off [10: 00 in reverse light dark room] food consumption was 5.8 ± 0.6,7.6 ± 0.7 
and 3.7 ± 0.7 g at 13: 00,16: 00 and 19: 00, respectively, and between 19: 00 and 
10: 00 total intake was 11.8 ± 0.7 g. These results demonstrate that food 
consumption occurs continually during the 24 h cycle and is not confined to specific 
feeding patterns. By confining food intake patterns to specified periods alterations 
in maternal glucose metabolism may provide long term benefits as gestation 
progresses. 
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CHAPTER 6. 
Studies of hepatic gluconeogenesis using 31P-NMR. 
6.1.1. Introduction. 
As mentioned in previous sections, gluconeogenesis plays a key role during 
starvation, maintaining glucose levels supplied to the brain. However, 
gluconeogenesis may have an aetiological role in certain disease states, such as non- 
insulin dependent diabetes mellitus (NIDDM). In NIDDM, gluconeogenesis may be 
a contributory factor to the characteristic post-absorptive hyperglycaemia found in 
these subjects. It may also be a significant factor during late pregnancy where there 
is an apparent insulin insensitivity by the mothers' peripheral tissues. Glucose 
turnover per kg increases during the course of gestation however, hypoglycaemia 
persists during late gestation. This would imply that any increased plasma glucose 
levels are for the benefit of the developing foetus(es) preferential to the mothers 
needs, see section 1.7.. Supplying the extra glucose demand required for the 
conceptus could be achieved by increased glycogenolysis and gluconeogenesis. 
However, pregnancy induces an accelerated starvation status which would cause 
accelerated glycogenolysis compared with non-pregnant subjects. This would greatly 
enhance the need for gluconeogenesis to operate in order to maintain sufficient 
glucose levels for both mother and conceptus. Unfortunately, the relative 
contributions of glycogenolysis and gluconeogenesis to any increase in hepatic glucose 
output is controversial and have not yet been established due to the lack of techniques 
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for measuring in vivo hepatic gluconeogenesis. 
Most gluconeogenic studies to date have used conventional radioactive isotopic 
techniques which employ the IT labelled precursors of gluconeogenesis (primarily 
alanine and lactate). The major problem with this lies in the total quantitation of 
gluconeogenesis since the label could be exchanged with "C as it is synthesised to 
oxaloacetate prior to phosphoenolpyruvate production seefigure 1. This would result 
in a loss of label via the Krebs cycle and labelling in other intermediates, such as 
glutamate (a gluconeogenic precursor), which would complicate results. Consoli et 
al. (1989) attempted to overcome the problem of substrate-cycling by dual isotope 
infusion of [6-1HI-glucose and [2- '4C]-acetate. By examining the distribution Of 14C 
within the glucose molecule, the relative contributions of precursors from the Krebs 
cycle'could be assessed since acetate is not a gluconeogenic precursor due to its direct 
entry into the cycle or biosynthesis into fatty acids and triglycerides. However, since 
aceta te is metabolised primarily by muscle, rather than liver, total quantitation of the 
Krebs cycle precursors cannot accurately be established (Schumann, et al., 1991). 
The important protein-derived precursor, L-alanine, has been shown to increase 
gluconeogenic rates in the perfused liver of the rat following its conversion to 
pyruvate (Ross, et aL, 1967). The effect of L-alanine infusion has been investigated 
using in vivo hepatic 3P-NMR (Dagnelie et aL, 1992). These studies showed 
maximal increases in the phosphomonoesters, reflected by the increase in 3- 
phosphoglycerate, and decreases in Pi ie. [PMEI/[ATP] and [Pj/[ATPI of 98% and 
33% respectively. The study discussed in this thesis used IIP-NMR to look at the 
Page 210 
relative changes in vivo of the hepatic phosphorus spectrum in the rat as 
gluconeogenic flux was manipulated by infusion of alanine and glucagon (Changani 
et aL, 1994(b)). The aim was to characterise all the major changes seen in the 
various components of the phosphorus spectrum to assess the validity of the technique 
for estimating gluconeogenic rates in disease states. In order to fully interpret 
changes seen in vivo, it was necessary to conduct in vitro high resolution IT NMR 
spectroscopy on freeze-clamped liver extracts from separate bench experiments which 
mimicked the in vivo protocol. This provided information on the specific changes in 
metabolites (eg. 3PG, sugar phosphates, PEP, ATP, ADP, etc. ) associated with the 
broad resonances of the in vivo phosphorus spectrum. In addition hepatic glucose 
output measurements were conducted on in situ perfused livers to correlate changes 
in gluconeogenic intermediates with glucose output. Potentially alanine/"P-NMR 
could be used clinically as a method of assessing hepatic gluconeogenesis in patients 
with NIDDM. 
6.1.2. Method of in vivo determination of gluconeogenesis bI MP NMR. 
6.1.2.1. Animals 
Male Wistar rats (275-325 gm) were maintained at 20 ± 2"C on a 12 hour light/12 
hour dark cycle (light off at 22: 00) and fed on a chow diet consisting of 52% 
carbohydrate, 15% protein, 3% fat and 30% non-digestible residue. Rats were 
starved for a 12 hour period prior to experimentation. This had the effect of reducing 
Page 211 
the hepatic glycogen content by 50% and hence promoting gluconeogenesis when 
supplied with a three carbon substrate such as lactate, pyruvate or alanine. 
6.1.2.2. Cannulation of the jugular vein. 
Cannulae were prepared as in section 2.1.. Following anaesthesia with sodium 
pentobarbital (60 mg/mI in dd. H20,, the inferior jugular vein was cannulated as 
described in section 2.1., however, the cannula remained external to the body cavity 
and hence an additional suture was used for anchorage. A midline abdominal incision 
was made to expose the liver and the coronary ligament severed to drop the liver 
away from the diaphragm. The cannula was connected to a5 metre line containing 
either saline (0.9% NaCl solution) or a 1.099 mol/I stock solution of alanine (T865, 
The Roots Co. p1c. Nottingham, U. K. ). The line was attached to an infusion pump 
set at 0.5 ml/min in order to give a total infusion of either 2.8 mmol/kg alanine ± 
250 yg/kg glucagon (HPLC purified Sigma -G 7774) or 5.6 mmol/kg alanine ± 250 
gg/kg glucagon or 250 yg/kg glucagon or 1.5 ml of saline. 
6.1.2.3. SDectroscovv methodolo 
The rat was positioned in a 4.7 Tesla 33 cm diameter horizontal bore SISCO system 
magnet as previously discussed in section 5.1.2.3.. A single turn 1 cm diameter 
phosphorus tuned coil was used to acquire blocked spectra at 80.984 MHz. After 
tuning the phosphorus channel, the magnet was shimmed for greatest field 
Page 212 
homogeneity. Phosphorus spectra were acquired using an acquisition time of 0.408s, 
a relaxation time of 5.0 s, a pulse width of 10OAs and a spectral width of 8.0 kHz 
used to produce 20 array elements consisting of 64 averages, over a period of 115 
mins.. After acquiring two base-line spectra, the infusion pump was started. 
Typically the experiment was run for a total of 60 minutes post-infusion. The spectra 
were referenced to the a-ATP resonance at -7.57 ppm 
6.1.3. Method for in vitro extraction of liver forDimiAorus NMR analvsis. 
6.1.3.1. Artimal ewerimentation. 
The experimental procedure was the same as that described in section 6.1.2. the only 
difference was that the animal was not placed in the magnet. The liver was freeze- 
clamped in situ at 25*minutes post-infusion of either saline, 5.8 mmol/l alanine, 5.8 
mmol/l alanine and 250 jAg/kg glucagon or 250 jig/kg glucagon. The liver was 
loosely tied with a length of cotton and held clear of the body cavity, small freeze 
clamps were pre-cooled in liquid nitrogen and positioned around the liver. As soon 
as the liver was clamped any connecting tissue around the clamp was quickly cut 
away and the liver placed in liquid nitrogen. Any tissue not in the clamps was 
chipped away leaving approximately 3-4 g of tissue in the clamps. This method of 
freeze-clamping limited the hypoxia of the liver. The tissues were stored in liquid 
nitrogen until the day of extraction. 
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6.2. Method of liver metabolite extraction. 
6.2.1. Extraction and Iyophilisation. 
The liver tissue (2 g) was ground to a powder under liquid nitrogen. This was 
achieved by placing a pestle and mortar, containing liquid nitrogen, into a polystyrene 
ice-bucket containing a2 cm depth of liquid nitrogen. The tissue was weighed into 
a pre-cooled glass scintillation vial and ice-cold 10% perchloric acid (5 ml) [PCA] 
added to de-proteinize the tissue. The powder was homogenised using a Tissue 
Homogeniser [Inter. Lab. App. Gmbh, Type X 1020; small probe; position 6), 
transferred to a plastic tube and centrifuged at 5000 rpm and VC for 15 minutes in 
a MSE Mistral 3L centrifuge. The supernatant was recovered and the pellet re- 
extracted with 2 ml of PCA. The pellet extract was briefly homogenised and 
centrifuged as above. The supernatant was pooled with that of the first extraction and 
neutralised to pH 7.0 - 7.5 using KOH and PCA. The perchlorate suspension was 
pelleted out at 5000 rpm at 4*C for 15 minutes. The supernatant was frozen at -70*C 
and lyophilised for 36 hours in a pre-weighed 100 ml beaker covered with perforated 
" parafilm". The dry weight of the total sample was assessed and then re-frozen until 
the day of analysis by NMR. 
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6.2.2. Preparation of sample for NMR analysis. 
Total dry weight sample re-suspended in: 0.9 ml distilled water 
0.6 ml D20 
50 /A Phosphocreatine standard (67mM) 
EDTA (100mM final concentration) 
and neutralised to pH 7.40 - 7.50 using appropriate concentrations of KOH and PCA. 
Any insoluble material was centrifuged out at full speed in an Eppendorf centrifuge. 
The addition of EDTA was to chelate any ions which cause broadening of peaks such 
as Mn, Fe and Mg which is bound to 93-97% of total ATP and hence, shifts the 
resonance of the ATP molecule. The sample (0.7 ml) was transferred into a high 
quality NMR tube (Wilmad Glass Company 507-pp). 
The sample was run on a Varian 500 MHz 11 .7 Tesla machine at 202.315 MHz using 
the following parameters: 
Acquisition time - 0.800 sec 
Relaxation delay - 0.100 sec 
Pulse width 13.0 Ysec 
Spectral width 10000.0 Hz 
Decoupler continuously on 
Waltz 16 modulated 
Line broadening 2.0 Hz 
No. of averages ca. 2000. 
From each group one sample was run overnight with a relaxation delay of 20 s, this 
allowed quantification of other samples run at shorter relaxation delays which would 
be partially saturated (Bell et al, 1993). This speeded up the process of running 
numerous samples. The PCr resonance was referenced to 0.00 ppm and the spectrum 
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analysed using a computer based calculation (NMRII). 
6.3. Isolated perfused liver experiments 
6.3.1. Perfusion apparatus 
The perfusion set-up was similar to that used by Exton and Park (1967) with the 
modifications of Cohen et al (1973). 
Ile perfusion apparatus consisted primarily of a perspex perfusate oxygenation drum 
designed to rotate at a fixed 60 revolutions per minute powered by an electric motor 
(Parvalux Electric Motors Ltd., Bournemouth, Dorset). Three stainless steel pipes 
contained within a sealed shaft were incorporated horizontally into the centre of the 
drum via the non-motor driven axle end. These tubes allowed oxygenated removal 
and deoxygenated perfusate disposal from the drum together with efficient perfusate 
oxygenation of up to 300 ml. The first tube was angled at 90* so as to draw 
oxygenated perfusate from the bottom of the drum, the second pipe transmitted 
venous perfusate back into the drum and the third, allowed access to the humidified 
gases. The deoxygenated perfusate disposal and oxygenation pipes were long enough 
to allow the perfusate to be smeared against the motor driven backplate increasing the 
surface area for oxygenation. A pressure regulated cylinder delivered the gas mixture 
(95%02 15 % CO) into a glass humidifier connected to the respective stainless tube 
pipe of the rotating drum. Both the humidifier and perfusate drum were contained 
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within a purpose built perspex box with detachable lid. Perfusate was pumped around 
the circuit using a variable speed peristaltic pump (Watson Marlow type MHRE 22; 
Falmouth U. K. ) via a silicone rubber tubing [(Portex 800/500/325) OD 8.00 mm ID 
5.0 mm], the rest of the circuit was connected with polyethylene tubing f(Portex 
800/010/180/800) OD 3.00 mm ID 2.45 mm]. Prior to entering the liver, the 
perfusate was filtered using 6 cm of transparent polyethylene tubing [(Portex 
800/000/450) OD 9.52 mm ID 6.35 mm] containing aI cm plug of polymer-wool 
(inter-Pet Ltd., Dorking, Surrey, U. K. ). Various circuit connections were made 
using male-male luer connectors (R93, Avon Medicals Ltd., Redditch, Worst., U. K. ), 
two 3-way disposable taps (Vygon, Ecouin, France. ) and three types of glass 
connectors (Chemlab Instruments Ltd., Hornchurch, Essex, London) ie. F and h- 
shaped. From the filter tubing the perfusate entered into a debubbler (F-shaped glass 
connector) which was also connected to the manometer. 'ne manometer consisted 
of a manometer chimney (Height I m, OD 15.0 mm, ID 13.0 mm) into which 
perfusate could be fed into the system and a length of polyethylene tubing [(Portex 
800/000/180/800 (OD 3.0 mm ID 2.0 mm) the same height as the chimney. The 
pressure of the perfusion system gave a reading on the manometer as a perfusate level 
within the chimney, if a blockage occurred this would result in an increase in the 
height of the perfusate within the manometer providing an important indicator of 
arterial pressure. From the filter the perfusate entered into the 'h' shaped glass 
connector via the straight'arm and exited from the curved end before entering the 
liver. The other straight end was capped with a rubber septum into which a needle 
thermocouple was inserted, this gave a digital temperature reading. The temperature 
of the perfusate was controlled by a fan-heater, electronically controlled to stabilise 
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the temperature at 37*C. To maintain the humidity of the box, to prevent drying out 
of the liver, swabs dipped in distilled water were placed within perfusion box. 
Incorporated into the tubing system were two 3-way taps, these allowed sampling at 
the venous end together with the quick adaption to a non-recirculatory system. One 
of the taps was immediate to the venous end and the other connected to the same 
peristaltic pump as above. It received pre-warmed perfusate (25'C) from a reservoir 
channelling it to the perfusate drum or could receive venous perfusate for re- 
oxygenation by the drum. By turning the taps simultaneously perfusate was either 
allowed to recirculate for oxygenation in the drum via the two taps or be discarded 
as waste via tap a (flgure 25) 
Figure 25 represents the complete plumbing of the perfusate system. 
6.3.2. Preparation of the perfusate. 
The perfusate used was a Krebs-Henseleit bicarbonate buffer (Krebs and Henseleit, 
1932). This was made up in a concentrated format, see table 21. and autoclaved in 
aliquots of 80 ml in brown bottles. On the day of the experiment each aliquot was 
made up to 1000 ml after the addition of sodium hydrogen carbonate. The pH was 
adjusted to 7.4 - 7.5 if required. 
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Table 21. Preparation of stock Krebs-Henseleit buffer. 
Chemical. gm/l. For II prep. 
NaCl 174. 40 ml 
KH2PO, 16.4 10 ml 
MgSO,. 7H20 29.6 10 ml 
KCI 35.7 10 ml 
CaC12.2H20 27.0 9.4 ml 
Sodium hydrogen bicarbonate was added on to the day of perfusion [2.1 g/11. 
6.3.3. Cannulation Drocedure of the isolated perfused liver. 
6.3.3.1. Preparation of perfusion circult. 
The perfusion circuit was washed thoroughly for 15 minutes with distilled water by 
placing the system in a non-recirculatory mode seefigure 25. Following this, Krebs- 
Henseleit bicarbonate buffer was washed through the system. A volume of 300 ml 
was pumped directly from the perfusate reservoir into the circuit and allowed to 
equilibrate at 37*C while constantly being pumped in a circulatory fashion to allow 
adequate oxygenation by the humidified gases (95 %02: 5% CO). It was imperative 
that time was taken to ensure no air bubbles remained in the arterial flow. 
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6.3.3.2. Cannulation. 
The animals used were male Wistar rats (275-325 gm) maintained at 20*C ±2 on 
a 12 hour light/12 hour dark cycle and fed on a standard chow diet consisting of 52 % 
carbohydrate, 15% protein, 3% fat and 30% non-digestible residue. Rats were 
starved for a 12-20 hour period prior to experimentation, this has the effect of 
reducing the hepatic glycogen content, hence promoting gluconeogenesis and glycogen 
synthesis when supplied with the correct substrate. 
Ile rat was anaesthetised with sodium pentobarbital (60 mg/ml/kg in distilled water) 
and its limbs taped to the perspex tray. A transverse abdominal incision was made 
exposing the liver and guts. The hepatic portal vein (HPV) was located and two 
loost sutures placed I cm apart, another loose suture was placed above the right renal 
vein of the inferior vena cava (IVC). Approximately 100 units of heparin was 
injected into the IVC just above the renal vein, via a fat pad, this would reduce the 
risk of blood clotting during the cannulation procedure. The peristaltic pump was 
turned off and the venous return line blocked by turning tap c (flgure 25) in the 
appropriate direction, the circuit was then broken and two cannulae fixed into 
position, the HPV cannula was placed bevel up and the IVC cannula bevel down. 
The lower HPV suture was tightened and the peristaltic pump started at a very slow 
flow rate. Using the tied suture the vein was raised and a cut made using a pair of 
micro surgical scissors and the cannula eased approximately 5 mm into the vein. The 
cannula was tightly secured using the top suture and the IVC immediately severed 
below the IVC suture to prevent pressure build up in the liver by allowing a route for 
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perfusate afflux. The peristaltic pump was increased to the optimum rate according 
to 10 ml/100g rat weight. The liver was now being artificially perfused and hence 
was isolated from the rat. Ischaemia and anoxia of the liver was kept to a minimum 
by performing the above cannulation procedure within 30 seconds. The chest cavity 
was completely opened to expose the heart; the venous cannula was inserted directly 
into the right atrium of the heart and pushed down I cm into the IVC. Tap c (flgure 
25) was turned to allow venous flow and the IVC tied resulting in a completely closed 
system where the venous return was routed back into the oxygenation drum. A good 
preparation was indicated by an even brown colouration, any blotches in colouration 
suggested uneven perfusion. 
The perfusion box lid was placed in position and the system allowed to equilibrate for 
15 - 20 minutes after which a venous sample (4 ml) was added to 10 % perchloric acid 
(1 ml) and stored at -70"C for future glucose analysis, see section 2.5.. Addition of 
alanine and glucagon was via the gas line followed by immediately turning taps a and 
b (flgure 25) to allow the perfusate reservoir to drain into the oxygenating drum and 
the venous return to go to waste or be sampled. The perfusate reservoir was warmed 
to 25*C and contained the correct concentration of I-alanine (T 865,10% solution, 
The Boots Co., p1c., Nottingham, U. K. ) and/or glucagon prior to cannulation. 
Samples were taken every 10 minutes after the introduction of the substrates for a 
total of 60 minutes, at the same time the flow rates were also measured. 
Concentrations of alanine and glucagon used are shown in Table 22. 
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Table 22. Summary of gluconeogenic eLcperiments. 
1.2.8 mmol/I L-Alanine [1.122M stock solution] 
2.5.6 mmol/I L-Alanine 
3.5.6 mmol/I L-Alanine + 250, Ag Glucagon [200 Pg/mlj 
4.250 pg Glucagon. 
5. Saline 
6.4. Quantification of `P liver spectra. 
The analysis of the phosphorus spectra obtained from these studies proved to be the 
most difficult aspect of the project. However, a method was decided upon which 
gave consistently precise results and described the obvious changes observed by eye. 
As briefly mentioned in section 4.5.2., the broad co-resonance of phospholipid 
components of plasma membranes, and slowly mobile proteins, produces a large 
"hump" between 30 and -30 ppm, coinciding with the metabolites of interest. This 
makes absolute integration of the resonant peaks far more difficult since a method 
must be devised to eliminate the contribution of the hump to the metabolite of 
interest. Several computer programs exist which are supposedly capable of removing 
the phospholipid hump, hence producing a flat base-line from which integration of the 
metabolites can be achieved. This was the initial method of choice for processing the 
huge amount of data shown in this chapter. Unfortunately, the program used 
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(NMRII) did not consistently remove the same phospholipid component from each 
spectra and invariably removed large areas associated with the PME and B-ATP 
regions. This was very evident when significant changes were being seen in these 
two components. Furthermore, all 700 spectra had to be manually phased since the 
auto-phasing feature of the program was inconsistent. As a result the calculated 
changes showed no correlation in the pre-infusion values between the groups and did 
not depict the observed changes; in fact the graphs were very random scatter 
diagrams with unacceptably large standard errors. The problems associated with the 
quantitation of the spectra obtained are at present being critically analysed. However, 
a rigorous solution is not achievable in the time scale for completion of this thesis. 
In order to assess the changes in the groups studied a new method was employed 
which gave relative values of change rather than absolute changes of the metabolites. 
The method involved obtaining the peak heights of the five observed metabolites 
measured from the spectral baseline, as illustrated infig. 25a (PME, P,, gamma ATP, 
alpha ATP and beta ATP) together with the sum of these peak heights. The 
component peak heights were divided by the sum of all the peak heights (total 
phosphorus peak height). The total phosphorus peak height within one experiment 
was found not to change and hence was regarded as a good standard to be employed 
for all experiments, allowing direct comparisons to be made for the relative changes 
in peak heights of the metabolites. All values are therefore expressed relative to the 
total phosphorus peak height and showed extremely high degrees of precision within 
the groups. The relative peak height changes are expressed with a component of 
phospholipid hence changes in PME are represented as PMEPL, the same is true for 
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Pi and ATP (ie. P'PLand ATPpL) It must however be emphasised that the percentage 
changes quoted are not representative of the absolute metabolite changes due to the 
substantial contribution of the phospholipid hump to each of the metabolites. 
Depending on the position of the metabolite a different peak height will be observed 
even though, for argument sake, the heights without the phospholipid hump 
contribution may be the same. From diagram 25a it can be seen that any metabolite 
near -15 ppm will always have a lower relative peak height to those at around 0 ppm 
due to the shape of the hump. It must also be noted that the total phosphorus line 
height is not a true representation of the total phosphorus signal since different 
metabolite resonances will have different line widths and a narrow peak will 
contribute more to the total phosphorus signal compared with a broader peak of equal 
area. All calculations are therefore based on the measurements shown in Figure 25a 
where-each metabolite is represented by the following equation: 
Peak height ratio (A + PL) 
Pi(tow) 
where: 
A metabolite peak height 
PL phospholipid height at frequency 
of A 
pi(t. t. 0 ý sum of all A heights including PL 
contribution. 
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It has also been assumed that the phospholipid component does not change during the 
course of the experiment. This assumption would be made even if absolute integrals 
could be obtained and bearing in mind the relatively short time period of the 
experiments, this seems a relatively valid assumption since it is unlikely that 
phospholipid and protein components would significantly alter. Verification of this 
was achieved by obtaining the integral of the total spectrum after applying a line 
broadening component of 1000 Hz, this resulted in no net change in the integral over 
the period of the experiment in all of the groups. 
A study by Cox et al. (1992) used similar methods to quantify the changes seen in 
patients with liver disease, from spectra with a rolling base-line. Two methods were 
employed, the first removed a base-I ine component by joining straight I ines between 
the extremities of the line-width which made up the metabolite resonance then 
integrating the remaining area. The second was to integrate everything under the 
metabolite resonance including the base-line contribution, this was thought to give an 
over-estimation of changes whereas, the first method produced an under-estimation. 
Therefore an average of the two different base-line measurements was calculated. 
Measurements were standardised with the B-ATP resonance which was assumed to 
remain constant. 
6.5. Statistics. 
Statistical significance differences between means was assessed by Student's paired 
t test. All results are given as means ± SEM for n=6 rats unless otherwise stated. 
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6.6. Results. 
The tables accompanying these results represent the actual mean figures obtained in 
the various infusion groups. Statistically significant differences are between the pre- 
infusion (time =0 in tables/time = -5.77 min on graphs) mean value and the 
corresponding post-infusion (infusion during second time =0 in tables/ time =0 on 
graphs) mean value, within the group. From tables 23 to 27, there were no 
significant differences in the pre-infusion values between each of the six groups 
studied, this eliminated the need to assess the relative changes within each group. 
This fact verified the accuracy in depicting the results on the basis of total phosphorus 
relativity, since pre-infusion ratios in any of the groups should be similar for the 
particular resonance considered, due to animals being age-matched and metabolically 
equivalent. Typical in vivo spectral changes are shown infigure 26. Differences can 
quite clearly be seen prior to and following infusion of 5.6 mmol/kg alanine in the 
PME, P, and the three resonances of ATP. 
6.6.1. Chan2es in heDatic phosphomonoesters plus underlying phospholipid 
during alanine infusion in the rat. 
Specific values have been tabulated in table 23 and comparisons have been made 
in figures 27 - 31. From figure 27 it is shown that saline has no net effect on the 
peak height ratio of PMEPL, however, infusion of glucagon alone does produce a 
slight increase in PMEPL, which becomes significant approximately 30 min post- 
infusion (P<0.05). This slight increase is due to the stimulative effect of glucagon 
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on gluconeogenesis, such that amino acids (especially alanine and glutamine), lactate 
and glycerol, primarily from extrahepatic tissues, are converted to glucose. The rate 
of increase in PMEPL, representing gluconeogenic intermediates, is relatively slow 
probably due to one or two factors. The first is the physiological condition of the rat, 
which had undergone 12 h of starvation, this would be insufficient to deplete all the 
hepatic glycogen stores and hence, blood glucose levels can be maintained via 
glycogenolysis. This may suggest that glucagon secretion is secondary to the 
initiation of gluconeogenesis. Secondly, the rate of gluconeogenesis will depend, 
amongst other factors, on substrate supply reflecting the degree of starvation. 
Figure 28 represents the comparison between infusing 2.8 mmol/kg alanine with or 
without glucagon. The graph shows a net increase in the PMEPL level within these 
two groups. On first inspection it appears that the group with added glucagon 
remains relatively low until 20 min post-infusion, after which an enhanced increase 
over and above the group infused with 2.8 mmol/kg alanine occurs. Infusion of 
alanine alone appears to have an almost immediate effect, seen within the first 5 min 
after infusion. Figure 28 shows quite clearly the net effect of alanine infusion, with 
glucagon administration producing the greater effects. However, the data must be 
looked at in more detail with the standard errors in mind. Taking this into 
consideration, no significance was seen in the 2.8 mmol/kg alanine infused group 
until 40 min post-infusion, where a transient increase was observed (P<0.05) after 
which, pre-infusion values were reinstated. Upon infusion of 2.8 mmol/kg alanine 
plus glucagon, increases were seen at approximately 30 min, with maximal increases 
of 13.1 % at 40 min post infusion (P < 0.02). Following this, the PMEPLdecreased 
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back to pre-infusion levels by 50 min, presumably due to the absence of further 
substrate for hepatic gluconeogenesis. 
Increasing the alanine bolus dose to 5.6 mmol/kg produced a greater change in the 
PMEPL region of the phosphorus spectrum compared with the above infusions. 
Significant increases to the pre-infusion status were seen approximately 10 min after 
administration of alanine of 6.8 % (P < 0.02), this increased further to a maximum of 
20.8% (P<0.01) at 35 min, with a maximal significance at 30 min (P<0.001). 
Compared with infusion of 2.8 mmol/kg alanine, where maximal increases were seen 
at 40 min, these results represent a further increase of 12.7 % (P < 0.02). Comparison 
of the two groups suggest that maximal increases occur at approximately the same 
time point after infusion, with the 5.6 mmol/kg group producing the highest increases 
of PMEPLat 35 min, as opposed to 40 min in the 2.8 mmol/kg group. Fromflgure 
29 significance between the two groups can be better appreciated. The two groups 
seem to follow the same upward trend up to 10 min post-infusion, after which the 5.6 
mmol/kg group dramatically increases to a maximum at approximately 35 min, at 
which point no further increases are achieved. However, the net maximal increase 
remained high until approximately 50-60 min. At this time point, the PMEPL level 
declines at a fairly rapid rate towards the pre-infusion value. If glucagon is included 
with the bolus of 5.6 mmol/kg alanine, fairly similar results are. obtained, Seefigure 
30. As with infusing alanine on its own, the rate of increase in PMEPLI With the 
added glucagon, seems to occur at the same rate; both plots can be seen to follow the 
same linear gradient as one another. One of the main differences between the two 
groups appears to be the enhancement of the PMEpL level, even at 75 min post- 
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infusion. Whereas, the alanine group shows a decline in PMEPL levels at 50 min, the 
glucagon group shows a far more gradual decline towards the pre-infusion values, 
starting at 55 min. Compared with pre-infusion values, PMEPL levels remain at a 
significantly high level even 75 min post infusion (+18.7%, P<0.001). Ignoringthe 
time point at 63.45 min, which does not follow the plateau trend of the graph and 
undoubtedly is spurious, the maximal increases in the PMEPL region are found at 30 
min post-infusion and remain at this level for a further 30 min, after which a slow 
decline is observed. The maximal value is 25.6% higher than pre-infusion values 
(P<0.001) but this is not significantly higher than the 5.6 mmol/kg group. In 
general there was a reduced recovery rate of PMEPL levels compared with the group 
without glucagon. 
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6.6.2. Changes in hepatic phosphodiesters during alanine infusion in the rat. 
Assigning the phosphodiester resonance proved to be very difficult due to the 
apparent variability of the chemical shift. This is to be expected for several reasons 
the first being the contribution of phosphoenolpyruvate, glycerophosphory1choline 
(GPQ and glycerophosphorylethanolamine (GPE) occurring at around the same 
chemical shift, the chemical shift difference being approximately 1.5 ppm. However, 
more importantly is the positioning and intensity of the PDE region with respect to 
the in vivo liver spectra. As is discussed in section 6.1.1., the contribution of 
membrane phospholipids to the phosphorus spectrum is extremely large, extending 
over 50 ppm. This phosphorus component produces a very broad hump which can 
be visualised by applying an exponential multiplication corresponding to a line 
broadening of 1000 Hz. This hump by virtue of its size, seems to interfere with the 
PDE region, varying its intensity quite dramatically, as well as producing 
contributions from mobile phospholipids at the lower field strength. This is not a 
problem in vitro as the phospholipid components are removed with the deproteinised 
phase during extraction procedures and field strengths are higher. Another possibility 
for the lack of specificity of the PDE resonance could be due to the relative long 
relaxation times of GPC and GPE (>4s), causing a certain degree of saturation, 
however I do not feel that this was the major contributor to the problems of assessing 
the PDE region in vivo. 
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6.6.3. Changes in hepatic P . plus underlying phospholipid during alanine infusion 
in the rat. 
Specific values have been tabulated in table 24 and comparisons have been made 
infigures 32 - 36. Figure 32 shows the effects of infusing either saline or glucagon, 
these results suggest, together with the values in table 24, that no substantial changes 
occur in hepatic inorganic phosphatepL (PipL) From the graph there may be a slight 
increase in PiPL levels approximately 25 min post glucagon infusion, which 
corresponds to the slight increase seen in the PMEPLregion. At 40 min post-infusion, 
the P'PL level drops back down to its initial level, this again corresponds to the 
response by the PMEPL. There was no significance between the values attained and 
the pre-infusion values. 
During the first 10 minutes of infusion with alanine at 2.8 mmol/kg, a reduction in 
PipL was observed, after which, levels increased by 4% (P<0.02) before returning 
to pre-infusion values, see figure 33 and table 24. After 60 minutes PiPL levels 
returned to pre-infusion levels. A similar response was seen in the group with added 
glucagon, where the Pi increased by a maximal 8.8% at 25 min post-infusion. After 
60 minutes the PiPL had returned to pre-infusion levels. 
Fromfigure 34, it can be seen that increasing the alanine dose to 5.6 mmol/kg, once 
again, showed an initial decrease inP'PL levels in the first 10 min which became 
significantly reduced by 5% (P<0.02). This was followed by a linear increase in 
levels, to a maximum of 14.1 % above pre-infusion levels, at 35 min. At this point 
Pa-ve 240 X2- 
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a plateau was reached until approximately 55 min post-infusion, where the PiPL 
returned to normal levels. When glucagon was infused together with the 5.6 
mmol/kg alanine an identical response was achieved with the same linear increases 
until approximately 30 min post-infusion, at this point the P'PL continued to rise to a 
level 28.8 % (P < 0.01) higher than the pre-infusion PiPL level at 40 minutes. At this 
point the 5.6 mmol/kg plus glucagon group was at a level 19.4 % (P < 0.1) higher 
than the corresponding time point without glucagon administration. Adding glucagon 
to the higher alanine concentration prevented hepatic PipL from returning to its 
original steady state. From figure 35 it can be seen that the P'PL begins to return to 
its pre-infusion levels at approximately 65 min, but even after a period of 75 min 
levels remain 16% above the pre-infusion value. Whereas the 5.6 mmol/kg group 
returned to its steady state at 65 min, the glucagon administered group remained 
27.4% higher (P<0.02). If these results are compared to the equivalent changes in 
the PMEPL, see figure 30, it should be noted that the rate at which the PMEPL 
declined after infusion was similar in groups infused with 5.6 mmol/kg alanine ± 
glucagon appeared to be relatively slow and comparable to the observations seen in 
the P'PL of the glucagon added group. The inferences of these results are discussed 
in section 6.4., however it is important to note that glucagon at high concentrations 
of alanine does seem to promote long lastingp'PLeffects, possibly due to phosphorus 
cascading following membrane protein stimulation. 
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Changes in Pi plus underlying phospholipid. 
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6.6.4. Changes in hepatic ATP Plus underlying phospholipid during alanine 
infusion in the rat. 
Specific values have been tabulated in tables 25,26 and 27, comparisons have been 
made infigures 37 - 41. The tables show the changes in all three ATPpL resonances 
following the various infusions of alanine. In general, all three phosphates show very 
similar responses to one another, however it must be remembered that the 'Y, Ct and 
B-ATP resonances contain various contributions from other nucleotides. The -y-ATP 
resonance contain contributions from the terminal phosphate groups of 'Y-ATP and 8- 
ADP together with the respective phosphorylated nucleoside which, in vivo, are 
impossible to differentiate. The a-ATP resonance also contains contributions from 
both triphosphate and diphosphate nucleosides (see below), as the resonant form is 
the phosphate closest to the particular nucleoside, together with NADH. The closest 
approximation of ATP can only be gleaned from the B-ATP which involves the 
resonance of the central phosphate of the nucleoside triphosphates (NTP), it is 
therefore impossible for nucleoside diphosphates (NDP) to co-resonate near this 
chemical shift. Even though O-ATP is the closest approximation to the ATP levels 
in the tissue, it must be noted that included within this resonance will be contributions 
from GTP, UTP, CTP and ITP (guanine, uridine, cytosine and inosine triphosphates, 
respectively) at a concentration equivalent to one fifth of the total observed ATP. 
From graph 37 it can be seen that no significant changes were seen on infusion of 
either saline or glucagon. A small increase was shown by the glucagon group, 
however there was no significance with the pre-infusion values. Infusing the alanine 
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substrate at 2.8 mmol/kg, both with and without glucagon, also produced no dramatic 
changes in hepatic B-ATPpL. Most significant changes were observed when the 
alanine dose was increased to 5.6 mmol/kg, seefigure 39. Decreases were seen from 
as early as 10 min post-infusion, with a maximal decrease of 14.4% (P<0.02) at 35 
min post-infusion. Following this, the B-ATPPL level recovered to its original pre- 
infusion level at approximately 60 minutes post-infusion. Upon addition of glucagon 
to the 5.6 mmol/kg alanine infusate, see graphs 40 and 41, a very similar decline of 
16.1 % (P < 0.02) was observed by the B-ATPPL. As can be seen from graph 40 the 
rates of decline in levels of B-ATPPLwere almost identical in the two groups ± 
glucagon, they both appear to reach a minimum value at 35 min and there-after, 
slowly recover. The recovery rate of these two groups however, are not quite as 
similar, since adding glucagon tended to slow the rate of recovery. Compared with 
pre-infusion values, the 5.6 mmol/kg + glucagon group showed the longest recovery 
rates with values 12.3% (P<0.05) lower at 70 min post-infusion. 
When the changes seen in the 5.6 mmol/kg alanine (± glucagon) groups are 
compared to the same time points of hepatic PiPL fluctuations, important similarities 
are observed. As the 3-ATPPL levels decrease there is a synchronous increase in PiPL, 
in fact, the maximal increases in P'PL, coincide directly with the maximum decrease 
in O-ATPPL in the two groups. Infusion of 5.6 mmol/kg alanine alone, results in the 
recovery to pre-infusion levels of the two metabolites over the same time scale. 
However when glucagon is present, both the PiPL and 8-ATPPL remain at their 
respectively altered levels for a longer length of time when compared with just 
alanine infusion. These observations would seem to highly correlate these two effects. 
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Changes in fl-ATP plus underlying phospholipid. 
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Figure 37. 0 250Ag/kg Glucagon 
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Changes in fl-ATP plus underlying phospholipid. 
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6.6.5. Assessment of overall hepatic metabolism following the inftisions of 
aIanine. 
Tables 28 and 29, represent the overall response by calculating the incremental area 
under the curve (IAUQ for the saline and alanine (2.8 and 5.6 mmol/1) groups. Due 
to the incorporation into the results of all the standard errors of all time points, this 
representation does not depict the changes observed in the above results section. 
However, the changes seen in vivo can be represented in this fashion, and do show 
significant changes. On infusion of both 2.8 mmol/I and 5.6 mmol/I significant 
increases in PMEPLcan be seen (P<0.05) when compared with saline controls. The 
P'PL also exhibits increases on addition of alanine, however they are not as well 
defined as in the section 6.6.3. due to the incorporation of all the errors from the 
means. With regard to B-ATPPL it can be seen from table 28 that decreases are 
clearly observed from 0.17 ± 0.11 (lAUC units / 70 min) in the saline group to - 
0.16_ ± 0.09 (P<0.05) and -0.43 ± 0.09 (P<0.05) in the 2.8 and 5.6 mmol/I 
alanine group, respectively. 
Page 258 
06 
Q 
Q 
.U 
In., 
< r- 110 rn 
C? 
< rn O\ 
CD 
rn 
-: 
vi 
N 
ON 
CD 
CD CD cý 
-H -H +i < 0 (D tý kn r- kfi 
ci ci ci 
(D CD CD 
-H _H -H 
ýt V 00 ri C> 
c1i CD 
C> CD C: ) 
+i +i -H 
Pw en 0 cý "0 
(9 
Q 
Jia 
13 4) 1 -s 
-Z gi 
-Z 
r. o2 cm 
ll! ý 
CD 
+i 
CD 
+i 
< ', 0 
C> 
9 
r- C> 
C> 
-H 
CD 
+i 
.e rn (> 
P.. CD 
+i 
0 
+i 
r- rn 
+i -H 
00 
c; 
rq 
c; 
-H -H 
0 05 
c: = 
,G "0 in, 'M' 
09 3 
Iti 
10 
ci 0 
40- 
r_ 
Cd 
co 
tA 0 
E 
10 Cd 4- 
1.0 
0 
"a 
cd 
00 
fA 
Od 
Page 259 
C; en 
42 Q 
+i 
C: 
a 
43 
A Bit 
2 
E 
IS 
C! 
vý 
-H 
00 
cri 
41 -+1 -H 
Cý -4 en tn Ci ci Vý 
cn tn 
C) 
-H -H 41 
tn o 
C) 
Cli 
-H 41 -H :n 
Page 260 
iz 
9 
LLI 
0 
CY 
fol 0 
b. EB im 
ce 
0 
ZL 
2 (Z 
"Ci 
ZL 
0 
22, g2 CL r= 
7B 
Figure 42- In 14tro analysis of liver using high resolution NMR. 
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Pi Figure 43. In vitro analYSis of liver using high 
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6.7. Discussion. 
This study set out to evaluate the possibility of using `P-NMR as a technique for 
assessing changes seen during hepatic gluconeogenesis in disease states such as 
NIDDM, cancer cachexia and liver cirrhosis. In order to accomplish this it is 
essential to characterise the changes associated with the phosphorus spectrum upon 
infusion of the gluconeogenic precursors such as alanine. From the results it is 
apparent that changes associated with gluconeogenic flux, with respect to changes in 
sugar phosphates, C3 intermediates, inorganic phosphate and ATP, are detectable by 
in vivo NMR. In order to assign the specific changes seen in vivo it was essential to 
perform in vitro tissue extracts, these'studies; accounted for some of the changes seen 
in the broad resonances of the in vivo spectrum. 
Alanine is a major gluconeogenic precursor of the liver due to its structural similarity 
to pyruvate, the sole difference being the amine group attached to C2. Alanine and 
glutamine make up 60% of the total release of amino acids from muscle which is 
surprising since the total content of these amino acids in contractile protein is only 
10%. Prior to its entry into the gluconeogenic pathway the amine group is removed 
by a transamination reaction with ci-ketoglutarate producing pyruvate and glutamate. 
Glutamate is then oxidatively deaminated releasing NH4+ for the urea cycle together 
with ct-ketoglutarate, seefigure 44. Pyruvate can then be oxidised to C02 (this is 
thought to be negligible [Felig, 19731), synthesised to fatty acids or converted to 
glucose via oxaloacetate and phosphoenolpyruvate. 
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Figure 44. Reactions of the urea cycle. 
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It must be noted that if hepatic glycogen content is sufficient to maintain euglycaemic 
plasma levels then the contribution of alanine to hepatic glucose release is small. 
However, alanine has the direct effect of deactivating pyruvate kinase [EC. 2.7.1.40.1 
which indirectly inhibits 6-phosphofructokinase [EC. 2.7.1.11.1, due to the build up 
of citrate. 
The results of this study showed increases in the PMEPL region of the phosphorus 
spectrum which was consistent with the human studies (Dagnelie et al., 1992). 
However, infusion of alanine at the lower dose of 2.8 mmol/kg produced only slight 
increases in both the PMEpL andp'PL, which was not true for the human study. The 
human study showed clear increases in PME at this concentration together with a 
concurrent decline in P1. Significant increases in the PMEPLregion were not achieved 
until a dose of 5.6 mmol/kg was administered in the rat. At this concentration 
dramatic increases were observed in both the PMEPLand PiPL region of the rat. The 
increases in PMEPL levels were secondary to increases in 3-phosphoglycerate and the 
sugar phosphates, which includes glucose-6-phosphate and fructose-6-phosphate, both 
of which are difficult to differentiate between following in vitro analysis, seefigures 
42 & 43. It is clear from in vitro analysis that increases seen in the PMEpL region 
of in vivo experiments are not due to increases in 3-phosphoglycerate alone but other 
gluconeogenic intermediates which are difficult to resolve even from in vitro extracts. 
Changes in the phosphodiesters were not evident during the in vivo protocol however, 
increases in the phosphoenolpyruvate moiety were seen from high resolution NMR. 
Fromfigure 43 it can be seen that upon administration of 5.6 mmol/kg alanine PEP 
concentrations substantially increased over and above administration of saline. The 
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failure to manifest in vivo changes associated with the PDE resonance is the result of 
the co-resonance of the broad phospholipid component of the spectrum. This 
resonance consists of various phospholipids associated with membrane structure and 
other less mobile phospholipids. There are four main ways in which removal of the 
broad hump can be achieved however, each method has its own inherent problem. 
The first would be to carry out the same experiments using a higher field magnet, the 
second would be to irradiate at some point on the spectrum, preferably at around 8 
pprn or 1 ppm whiC'h would avoid irradiation of relevant metabolites. The third 
method is not really applicable to the protocol required for this study and that is in 
vitro liver perfusions performed at 6-10*C to "crystallise" cholesterol associated 
phospholipid membranes. Cholesterol in plasma membranes has the effect of 
allowing greater mobility of the phospholipid moiety and hence creating a "fluid" 
struciure, at low temperatures the membrane becomes more rigid therefore, reducing 
the phospholipid component of the spectrum. This method has been used as a 
confirmation study for its viability and does suggest good preservation properties with 
respect to low P, and high ATP levels (results not shown). However, for perfusions 
to be carried out at this temperature does reduce the physiological importance of the 
study. The fourth method is to use computer assisted processing packages which 
supposedly can remove this peak. Unfortunately, for this study the latter was the 
method of choice, however it became apparent that the computer program was not 
able to consistently remove the correct component associated with the phospholipid 
hump. Invariably large components associated with the ATP and PME resonances 
were removed along with the broad resonance. This produced spurious results not 
consistent with the observed changes. 
Page 266 
From the in vitro results it is likely that dose dependent increases of the PME and 
PDE reflect the relative flux of alanine through the gluconeogenic pathway. The 
increases are directly attributed to increases in 3-phosphoglycerate and 
phosphoenolpyruvate. It is interesting to note that conversion of pyruvate to PEP is 
catalysed by non-equilibrium reactions however, conversion of PEP to 2- 
phosphoglycerate and 3-phosphoglycerate are controlled by near equilibrium reactions 
which is followed by an ATP dependent reaction to 3-phosphoglyceroyl phosphate, 
see figure 45. From the in vitro perfusion study glucose outputs confirmed the 
influence of alanine on the gluconeogenic pathway. Infusion of 5.6 mmol/I alanine 
produced an hepatic glucose output of 0.551 ± 0.024 jumol/min/100g rat whereas 
perfusion with the addition of just glucagon or saline produced a negligible output of 
0.032 ± 0.004 Itmol/min/100g rat at the time point corresponding to maximal 
spectral changes (30-40 min. post infusion). Infusion of glucagon plus alanine did 
not produce any significant changes in hepatic glucose output which is consistent with 
the findings of Ross et al. (1967) in 48 h starved perfused livers. An attempt was 
made to perform liver perfusions within the horizontal bore magnet system to obtain 
simultaneous hepatic glucose output measurements with real time changes in the 
phosphorus spectrum, however various problems arose from the inherent difficulties 
associated with a horizontal magnet. The first major problem was maintaining the 
temperature of the perfusate prior to liver entry due to a tubing length of 8m being 
necessary between the perfusate box and the bore of the 4.7 T magnet. This distance 
was essential to prevent stray field lines affecting the perfusion apparatus (a 
stipulation enforced by the college). An elaborate heat transfer technique was applied 
involving water heated to 45*C running side by side with the perfusate tubing 
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maintaining the perfusate temperature at 37*C. However, a problem associated with 
prolonged heating caused denaturing of albumin which increased the pressure of the 
system due to liver blockage. A final problem also associated with distance required 
for the perfusate to flow which produced a general increase in the pressure of the 
system. The problems associated with the setup have now been rectified allowing 
NMR analysis and concurrent glucose output studies to be achieved in the 4.7 T 
horizontal bore magnet (but too late to use for this project). 
An interesting observation with respect to changes seen from the NMR analysis was 
the time course of the changes. Alanine did not produce maximal changes until 
approximately 30 - 40 min. post infusion. These observations were very similar to 
the changes associated with human alanine studies. The study by Dagnelie et aL 
(1992) showed increases in the PME which attained maximal levels at 35 - 45 min. 
post infusion of alanine (2.8 mmol/kg). It does seem surprising that maximal 
increases in the PME region do not occur quicker in the rat compared with humans 
since metabolic rates are far quicker. It would be interesting, therefore, to evaluate 
the time course that lactate might have on gluconeogenic intermediates. If increases 
in the PME attain maximal levels quicker using lactate then it could be assumed that 
the deamination/transamination reactions are rate limiting for gluconeogenesis. 
One of the major differences between the human and rat studies was the increase seen 
in the PiPL in this study. Dagnelie et al. (1992) suggested that the reduction in P, 
levels following alanine infusion could be due to loss of P, into the extracellular 
compartment or because of the extent of phosphorylation required for gluconeogenic 
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intermediates. Another possibility suggested was the movement of P, into NMR 
invisible pools due to no apparent differences seen in their in vitro extractions of 
liver. The study presented in this thesis shows quite clear increases in intracellular 
PipL together with concurrent declines in intracellular ATPPL (together with decreases 
in ATP: ADP ratios) which was confirmed from in vitro analysis. These changes 
could be due to a number of factors. Firstly, it must be noted that upon 
administration of glucagon, Pi and ADP: ATP levels exceed those in rats not infused 
with this hormone. This could be due to the membrane signalling mechanism via the 
stimulation of adenylate cyclase converting ATP to cyclic AMP (cAMP) thus 
releasing 2Pj, however this contribution is relatively small and not large enough to 
detect by NMR. Secondly, gluconeogenic flux requires both ATP and GTP, see 
flgure 45, which upon glucose production will liberate PI, adding to the intracellular 
pool. Thirdly, following deam i nation/transam i nation of alanine, ammonia and 
aspartate enter the urea cycle which has the effect of consuming 3 ATP and liberating 
four Pi molecules, however, in order for the cycle to complete, NADH is regenerated 
which should produce three molecules of ATP, therefore, producing a net ATP deficit 
of one. This would only be true once normal steady state had been achieved. 
However during gluconeogenesis, this pathway may be operating far quicker than the 
re-synthesis of ATP, hence producing an energy deficit. Another important area of 
consideration is the translocation of alanine into cells which can be achieved by a 
number of processes including carrier mechanisms (Guidotti et al., 1978) and by the 
-y-glutamyl cycle (Meister et al., 1981). The latter process converts the amino acid 
to -y-glutamyl-amino acid following the reaction with y-glutamylcysteinylglycine. 
This compound can then enter the cytosolic compartment from where it is cleaved by 
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-y-glutamylcyclotransferase to release the amino acid and 5-oxoproline. The latter 
compound is then re-synthesised to glutathione to complete the cycle. The 
translocation of one amino acid requires three ATP molecules and hence can be 
regarded as an expensive utiliser of energy rich phosphate. The net effect would be 
to reduce ATP: ADP ratios and increase intracellular P,. The dramatic changes 
associated with the Pi and ATP: ADP do appear to be clearly linked in this study. 
However, the discrepancy between this study and previous human studies with respect 
to Pi changes must be addressed. Even from the in vitro analysis of the livers it is 
apparent that P, levels do increase which supports the observations seen in vivo. One 
variation between the pathways of gluconeogenesis seen in humans and rats must be 
considered when relating changes seen in experiments with rats to those seen in 
humans. All human gluconeogenic enzymes are located in the cytosol, except for 
pyruvate carboxylase [EC. 6.4.1.1. ] which is found in the mitochondria. 
Phosphoenolpyruvate carboxykinase [EC. 4.1.1.31.1 is found both in mitochondria 
and the cYtosol. Conversion of oxaloacetate to PEP can be achieved within the 
mitochondria, after which PEP is transported to the cytosol presumably via the 
tricarboxylate mitochondrial carrier. This has consequences for the transfer of 
phosphate across the mitochondria and hence possible Pi "loss" in human 
gluconeogenic studies (Dagnelie et al., 1992). In the rat however, 
phosphoenolpyruvate carboxykinase is found only in the cytosoli This then requires 
the transport of oxaloacetate into the cytosol via its conversion to malate or aspartate. 
Conversion of oxaloacetate to malate involves the reduction of NADI to NADH, 
which is conveniently required for the conversion of 1,3 bis-phosphoglycerate to 3- 
phosphoglyceraldehyde during gluconeogenesis. 
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It appears, therefore, that increasing the alanine dose in vivo from 2.8 - 5.6 mmol/kg 
causes a fall in hepatic ATPPLand increase in PipL in rats whereas, at the maximum 
dose used in human studies (2.8 mmol/kg) Pi fell and ATP appeared to be unchanged 
(Dagnelie et al., 1992). Assuming that increasing the alanine infusion dose provokes 
an increase in gluconeogenesis then a possible explanation for this phenomenon is the 
increased demand on supply of ATP. A lower hepatic ATP has been observed 
previously in the perfused rat liver after a rapid transition of perfusate lactate 
concentration from 1-10 mmol/l, whereas in the presence of acidosis, which inhibits 
gluconeogenesis, ATP was unaffected (Iles et al., 1981). Complete disposal of 
alanine requires the urea cycle in addition to gluconeogenesis, since the nitrogen must 
be processed. Both of these pathways require ATP. Whatever the relative 
contributions of these pathways, under the conditions of these experiments, the 
normal balance between ATP synthesis and disposal is apparently altered. Further 
in vitro studies are required to determine whether the fall in ATP correlates with 
increases in gluconeogenic rate. 
This study has demonstrated the potential for the alanine/11P test in disease states 
which may show alterations in the gluconeogenic pathway. Further developments are 
required using `P NMR and concurrent liver perfusions, to directly assess the relative 
spectral changes to hepatic glucose output. It is quite clear from this study that 
spectral changes seen in vivo are secondary to the changes seen in 3-phosphoglycerate 
and PEP. A fundamental observation from this study was the decrease in ATP which 
directly relates the high demand on energy imposed by gluconeogenesis. Decreases 
in ATP levels however, may be species specific due to the high metabolic rate of rats 
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but are an important consideration if development to the human model are envisaged. 
If ATP decreases are present in humans then methods of absolute quantitation are 
required since using the B-ATP resonance as an internal standard would produce 
values of gluconeogenic flux far higher than the true value. Using alanine and NMR 
as a test for gluconeogenic changes in pathophysiological conditions could identify the 
key changes associated with diseases such as NIDDM. 
6.8. Future work., 
An important aspect of this work was to evaluate the possibility of using alanine/"P 
NMR as a test for gluconeogenic changes in disease states. A natural progression 
would therefore be to use a rat model of non insulin dependent diabetes which would 
be expected to give higher rates of gluconeogenesis than control rats. If these rats 
are then placed on therapy then the relative changes in the gluconeogenic flux could 
be monitored by `P NMR and correlated to the extent of treatment. The various 
treatments for NIDDM, such as the sulphonylurea drugs and metformin, can then be 
assessed which could provide an insight into producing new therapies. Other 
possibilities would be to use "C alanine as a precursor for the test, to assess the 
relative amount of 11C glycogen repleted. If a phosphorus/carbon coil could be made 
then inter-leaved phosphorus and carbon spectra could be acquired one after the other. 
This would provide a wealth of information on gluconeogenic changes together with 
glycogen synthesis ability of the liver. Hepatic perfusions within the horizontal 
magnet could also be performed where spectral changes can directly be correlated 
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with hepatic glucose outputs. It would also be interesting to see the time course of 
changes using lactate as the gluconeogenic precursor. It was apparent in this study 
that maximal changes were not seen until approximately 3040 min post alanine 
infusions. This could be due to slow intracellular transport of alanine or a rate 
limiting step at the level of transamination/deamination of the alanine prior to entry 
into the oxaloacetate pool. Since lactate can easily be converted to pyruvate, without 
the need of deamination, it is reasonable to assume an enhanced gluconeogenic rate. 
Other important points which must be addressed include the method of absolute 
quantitation of the phosphorus spectrum which in most studies relies on the 8 ATP 
resonance. However, in this study it is clear that ATP decreases upon alanine 
infusions in rats. If this is to be used on human patients then this problem must 
clearly be investigated. 
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